Processing 00000000.tx.1: A42-induced Increase in Neprilysin Is Associated with Prevention of Amyloid Plaque Formation in Vivo* M. 

Phrase: "A42-induced Increase in Neprilysin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "Is"

Phrase: "Associated with Prevention of Amyloid Plaque Formation"
Meta Candidates (Total=18; Excluded=2; Pruned=0; Remaining=16)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C0333463:amyloid plaque [Acquired Abnormality]
           plaque
   778   C2936349:Plaque, Amyloid [Acquired Abnormality]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011389:Plaque [Disease or Syndrome]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0199176:Prevention [Therapeutic or Preventive Procedure]
   748   C0220781:formation [Biologic Function]
   748   C0332461:Plaque [Finding]
   748   C0439634:formation [Spatial Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1522492:Formation [Functional Concept]
   748   C1706420:PREVENTION [Research Activity]
   748   C2700409:prevention [Qualitative Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in Vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "* M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.2: Hasan Mohajeri, M. 

Phrase: "Hasan Mohajeri,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.3: Axel Wollmer, and Roger M. 

Phrase: "Axel Wollmer,"

Phrase: "and"

Phrase: "Roger M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.4: Nitsch From the Division of Psychiatry Research, University of Zurich, August Forel Strasse 1,8008Zurich, Switzerland Received for publication, March 25,2002, and in revised form, June 19,2002  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Brain -amyloid plaques are principal targets for the development of treatments designed to slow the progression of Alzheimer's disease. 

Phrase: "Nitsch From the Division of Psychiatry Research,"

Phrase: "University of Zurich,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "August Forel Strasse 1,"

Phrase: "8008Zurich,"

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "March 25,"

Phrase: "2002,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "June 19,"

Phrase: "2002  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Brain -amyloid plaques"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
   901   C2936349:Plaques, Amyloid [Acquired Abnormality]
   793 E C0011389:Plaque [Disease or Syndrome]
   793 E C0332461:Plaque [Finding]

Phrase: "are"

Phrase: "principal targets for the development of treatments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1521840:Target [Functional Concept]
   714   C2986546:TARGET [Diagnostic Procedure]

Phrase: "designed to slow"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0439834:Slow [Qualitative Concept]
   756   C1707689:Design [Activity]
   756   C2983265:DESIGN [Intellectual Product]

Phrase: "the progression of Alzheimer's disease."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0242656:Disease Progression [Pathologic Function]
           progression
   797   C1947900:Disease progression NOS [Finding]
   760   C0449258:Progression [Functional Concept]
Processing 00000000.tx.5: Intracranial injections of synthetic -amyloid peptide (A42) in transgenic mice expressing the Alzheimer's disease-causing Swedish APP double mutations increased neuronal levels of neprilysin, a metalloendopeptidase that degrades A42 in vivo, on mRNA and protein level. 

Phrase: "Intracranial injections of synthetic -amyloid peptide"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0021485:injections [Therapeutic or Preventive Procedure]
   753   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
   753   C1828121:Injections [Functional Concept]
   719 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "(A42"

Phrase: ")"

Phrase: "in transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "the Alzheimer's disease-"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "Swedish APP double mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "neuronal levels of neprilysin,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "a metalloendopeptidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442934:Metalloendopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that"

Phrase: "degrades"

Phrase: "A42"

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "on mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "protein level."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0428479:Protein level [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.6: This increase was associated with significant reductions in brain levels of A and with almost complete prevention of amyloid plaque formation throughout the brain. 

Phrase: "This increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "associated with significant reductions"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0237881:significant [Quantitative Concept]
   770   C0301630:reductions [Natural Phenomenon or Process]
   770   C0441610:reductions [Therapeutic or Preventive Procedure]
   770   C0750502:Significant [Idea or Concept]
   770   C1546944:Significant [Qualitative Concept]
   737 E C0392756:Reduction [Qualitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in brain levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0441889:Levels [Qualitative Concept]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "of A"

Phrase: "and with almost"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "complete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Complete [Qualitative Concept]

Phrase: "prevention of amyloid plaque formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0199176:Prevention [Therapeutic or Preventive Procedure]
   760   C1706420:PREVENTION [Research Activity]
   760   C2700409:prevention [Qualitative Concept]

Phrase: "throughout the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.7: In addition, astrogliosis normally associated with amyloidosis was significantly reduced. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "astrogliosis normally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017639:Astrogliosis [Pathologic Function]

Phrase: "associated with amyloidosis"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0002726:Amyloidosis [Disease or Syndrome]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "was"

Phrase: "significantly"

Phrase: "reduced."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]
Processing 00000000.tx.8: Our results suggest that up-regulation of neprilysin in brain may represent an opportunity to reduce or prevent amyloid plaque formation in vivo.  

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that up-regulation of neprilysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "in brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "an opportunity to"

Phrase: "reduce"

Phrase: "or"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "amyloid plaque formation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   734   C0333463:amyloid plaque [Acquired Abnormality]
   734   C2936349:Plaque, Amyloid [Acquired Abnormality]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.9: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Alzheimer's disease (AD)1 is the most common cause of dementia in the elderly. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD)1"

Phrase: "is"

Phrase: "the most common cause of dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0015127:cause [Functional Concept]
   753   C1524003:Cause [Conceptual Entity]

Phrase: "in the elderly."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001792:Elderly [Population Group]
  1000   C1999167:elderly [Population Group]
Processing 00000000.tx.10: AD is characterized immunohistologically by the deposition of extracellular fibrillary -amyloid in brain, which is believed to be associated with impairment of neuronal functions and loss of neurons (1-3). 

Phrase: "AD"

Phrase: "is"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "immunohistologically by the deposition of extracellular fibrillary -amyloid"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   767   C0011560:Amyloid deposition [Pathologic Function]
           Amyloid
   767   C1705760:Amyloid Deposition [Finding]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0333562:Deposition [Functional Concept]
   744   C0521119:Extracellular [Cell Component]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "which"

Phrase: "is"

Phrase: "believed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated with impairment of neuronal functions"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   767   C1292719:Associated function [Functional Concept]
   753   C0521390:Neuronal [Immunologic Factor]
   753   C0542341:Functions [Functional Concept]
   753   C0684336:Impairment [Pathologic Function]
   719 E C0031843:function [Physiologic Function]
   719 E C0700205:FUNCTION [Classification]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1705273:Function [Intellectual Product]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "loss of neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0598940:Loss of neurons [Finding]
           neuron loss
   816 E C1850496:Neuronal loss [Finding]
   790   C1517945:Loss [Quantitative Concept]

Phrase: "(1-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.11: -Amyloid deposits are composed of several species of -amyloid peptides (A) including A42 that is deposited early and progressively in amyloid plaques. 

Phrase: "-Amyloid deposits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2936349:Amyloid Deposits [Acquired Abnormality]
   861   C0333562:Deposits [Functional Concept]

Phrase: "are"

Phrase: "composed of several species of -amyloid peptides"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1705920:Species [Conceptual Entity]

Phrase: "(A)"

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "A42"

Phrase: "that"

Phrase: "is"

Phrase: "deposited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:deposited [Functional Concept]

Phrase: "early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279919:Early [Temporal Concept]

Phrase: "and"

Phrase: "progressively in amyloid plaques."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
   833   C2936349:Plaques, Amyloid [Acquired Abnormality]
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737 E C0011389:Plaque [Disease or Syndrome]
   737 E C0332461:Plaque [Finding]
Processing 00000000.tx.12: Genetic evidence suggests that increased amounts of A42 are produced in many, if not all, genetic conditions that cause familial AD (4-7), suggesting that amyloid formation may be caused either by increased generation of A42, decreased degradation, or both (8). 

Phrase: "Genetic evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that increased amounts of A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]

Phrase: "are"

Phrase: "produced in many,"

Phrase: "if"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "all,"

Phrase: "genetic conditions"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   983   C0019247:Genetic Condition [Disease or Syndrome]
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "that"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "familial AD (4-7"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0015576:familial [Family Group]
   812   C0241888:Familial [Functional Concept]
   741 E C1704727:Family [Conceptual Entity]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that amyloid formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "may"

Phrase: "be"

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "either by increased generation of A42,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0079411:Generation [Temporal Concept]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C3146294:Generation [Activity]

Phrase: "decreased degradation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "or"

Phrase: "both"

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.13: Therefore, reducing A production in brain or the activation of mechanisms that accelerate its clearance from brain has become major targets for the development of drugs designed to reduce amyloid plaque formation and ameliorate AD pathology (1, 6, 9). 

Phrase: "Therefore,"

Phrase: "reducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reducing [Qualitative Concept]

Phrase: "A production in brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033268:production [Occupational Activity]

Phrase: "or"

Phrase: "the activation of mechanisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "that"

Phrase: "accelerate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "its clearance from brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0449297:Clearance [Qualitative Concept]
   770   C1382187:Clearance [Clinical Attribute]
   770   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "has"

Phrase: "become"

Phrase: "major targets for the development of drugs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0085104:drugs targets [Medical Device]
   714   C1521840:Target [Functional Concept]
   714   C2986546:TARGET [Diagnostic Procedure]

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reduce"

Phrase: "amyloid plaque formation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   734   C0333463:amyloid plaque [Acquired Abnormality]
   734   C2936349:Plaque, Amyloid [Acquired Abnormality]

Phrase: "and"

Phrase: "ameliorate"

Phrase: "AD pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "6,"

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.14: Experimental removal of A was achieved by immunization in mouse models of AD (10), but clinical immunizations are on hold because of the occurrence of meningoencephalitis. 

Phrase: "Experimental removal of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015252:Removal [Therapeutic or Preventive Procedure]
   770   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "achieved by immunization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   790   C0042196:immunisation [Therapeutic or Preventive Procedure]
   790   C3244291:immunization [Functional Concept]

Phrase: "in mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "models of AD (10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3161035:Model [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "clinical immunizations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0020971:Immunizations [Therapeutic or Preventive Procedure]
   827 E C0042196:immunization [Therapeutic or Preventive Procedure]
   827 E C3244291:immunization [Functional Concept]

Phrase: "are"

Phrase: "on"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720176:On [Functional Concept]
  1000   C1720294:On [Intellectual Product]

Phrase: "hold because of the occurrence of meningoencephalitis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0025309:Meningoencephalitis [Disease or Syndrome]
   748   C0243132:occurrence [Functional Concept]
   748   C1553387:Hold [Idea or Concept]
   748   C1554210:occurrence [Idea or Concept]
   748   C1948035:Hold [Activity]
   748   C2745955:Occurrence [Temporal Concept]
Processing 00000000.tx.15: Alternatively, the activation of proteases involved in A degradation could contribute to A removal from the brain. 

Phrase: "Alternatively,"

Phrase: "the activation of proteases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "involved in A degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]
   770   C1314939:Involved [Functional Concept]

Phrase: "could"

Phrase: "contribute to A removal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0015252:Removal [Therapeutic or Preventive Procedure]
   770   C0728940:Removal [Therapeutic or Preventive Procedure]
   770   C1880177:Contribute [Activity]

Phrase: "from the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.16: Such proteases include insulin-degrading enzyme (IDE) (11), metalloendopeptidase (EC 3.4.24.15) (12), and neprilysin (NEP) also known as neutral endopeptidase (EC 3.4.24.11) (1). 

Phrase: "Such proteases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Proteases [Enzyme]

Phrase: "include insulin-degrading enzyme (IDE)"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0332257:include [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1552866:include [Idea or Concept]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C2700399:Include [Activity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(11"

Phrase: ")"

Phrase: ","

Phrase: "metalloendopeptidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442934:Metalloendopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(EC 3.4.24.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "(12"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "neprilysin (NEP) also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "known as neutral endopeptidase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0025250:Neutral Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1366499:neutral endopeptidase [Gene or Genome]
   770   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C0205309:Known [Qualitative Concept]
   770   C1882074:Neutral [Qualitative Concept]
   770   C2825492:Neutral [Phenomenon or Process]

Phrase: "(EC 3.4.24.11"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.17: Among these enzymes, only NEP was shown to degrade A42 in vivo (1). 

Phrase: "Among these enzymes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014442:Enzymes [Enzyme,Organic Chemical]
  1000   C0014445:enzymes [Functional Concept]

Phrase: "only NEP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "degrade"

Phrase: "A42"

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.18: NEP is a 94-kDa type 2membrane-bound Zn-metallopeptidase implicated in inactivation of several biologically active peptides including enkephalins, tachykinins, bradykinin, endothelins, and atrial natriuretic peptide (13-16). 

Phrase: "NEP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "is"

Phrase: "a 94-kDa type 2membrane-bound Zn-metallopeptidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0025543:Metallopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "implicated in inactivation of several biologically active peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   744   C0205177:Active [Functional Concept]
   744   C0205460:Biologically [Qualitative Concept]
   744   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "enkephalins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014298:Enkephalins [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "tachykinins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039241:Tachykinins [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]

Phrase: "bradykinin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006100:Bradykinin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1537501:bradykinin [Gene or Genome]

Phrase: "endothelins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079284:Endothelins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2984383:Endothelins [Functional Concept]

Phrase: "and"

Phrase: "atrial natriuretic peptide"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   901   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   827   C0018792:Atrial [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0597421:natriuretic [Pharmacologic Substance]
   755 E C0524422:atria [Body Part, Organ, or Organ Component]
   755 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: "(13-16"

Phrase: ")."
Processing 00000000.tx.19: NEP is present in peptidergic neurons in the central nervous system (14, 15), and its expression in brain is regulated in a cell-specific manner. 

Phrase: "NEP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "is"

Phrase: "present in peptidergic neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "in the central nervous system"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0927232:Central Nervous System [Body System]
  1000   C1269563:Central nervous system [Body System]
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0205099:Central [Spatial Concept]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   827   C1879652:Central - [Laboratory Procedure]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "(14,"

Phrase: "15"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "its expression in brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "regulated in a cell-specific manner."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0007634:Cell [Cell]
   753   C0205369:Specific [Qualitative Concept]
   753   C0851285:Regulated [Governmental or Regulatory Activity]
   753   C1269647:Cell [Cell]
   753   C1552740:specific [Intellectual Product]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.20: Although type 2NEP transcripts are absent from the central nervous system, types 1and 3transcripts are localized in neurons and in oligodendrocytes of the corpus callosum, respectively (16, 17). 

Phrase: "Although"

Phrase: "type 2NEP transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "absent from the central nervous system,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:Absent [Quantitative Concept]
   753   C2699517:ABSENT [Finding]

Phrase: "types 1and 3transcripts"

Phrase: "are"

Phrase: "localized in neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0027882:Neurons [Cell]
   790   C0392752:Localized [Spatial Concept]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and in oligodendrocytes of the corpus callosum,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   778   C0010090:Corpus Callosum [Body Part, Organ, or Organ Component]
   774 E C0152320:callosum corpus [Body Part, Organ, or Organ Component]
   748   C0028944:Oligodendrocytes [Cell]
   748   C0227813:Corpus [Body Part, Organ, or Organ Component]
   748   C1515981:And [Idea or Concept]

Phrase: "respectively"

Phrase: "(16,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.21: To characterize mechanisms involved in A clearance in vivo, we injected aggregated A42 into brains of 11-week-old transgenic mice that expressed the disease-causing Swedish double mutation of APP (SwAPP) under the control of the hamster PrP promoter as well as into non-transgenic littermates (18, 19). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "characterize"

Phrase: "mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "involved in A clearance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0449297:Clearance [Qualitative Concept]
   770   C1314939:Involved [Functional Concept]
   770   C1382187:Clearance [Clinical Attribute]
   770   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "we"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "aggregated A42 into brains of 11-week-old transgenic mice"

Phrase: "that"

Phrase: "expressed"

Phrase: "the disease-causing Swedish double mutation of APP (SwAPP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   784   C2985434:Disease-causing Mutation [Cell or Molecular Dysfunction]
   742   C0026882:Mutation [Genetic Function]
   742   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: ")"

Phrase: "under the control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "of the hamster PrP promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "as well as into non-transgenic littermates"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0003069:Transgenic [Animal]
   748   C0205170:Well [Qualitative Concept]
   748   C1518422:Non [Functional Concept]
   748   C3146287:Well [Manufactured Object]

Phrase: "(18,"

Phrase: "19"

Phrase: ")."
Processing 00000000.tx.22: At this age, our SwAPP mice had not developed amyloid plaques (18, 19). 

Phrase: "At this age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "our SwAPP mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "had"

Phrase: "not developed amyloid plaques"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
   861   C2936349:Plaques, Amyloid [Acquired Abnormality]
   779 E C0011389:Plaque [Disease or Syndrome]
   779 E C0332461:Plaque [Finding]

Phrase: "(18,"

Phrase: "19"

Phrase: ")."
Processing 00000000.tx.23: We report here that A42 aggregates caused sustained increases in brain levels of NEP and that these increases were associated with dramatically reduced brain concentrations of A as well as with prevention of brain amyloid plaque formation and reduced astrogliosis.  

Phrase: "We"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "here"

Phrase: "that A42 aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "sustained increases in brain levels of NEP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:increases [Functional Concept]

Phrase: "and"

Phrase: "that"

Phrase: "these increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:increases [Functional Concept]

Phrase: "were"

Phrase: "associated with dramatically reduced brain concentrations of A"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   750   C0424099:Reduced concentration [Finding]
   744   C0006104:Brain [Body Part, Organ, or Organ Component]
   744   C0086045:Concentrations [Mental Process]
   744   C0392756:Reduced [Qualitative Concept]
   744   C1269537:Brain [Body Part, Organ, or Organ Component]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1446561:Concentration [Quantitative Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "as well as with prevention of brain amyloid plaque formation"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   760   C0333463:amyloid plaque [Acquired Abnormality]
           plaque
   760   C2936349:Plaque, Amyloid [Acquired Abnormality]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0006104:Brain [Body Part, Organ, or Organ Component]
   739   C0011389:Plaque [Disease or Syndrome]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0199176:Prevention [Therapeutic or Preventive Procedure]
   739   C0205170:Well [Qualitative Concept]
   739   C0220781:formation [Biologic Function]
   739   C0332461:Plaque [Finding]
   739   C0439634:formation [Spatial Concept]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1269537:Brain [Body Part, Organ, or Organ Component]
   739   C1522492:Formation [Functional Concept]
   739   C1706420:PREVENTION [Research Activity]
   739   C2700409:prevention [Qualitative Concept]
   739   C3146287:Well [Manufactured Object]

Phrase: "and"

Phrase: "reduced astrogliosis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017639:Astrogliosis [Pathologic Function]
Processing 00000000.tx.24: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Animals-- Transgenic mice expressing the AD-causing Swedish double mutant of the human APP (SwAPP) were generated and bred as described previously (18, 19). 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "--"

Phrase: "Transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "the AD-"

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "Swedish double mutant of the human APP (SwAPP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: ")"

Phrase: "were"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "and"

Phrase: "bred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0006159:breed [Organism Function]
   966   C1704650:Breed [Classification]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(18,"

Phrase: "19"

Phrase: ")."
Processing 00000000.tx.25: All mice used in this study were the progeny of a single SwAPP male cross-bred to non-transgenic (non-tg) littermates. 

Phrase: "All mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "used in this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "the progeny of a single SwAPP male"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0680063:Progeny [Family Group]

Phrase: "cross-bred to non-transgenic (non-tg) littermates."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C2828360:Cross [Conceptual Entity]
   719   C0006159:breed [Organism Function]
   719   C1704650:Breed [Classification]
Processing 00000000.tx.26: The colony was housed under a light cycle of 12h with dry food and water ad libitum. 

Phrase: "The colony"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439158:colony [Quantitative Concept]
  1000   C1947989:Colony [Cell]

Phrase: "was"

Phrase: "housed under a light cycle of 12h"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   778   C2718082:Light Cycle [Temporal Concept]
   748   C0020056:Housed [Manufactured Object]
   748   C0023693:Light [Natural Phenomenon or Process]
   748   C0456695:/12h [Temporal Concept]
   748   C1306462:Light [Functional Concept]
   748   C1511572:Cycle [Temporal Concept]
   748   C1881376:Light [Qualitative Concept]
   714 E C0442519:house [Conceptual Entity]
   714 E C2003847:House [Manufactured Object]

Phrase: "with dry food"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1305741:Dry food [Food]
   861   C0016452:Food [Food]

Phrase: "and"

Phrase: "water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]

Phrase: "ad libitum."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879743:ad libitum [Qualitative Concept]
Processing 00000000.tx.27: The presence of the transgene was determined by PCR on genomic DNA isolated from tail biopsies using specific primers 5'-GTG GAT AAC CCC TCC CCC AGC CTA GAC CA-3' and 5'-CTG ACC ACT CGA CCA GGT TCT GGG T-3' to the transgene (18). 

Phrase: "The presence of the transgene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "determined by PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]

Phrase: "on genomic DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017428:Genomic [Gene or Genome]
   861   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "isolated from tail biopsies"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0005558:biopsies [Diagnostic Procedure]
   770   C0039259:Tail [Body Part, Organ, or Organ Component]
   770   C0205409:Isolated [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0220797:biopsy [Functional Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "specific primers 5'-GTG GAT AAC CCC TCC CCC AGC CTA GAC CA-3'"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   786   C0061145:GAT [Amino Acid, Peptide, or Protein]
   786   C0077072:TCC [Organic Chemical,Pharmacologic Substance]
   786   C0205369:Specific [Qualitative Concept]
   786   C1167383:TCC [Cell Component]
   786   C1422172:GAT [Gene or Genome]
   786   C1455888:AGC [Cell]
   786   C1552740:specific [Intellectual Product]
   786   C1861305:TCC [Disease or Syndrome]
   786   C3540513:CTA [Gene or Genome]
   752   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "5'-CTG ACC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0175754:ACC [Congenital Abnormality,Disease or Syndrome]
   827   C0282160:ACC [Congenital Abnormality]
   827   C3541413:ACC [Gene or Genome]

Phrase: "ACT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "CGA CCA GGT TCT GGG T-3'"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   795   C0220668:CCA [Congenital Abnormality]
   795   C0677634:TCT [Laboratory Procedure]
   795   C1415053:GGT [Gene or Genome]
   795   C3539168:CGA [Disease or Syndrome]

Phrase: "to the transgene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282641:Transgene [Gene or Genome]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.28: Fibrillar aggregated synthetic A42 was prepared by resuspending lyophilized A42 (Bachem) in phosphate-buffered saline (PBS), pH 7.4,by shaking for 48h at 37C. 

Phrase: "Fibrillar aggregated synthetic A42"

Phrase: "was"

Phrase: "prepared by resuspending lyophilized A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1521827:Prepare [Functional Concept]

Phrase: "(Bachem"

Phrase: ")"

Phrase: "in phosphate-buffered saline (PBS),"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "by shaking"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040822:Shaking [Sign or Symptom]
   966 E C1883023:Shake [Activity]

Phrase: "for 48h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]

Phrase: "at 37C."
Processing 00000000.tx.29: At 11weeks of age, SwAPP (n=5) and non-tg littermates (n=4) were anesthetized, 1l of fibrillar A42 (350M stock concentration) was stereotaxically injected unilaterally into the parietal cortex 1.7-mm anterior, 1-mm lateral, and 1-mm ventral to the bregma above the hippocampus within 1min (20). 

Phrase: "At 11weeks"

Phrase: "of age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "SwAPP"

Phrase: "(n=5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "non-tg littermates"

Phrase: "(n=4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "anesthetized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720436:Anesthetized [Finding]

Phrase: ","

Phrase: "1l of fibrillar A42"

Phrase: "(350M stock concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: ")"

Phrase: "was"

Phrase: "stereotaxically"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "unilaterally"

Phrase: "into the parietal cortex 1.7-mm anterior, 1-mm"

Phrase: "lateral,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205093:Lateral [Spatial Concept]

Phrase: "and"

Phrase: "1-mm"

Phrase: "ventral to the bregma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704448:Ventral [Spatial Concept]

Phrase: "above the hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "within 1min"

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.30: After the injection, the needle was left in place for one more minute and then was slowly withdrawn over a period of 1min. 

Phrase: "After the injection,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021485:injection [Therapeutic or Preventive Procedure]
  1000   C1272883:Injection [Biomedical or Dental Material]
  1000   C1533685:Injection [Therapeutic or Preventive Procedure]
  1000   C1828121:Injection [Functional Concept]

Phrase: "the needle"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027551:Needle [Medical Device]
  1000   C1704318:Needle [Medical Device]
  1000   C1882041:Needle [Spatial Concept]

Phrase: "was"

Phrase: "left in place"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0205091:Left [Spatial Concept]
   790   C0442504:Place [Spatial Concept]
   790   C1552822:left [Functional Concept]
   790   C1704765:Place [Functional Concept]
   790   C1882509:Place [Activity]
   790   C3496241:place [Disease or Syndrome]

Phrase: "for one more minute"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0439232:minute [Temporal Concept]
   827   C0700321:minute [Quantitative Concept]
   827   C0702093:/minute [Temporal Concept]
   827   C1282918:Minute [Quantitative Concept]
   827   C2347166:Minute [Quantitative Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "was"

Phrase: "slowly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439834:Slowly [Qualitative Concept]

Phrase: "withdrawn over a period of 1min."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0424092:Withdrawn [Finding]
   753   C0439531:/period [Temporal Concept]
   753   C1948053:Period [Temporal Concept]
   753   C2349954:Withdrawn [Activity]
   753   C2825032:Withdrawn [Mental or Behavioral Dysfunction]
Processing 00000000.tx.31: Control groups consisted of SwAPP mice and non-tg mice that received PBS injections (n=4each). 

Phrase: "Control groups"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
  1000   C0009932:Control Groups [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1550141:Control [Substance]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "consisted of SwAPP mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   737   C0332529:CONSIST [Qualitative Concept]

Phrase: "and"

Phrase: "non-tg mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0025936:Mice, Transgenic [Mammal]
   896   C1513853:NON Mouse [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "that received PBS injections"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0021485:injections [Therapeutic or Preventive Procedure]
   804   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
   804   C1828121:Injections [Functional Concept]
   771 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "(n=4each"

Phrase: ")."
Processing 00000000.tx.32: In a second set of experiments, we used C57BL/6 mice purchased from RCC Ltd. 

Phrase: "In a second"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "set of experiments,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0036849:Set [Mental Process]
   790   C0681814:Experiments [Research Activity]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]
   756 E C1706386:Experiment [Conceptual Entity]
   706 E C1517586:Experimental [Qualitative Concept]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "C57BL/6 mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   988   C1521751:C57BL/6 Mouse [Mammal]
           C57BL/6
   913   C0025921:Mice, C57BL [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "purchased from RCC Ltd."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0869011:purchased [Activity]
   770   C1136140:LTD [Organ or Tissue Function]
Processing 00000000.tx.33: Biotechnology &Animal Breeding (Fllingsdorf, Switzerland) at the age of 6weeks and housed for 5weeks in our animal facility. 

Phrase: "Biotechnology &Animal Breeding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0178477:Animal Breeding [Occupational Activity]
   827   C0006159:Breeding [Organism Function]

Phrase: "(Fllingsdorf,"

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")"

Phrase: "at the age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "of 6weeks"

Phrase: "and"

Phrase: "housed for 5weeks"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0020056:Housed [Manufactured Object]
   756 E C0442519:house [Conceptual Entity]
   756 E C2003847:House [Manufactured Object]

Phrase: "in our animal facility."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0872329:animal facility [Manufactured Object]
   861   C1547538:Facility [Idea or Concept]
Processing 00000000.tx.34: At 11weeks of age, these mice received bilateral injections of A42, reversed A42-peptide (A42R, Bachem, aggregated as described for A42), bovine serum albumin (BSA, 1.61mg/ml), or PBS as described above and were sacrificed 1,3,12,and 20weeks post-injection for combined analysis of mRNA and protein levels (n=4for each group and time). 

Phrase: "At 11weeks"

Phrase: "of age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "these mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "bilateral injections of A42,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0021485:injections [Therapeutic or Preventive Procedure]
   770   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
   770   C1828121:Injections [Functional Concept]
   737 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "reversed A42-peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(A42R,"

Phrase: "Bachem,"

Phrase: "aggregated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332621:Aggregated [Functional Concept]
   966 E C0205418:Aggregate [Qualitative Concept]

Phrase: "as"

Phrase: "described for A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "bovine serum albumin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   901   C0728877:serum albumin [Laboratory or Test Result]
   827   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0007452:Bovine [Mammal]
   827   C0229671:Serum [Body Substance]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "(BSA,"

Phrase: "1.61mg/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "PBS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "as"

Phrase: "described above"

Phrase: "and"

Phrase: "were"

Phrase: "sacrificed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0681205:Sacrifice [Idea or Concept]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "12,"

Phrase: "and"

Phrase: "20weeks"

Phrase: "post-injection for combined analysis of mRNA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0021485:injection [Therapeutic or Preventive Procedure]
   748   C0687676:Post [Temporal Concept]
   748   C1272883:Injection [Biomedical or Dental Material]
   748   C1533685:Injection [Therapeutic or Preventive Procedure]
   748   C1704687:Post [Manufactured Object]
   748   C1828121:Injection [Functional Concept]

Phrase: "and"

Phrase: "protein levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   966   C0428479:Protein level [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "(n=4for"

Phrase: "each group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.35: Tissue Preparation-- For combined A-ELISA and immunohistochemistry, SwAPP and non-tg littermates injected with A42 aggregates or PBS were deeply anesthetized 20weeks following the injections by intraperitoneal injection of a mixture containing 60g/g Ketaminol (Veterina, Zurich, Switzerland) and 20g/g Rompun (Provet, Lyssach, Switzerland) body weight and were perfused transcardially using ice-cold PBS, pH 7.4,followed by 4% paraformaldehyde and post-fixed in the same solution overnight. 

Phrase: "Tissue Preparation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0200728:Tissue Preparation [Laboratory Procedure]
   861   C0455052:Preparation [Health Care Activity]
   861   C1521827:Preparation [Functional Concept]

Phrase: "-"

Phrase: "-"

Phrase: "For combined A-ELISA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0014441:ELISA [Laboratory Procedure]

Phrase: "and"

Phrase: "immunohistochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021044:Immunohistochemistry [Laboratory Procedure]

Phrase: "SwAPP"

Phrase: "and"

Phrase: "non-tg littermates"

Phrase: "injected with A42 aggregates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205418:aggregates [Qualitative Concept]
   737   C1720154:Inject [Functional Concept]

Phrase: "or"

Phrase: "PBS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "deeply anesthetized 20weeks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0475747:Deeply anaesthetised [Finding]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the injections by intraperitoneal injection of a mixture containing 60g/g Ketaminol"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   751   C0021493:Injections, Intraperitoneal [Therapeutic or Preventive Procedure]
   736   C0021485:injections [Therapeutic or Preventive Procedure]
   736   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
   736   C1828121:Injections [Functional Concept]
   703 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "(Veterina,"

Phrase: "Zurich,"

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "20g/g Rompun"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0947699:Rompun [Organic Chemical,Pharmacologic Substance]

Phrase: "(Provet,"

Phrase: "Lyssach,"

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")"

Phrase: "body weight"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0005910:Body Weight [Organism Attribute]
           weight
  1000   C1305866:body weight [Diagnostic Procedure]
           weight
   861   C0043100:Weight [Quantitative Concept]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   861   C1705104:Weight [Idea or Concept]
   777 E C1995017:Bodies [Cell Component]

Phrase: "and"

Phrase: "were"

Phrase: "perfused"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1549542:Perfuse [Functional Concept]

Phrase: "transcardially"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ice-cold PBS,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   823   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   804   C0031701:phosphate [Organophosphorus Compound]
   804   C0036082:Saline [Substance]
   804   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "followed by 4% paraformaldehyde"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "post-fixed in the same solution overnight."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0037633:Solution [Substance]
   748   C0231441:Fixed [Finding]
   748   C0439583:Overnight [Temporal Concept]
   748   C0443218:Fixed [Qualitative Concept]
   748   C0445247:Same [Qualitative Concept]
   748   C0525069:Solution [Biomedical or Dental Material]
   748   C0687676:Post [Temporal Concept]
   748   C1704687:Post [Manufactured Object]
   748   C2827483:Fixed [Body Substance]
Processing 00000000.tx.36: Tissue was washed several times in PBS, and the caudal parts of the brains reaching from interaural 0to 1 excluding the cerebellum (20) were dissected and prepared for A-ELISA. 

Phrase: "Tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]

Phrase: "was"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "several times in PBS,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "the caudal parts of the brains"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   798   C0445620:Part of brain [Body Location or Region]
           brain parts
   773   C1292711:Part of [Spatial Concept]
   753   C0449719:parts [Spatial Concept]
   753   C1709471:PARTS [Quantitative Concept]

Phrase: "reaching from interaural 0to 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2584321:Reaching [Organism Function]

Phrase: "excluding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0332196:Exclude [Functional Concept]
   966   C2828389:Exclude [Activity]

Phrase: "the cerebellum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]

Phrase: "(20"

Phrase: ")"

Phrase: "were"

Phrase: "dissected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205239:dissected [Functional Concept]

Phrase: "and"

Phrase: "prepared for A-ELISA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0014441:ELISA [Laboratory Procedure]
   737   C1521827:Prepare [Functional Concept]
Processing 00000000.tx.37: The remaining parts of the brain containing both hippocampi were embedded in paraffin and processed for IHC. 

Phrase: "The remaining parts of the brain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   809   C0445620:Part of brain [Body Location or Region]
           brain parts
   773   C1292711:Part of [Spatial Concept]
   753   C0449719:parts [Spatial Concept]
   753   C1709471:PARTS [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "both hippocampi"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "embedded in paraffin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0085185:embedded paraffin [Laboratory Procedure]
   790   C0030415:Paraffin [Biomedical or Dental Material,Lipid]
   790   C1707903:Embedded [Laboratory Procedure]

Phrase: "and"

Phrase: "processed for IHC."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0021044:IHC [Laboratory Procedure]
   790   C1522240:Processed [Phenomenon or Process]
   756 E C1184743:Process [Body Part, Organ, or Organ Component]
Processing 00000000.tx.38: 5-m thick paraffin sections were probed with antibodies against A (4G8 and 6E10, Serotec; 6H1 and 9G10, Evotec), NEP, IDE, angiotensin-converting enzyme (ACE), 24.15protein, and GFAP according to providers' protocols and counterstained with Nuclear Fast Red (Sigma). 

Phrase: "5-m thick paraffin sections"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0030415:Paraffin [Biomedical or Dental Material,Lipid]
   771   C0205155:Section [Spatial Concept]
   771   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   771   C1522472:Section [Substance]
   771   C1552923:Section [Quantitative Concept]
   771   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "probed with antibodies"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   756   C0182400:Probe [Medical Device]
   756   C1704681:Probe [Gene or Genome]
   756   C2347609:Probe [Chemical Viewed Functionally]
   756   C3536729:Probe [Manufactured Object]

Phrase: "against A (4G8"

Phrase: "and"

Phrase: "6E10,"

Phrase: "Serotec"

Phrase: "; 6H1"

Phrase: "and"

Phrase: "9G10,"

Phrase: "Evotec"

Phrase: ")"

Phrase: ","

Phrase: "NEP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "IDE,"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0332257:include [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1552866:include [Idea or Concept]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C2700399:Include [Activity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "angiotensin-converting enzyme (ACE),"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "24.15protein,"

Phrase: "and"

Phrase: "GFAP according to providers' protocols"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017626:GFAP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1415042:GFAP [Gene or Genome]

Phrase: "and"

Phrase: "counterstained with Nuclear Fast Red (Sigma"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0303913:nuclear fast red [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0015663:Fast [Finding]
   753   C0332575:Red [Finding]
   753   C0456962:Fast [Qualitative Concept]
   753   C0521447:Nuclear [Spatial Concept]
   753   C1260956:Red [Qualitative Concept]
   753   C1719918:Sigma [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.39: For combined Western blotting and reverse transcription-PCR, mice were killed and the frontal parts of the brain containing interaural region 6-4 were processed immediately for RNA isolation. 

Phrase: "For combined Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   884 E C0949466:Western Blot [Laboratory Procedure]
   827   C1705493:Western [Spatial Concept]

Phrase: "and"

Phrase: "reverse transcription-PCR,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0677874:pCR [Finding]
   734   C0035380:Reverse Transcription [Genetic Function]

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "killed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:killed [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]

Phrase: "and"

Phrase: "the frontal parts of the brain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   809   C0445620:Part of brain [Body Location or Region]
           brain parts
   773   C1292711:Part of [Spatial Concept]
   753   C0449719:parts [Spatial Concept]
   753   C1709471:PARTS [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "interaural region 6-4"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]

Phrase: "were"

Phrase: "processed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522240:Processed [Phenomenon or Process]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "immediately for RNA isolation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0204727:Isolation [Therapeutic or Preventive Procedure]
   770   C0205409:Isolation [Functional Concept]
   770   C0205548:Immediately [Temporal Concept]
   770   C0220862:isolation [Laboratory Procedure]
Processing 00000000.tx.40: The rest of the brains excluding the cerebellum were homogenized in lysis buffer containing 250mM sucrose, 10mM Tris, 1% Triton X-100, 1% SDS, and 1 Complete proteinase inhibitor mixture, pH=8(Roche Molecular Biochemicals), for Western blotting as described previously (1). 

Phrase: "The rest of the brains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035253:Rest [Daily or Recreational Activity]
   760   C1622890:ResT [Molecular Function]

Phrase: "excluding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0332196:Exclude [Functional Concept]
   966   C2828389:Exclude [Activity]

Phrase: "the cerebellum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]

Phrase: "were"

Phrase: "homogenized in lysis buffer containing 250mM sucrose,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0024348:Lysis [Pathologic Function]
   748   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0332256:Containing [Functional Concept]
   748   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]
   748   C1536403:lysis [Cell Function]
   748   C2700400:Containing [Activity]

Phrase: "10mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   861   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   861   C0814229:TRI [Intellectual Product]

Phrase: "1% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: "1% SDS,"

Phrase: "and"

Phrase: "1 Complete proteinase inhibitor mixture,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0439962:Mixture [Substance]

Phrase: "pH=8"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "(Roche Molecular Biochemicals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0205474:Biochemical [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "for Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.41: Total RNA was isolated by the peqGOLD RNAPureTM kit (Axon Laboratories) according to the manufacturer's protocol. 

Phrase: "Total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "isolated by the peqGOLD RNAPureTM kit (Axon Laboratories"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   744   C0004461:Axon [Cell Component]
   744   C0022877:Laboratories [Manufactured Object,Organization]
   744   C0205409:Isolated [Functional Concept]
   744   C0812225:KIT [Medical Device]
   744   C1150635:KIT [Molecular Function]
   744   C1548221:Isolated [Idea or Concept]
   744   C1619828:Laboratories [Intellectual Product]
   744   C1705212:Kit [Medical Device]
   744   C1705213:KIT [Medical Device]
   744   C3273202:Kit [Manufactured Object]
   711 E C0370215:Isolate [Substance]
   711 E C1875400:ISOLATE [Pharmacologic Substance]
   711 E C3244292:laboratory [Functional Concept]

Phrase: ")"

Phrase: "according to the manufacturer's protocol."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.42: NEP mRNA levels were determined by quantitative real time reverse transcription-PCR performed on total RNA in the LightCycler (Roche Diagnostics) using the NEP-specific primers 5'-TAA GCA GCC TCA GCC GAA ACT ACA A-3' and 5'-GAC TAC AGC TGC TCC ACT TAT CCA CTC A-3' and CYBRGreen (Roche Molecular Biochemicals) in the reaction mixture. 

Phrase: "NEP mRNA levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "determined by quantitative real time reverse transcription-PCR"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   793   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   770   C0035380:Reverse Transcription [Genetic Function]
   770   C1550177:Real Time [Idea or Concept]
   744   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0040223:Time [Temporal Concept]
   744   C0040649:Transcription [Genetic Function]
   744   C0237400:Real [Qualitative Concept]
   744   C0392762:Quantitative [Quantitative Concept]
   744   C0677874:pCR [Finding]
   744   C1555029:Reverse [Idea or Concept]
   744   C3272377:REAL [Intellectual Product]
   744   C3541383:Time [Temporal Concept]

Phrase: "performed on total RNA"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0439175:% total [Quantitative Concept]
   770   C0439810:Total [Qualitative Concept]
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "in the LightCycler"

Phrase: "(Roche Diagnostics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011900:Diagnostic [Finding]
   827   C0348026:Diagnostic [Functional Concept]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the NEP-specific primers 5'-TAA GCA GCC TCA GCC GAA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1414899:GAA [Gene or Genome]

Phrase: "ACT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "ACA A-3'"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0149561:ACA [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "5'-GAC TAC AGC TGC TCC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0077072:TCC [Organic Chemical,Pharmacologic Substance]
   799   C1167383:TCC [Cell Component]
   799   C1861305:TCC [Disease or Syndrome]

Phrase: "ACT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "TAT CCA CTC A-3'"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0220668:CCA [Congenital Abnormality]

Phrase: "and"

Phrase: "CYBRGreen"

Phrase: "(Roche Molecular Biochemicals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0205474:Biochemical [Functional Concept]

Phrase: ")"

Phrase: "in the reaction mixture."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:Mixture [Substance]
Processing 00000000.tx.43: As a standard, mRNA levels of -actin was amplified in same samples using 5'-TGG AAC GGT GAA GGT GAC A-3' and 5'-GGC AAG GGA CTT CCT GTA A-3' primers. 

Phrase: "As a standard,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1442989:Standard [Qualitative Concept]
  1000   C2828392:Standard [Intellectual Product]

Phrase: "mRNA levels of -actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   741 E C0439681:Actinic [Qualitative Concept]

Phrase: "was"

Phrase: "amplified in same samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0445247:Same [Qualitative Concept]
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "5'-TGG AAC GGT GAA GGT GAC A-3'"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   791   C0439084:>5 [Quantitative Concept]
   791   C0728893:+5 [Quantitative Concept]
   791   C1414899:GAA [Gene or Genome]
   791   C1415053:GGT [Gene or Genome]

Phrase: "and"

Phrase: "5'-GGC AAG GGA CTT CCT GTA A-3' primers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.44: The levels of NEP mRNA were normalized to the corresponding amount of -actin mRNA in each mouse. 

Phrase: "The levels of NEP mRNA"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "normalized to the corresponding amount of -actin mRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C1265611:Amount [Quantitative Concept]
   744   C1882115:Normalized [Research Activity]

Phrase: "in each mouse."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]
Processing 00000000.tx.45: The average was calculated for each group and compared with levels of uninjected mice for each time point. 

Phrase: "The average"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1510992:Average [Quantitative Concept]
  1000   C2825518:AVERAGE [Quantitative Concept]

Phrase: "was"

Phrase: "calculated for each group"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0441833:Group [Idea or Concept]
   770   C0444686:Calculated [Functional Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1441506:Calculated [Activity]
   770   C1443182:Calculated [Laboratory Procedure]
   770   C1552516:Group [Health Care Related Organization]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "compared with levels of uninjected mice"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0441889:Levels [Qualitative Concept]
   753   C1707455:Compared [Activity]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "for each time point."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C2348792:Time Point [Temporal Concept]
   861   C0040223:Time [Temporal Concept]
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.46: Western Blot Analysis-- Protein concentration of brain extracts were determined with the Bradford protein assay (Bio-Rad), and equal amounts of protein (50g) were loaded to each lane of a Novex 10-20% Tricine/SDS-PAGE (Invitrogen). 

Phrase: "Western Blot Analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]

Phrase: "--"

Phrase: "Protein concentration of brain extracts"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0427716:Protein concentration [Laboratory Procedure]
   806   C1304757:Protein concentration [Laboratory or Test Result]
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]
   745   C1720005:Concentrated extract [Biomedical or Dental Material]

Phrase: "were"

Phrase: "determined with the Bradford protein assay"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0005507:Assay [Laboratory Procedure]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0243073:assay [Qualitative Concept]
   753   C1510438:Assay [Laboratory Procedure]

Phrase: "(Bio-Rad"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "equal amounts of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "(50g"

Phrase: ")"

Phrase: "were"

Phrase: "loaded to each lane"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C1708639:Lane [Spatial Concept]
   770   C1708715:Loaded [Activity]
   737 E C1550025:Load [Idea or Concept]
   737 E C1704782:Load [Manufactured Object]

Phrase: "of a Novex 10-20% Tricine/SDS-PAGE (Invitrogen"

Phrase: ")."
Processing 00000000.tx.47: After the electrophoresis, proteins were blotted on nitrocellulose membranes (Amersham Biosciences). 

Phrase: "After the electrophoresis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013855:Electrophoresis [Laboratory Procedure]

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "blotted on nitrocellulose membranes"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0025255:Membranes [Tissue]
   770   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   737 E C0596901:Membrane [Cell Component]
   737 E C1706182:Membrane [Manufactured Object]

Phrase: "(Amersham Biosciences"

Phrase: ")."
Processing 00000000.tx.48: Membranes were probed for NEP using the monoclonal antibody 56C6 at a dilution of 1:75. 

Phrase: "Membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "probed for NEP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1366499:NEPRILYSIN [Gene or Genome]
   756   C0182400:Probe [Medical Device]
   756   C1704681:Probe [Gene or Genome]
   756   C2347609:Probe [Chemical Viewed Functionally]
   756   C3536729:Probe [Manufactured Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the monoclonal antibody 56C6 at a dilution of 1"

Phrase: ":"

Phrase: "75."
Processing 00000000.tx.49: Blots were stripped in a buffer containing 2% SDS, 62.5mM Tris, pH 6.8,and 100mM -mercaptoethanol at 50C for 30min and probed for -actin (1:5000) and glyceraldehyde-3-phosphate dehydrogenase (1:1000) as loading controls. 

Phrase: "Blots"

Phrase: "were"

Phrase: "stripped in a buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   737   C1321564:Strip [Medical Device]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "2% SDS,"

Phrase: "62.5mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "pH 6.8,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "100mM -mercaptoethanol at 50C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0025402:Mercaptoethanol [Organic Chemical]

Phrase: "for 30min"

Phrase: "and"

Phrase: "probed for -actin"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0182400:Probe [Medical Device]
   756   C1704681:Probe [Gene or Genome]
   756   C2347609:Probe [Chemical Viewed Functionally]
   756   C3536729:Probe [Manufactured Object]
   718 E C0439681:Actinic [Qualitative Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "5000"

Phrase: ")"

Phrase: "and"

Phrase: "glyceraldehyde-3-phosphate dehydrogenase"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
  1000   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]
           glyceraldehyde phosphate
   923   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   812   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000"

Phrase: ")"

Phrase: "as"

Phrase: "loading controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.50: Similar blots were probed with IDE-1 (1:500), ACE (1:200), and the polyclonal antibody to 24.15protein (1:600). 

Phrase: "Similar blots"

Phrase: "were"

Phrase: "probed with"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0182400:Probe [Medical Device]
   799   C1704681:Probe [Gene or Genome]
   799   C2347609:Probe [Chemical Viewed Functionally]
   799   C3536729:Probe [Manufactured Object]

Phrase: "IDE-1"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0332257:include [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1552866:include [Idea or Concept]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C2700399:Include [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "500"

Phrase: ")"

Phrase: ","

Phrase: "ACE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the polyclonal antibody to 24.15protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "600"

Phrase: ")."
Processing 00000000.tx.51: The antibodies to NEP, ACE, GFAP, -actin, and glyceraldehyde-3-phosphate dehydrogenase were purchased from Novacastra, QED Bioscience, InnoGenex, Abcam, and Biodesign, respectively. 

Phrase: "The antibodies to NEP,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "ACE,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "GFAP, -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017626:GFAP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415042:GFAP [Gene or Genome]

Phrase: "actin,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "and"

Phrase: "glyceraldehyde-3-phosphate dehydrogenase"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
  1000   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]
           glyceraldehyde phosphate
   923   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   812   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "purchased from Novacastra,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]

Phrase: "QED Bioscience,"

Phrase: "InnoGenex,"

Phrase: "Abcam,"

Phrase: "and"

Phrase: "Biodesign,"

Phrase: "respectively."
Processing 00000000.tx.52: The polyclonal antibody to IDE (IDE-1) was a gift from Drs. 

Phrase: "The polyclonal antibody to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "IDE"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0332257:include [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1552866:include [Idea or Concept]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C2700399:Include [Activity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: "IDE-1"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0332257:include [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1552866:include [Idea or Concept]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C2700399:Include [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "was"

Phrase: "a gift from Drs."
Processing 00000000.tx.53: Vekrellis and Selkoe (11), and the antibodies to 24.15protein were gifts from Dr. 

Phrase: "Vekrellis"

Phrase: "and"

Phrase: "Selkoe"

Phrase: "(11"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the antibodies to 24.15protein"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "gifts from Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1136188:Gifts [Entity]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.54: C.

Phrase: "C."
Processing 00000000.tx.55: Abraham (12). 

Phrase: "Abraham"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442982:Abraham [Intellectual Product]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.56: A-ELISA-- For quantitation of A content in mouse brain, protein extracts of brain tissue reaching from the stereotaxic coordinates interaural 0to interaural 1 were prepared. 

Phrase: "A-ELISA-- For quantitation of A content"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0014441:ELISA [Laboratory Procedure]

Phrase: "in mouse brain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1521713:Mouse Brain [Tissue]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "extracts of brain tissue reaching"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0440746:Brain tissue [Tissue]
   806   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   797   C0040291:Tissue Extracts [Biologically Active Substance]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0040300:Tissue [Tissue]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C1547928:Tissue [Intellectual Product]
   760   C2584321:Reaching [Organism Function]
   760   C2828366:Extract [Substance]

Phrase: "from the stereotaxic coordinates interaural 0to interaural 1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0427184:coordinates [Finding]
   799   C0700114:coordinates [Functional Concept]
   799   C1707511:Coordinates [Spatial Concept]
   727   C1514967:Stereotaxis [Diagnostic Procedure]
   727   C1621832:stereotaxis [Organism Function]

Phrase: "were"

Phrase: "prepared."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]
Processing 00000000.tx.57: This area lies outside of the site of the brain that was injected with A42. 

Phrase: "This area"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017446:Area [Geographic Area]
  1000   C0205146:Area [Spatial Concept]

Phrase: "lies outside of the site of the brain"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   767   C2945843:Site of [Qualitative Concept]
   744   C0006104:Brain [Body Part, Organ, or Organ Component]
   744   C0205101:Outside [Spatial Concept]
   744   C0205145:Site [Spatial Concept]
   744   C1269537:Brain [Body Part, Organ, or Organ Component]
   744   C1515974:Site [Body Location or Region]
   744   C2825164:Site [Spatial Concept]

Phrase: "that"

Phrase: "was"

Phrase: "injected with A42."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1720154:Inject [Functional Concept]
Processing 00000000.tx.58: Tissue samples were homogenized in a 25-fold wet weight amount of 70% formic acid, homogenates were centrifuged at 200,000g for 1h at 4 C, and supernatant fluids were neutralized by adding the 20-fold volume of 1M Tris base. 

Phrase: "Tissue samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C1292533:Tissue Sample [Tissue]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "homogenized in a 25-fold wet weight amount"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0005910:weight [Organism Attribute]
   744   C0043100:Weight [Quantitative Concept]
   744   C0205381:Wet [Qualitative Concept]
   744   C0332462:Fold [Spatial Concept]
   744   C1265611:Amount [Quantitative Concept]
   744   C1305866:weight [Diagnostic Procedure]
   744   C1705104:Weight [Idea or Concept]
   744   C1880834:FOLD [Phenomenon or Process]

Phrase: "of 70% formic acid,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   901   C0885348:formic acid [Organic Chemical]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "homogenates"

Phrase: "were"

Phrase: "centrifuged at 200,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "000g for 1h"

Phrase: "at 4 C,"

Phrase: "and"

Phrase: "supernatant fluids"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0005889:Fluids [Body Substance]
   861   C0302908:fluids [Substance]
   861   C1521806:Fluids [Tissue]
   861   C1550101:Supernatant [Body Substance]
   827 E C0444611:Fluid [Qualitative Concept]
   827 E C1704353:Fluid [Substance]

Phrase: "were"

Phrase: "neutralized by adding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1883712:Add [Functional Concept]

Phrase: "the 20-fold volume of 1M Tris base."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0449468:*Volume [Quantitative Concept]
   744   C1690016:% volume [Qualitative Concept]
   744   C1705102:Volume [Intellectual Product]
   744   C2700258:Volume [Laboratory Procedure]
Processing 00000000.tx.59: To measure the total content of brain A, microtiter plates (Maxi Sorb, Nunc, Belgium) were coated with 150l of monoclonal mouse antibody 22C4 directed against the C terminus of A40 and A42 (amino acids 30-42) at a concentration of 20g/ml PBS. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "the total content of brain A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0423896:Content [Mental Process]
   753   C0456205:Content [Conceptual Entity]

Phrase: "microtiter plates"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   966   C1709027:Microtiter Plate [Research Device]
   861   C1139930:plates [Medical Device]
   827 E C0005971:Plate [Medical Device]
   827 E C3537155:Plate [Manufactured Object]

Phrase: "(Maxi"

Phrase: "Sorb"

Phrase: ","

Phrase: "Nunc,"

Phrase: "Belgium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]

Phrase: ")"

Phrase: "were"

Phrase: "coated with 150l of monoclonal mouse antibody 22C4"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   789   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   767   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0025914:Mouse [Mammal]
   744   C0025929:mouse [Mammal]
   744   C0026809:Mouse [Mammal]
   744   C0746619:monoclonal [Finding]
   744   C1522408:Coated [Qualitative Concept]
   711 E C0453946:Coat [Manufactured Object]
   711 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "directed against the C terminus of A40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C0439851:Direct [Qualitative Concept]
   714   C1947931:Direct [Qualitative Concept]

Phrase: "and"

Phrase: "A42"

Phrase: "(amino acids 30-42"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "at a concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 20g/ml PBS."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   823   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   804   C0031701:phosphate [Organophosphorus Compound]
   804   C0036082:Saline [Substance]
   804   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.60: Plates were blocked with 1% BSA, 1% gelatin in 100mM Tris, 5mM EDTA, and 0.1% Tween 20,pH 7.6,for 4h at 37C and washed three times with PBS containing 0.02% Tween 20.150-l diluted samples or standards (A40, Bachem) were incubated overnight, washed, and detected with biotinylated monoclonal mouse antibody 6H1 directed against amino acids 1-17 of human A (Evotec), incubated at a concentration of 1g/ml in blocking buffer for 4h at 37C, and visualized with a peroxidase reaction using 3,3',5,5'-tetramethylbenzidine as substrate and detected at 450nm. 

Phrase: "Plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1139930:plates [Medical Device]
   966 E C0005971:Plate [Medical Device]
   966 E C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "blocked with 1% BSA,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0028778:Blocked [Pathologic Function]
   770   C0332206:Blocked [Functional Concept]
   770   C2983591:BLOCKED [Research Activity]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "1% gelatin in 100mM Tris,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   760   C1145617:Gelatin [Food]

Phrase: "5mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.1% Tween 20,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   833 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   812   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   756 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "pH 7.6,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "for 4h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292426:4H [Temporal Concept]

Phrase: "at 37C"

Phrase: "and"

Phrase: "washed three times with PBS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0040223:times [Temporal Concept]
   748   C1632851:Times [Quantitative Concept]
   714 E C3541383:Time [Temporal Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.02% Tween 20.150-l diluted samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0370003:Sample [Substance]
   760   C2347026:Sample [Conceptual Entity]

Phrase: "or"

Phrase: "standards"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0038137:standards [Intellectual Product]
  1000   C0175675:Standards [Qualitative Concept]
   966 E C1442989:Standard [Qualitative Concept]
   966 E C2828392:Standard [Intellectual Product]

Phrase: "(A40,"

Phrase: "Bachem"

Phrase: ")"

Phrase: "were"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "overnight,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439583:Overnight [Temporal Concept]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: ","

Phrase: "and"

Phrase: "detected with biotinylated monoclonal mouse antibody 6H1"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   800   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   774   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0025914:Mouse [Mammal]
   748   C0025929:mouse [Mammal]
   748   C0026809:Mouse [Mammal]
   748   C0442726:Detected [Finding]
   748   C0746619:monoclonal [Finding]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "directed against amino acids 1-17 of human A (Evotec"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   739   C0001128:Acids [Chemical]
   739   C0086418:Human [Human]
   726 E C2917660:Amino Acid [Pharmacologic Substance]
   706 E C0202406:Acid [Laboratory Procedure]
   706   C0439851:Direct [Qualitative Concept]
   706   C1947931:Direct [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "incubated at a concentration of 1g/ml"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0086045:Concentration [Mental Process]
   748   C0439526:/mL [Quantitative Concept]
   748   C1439852:Incubated [Laboratory Procedure]
   748   C1446561:Concentration [Quantitative Concept]

Phrase: "in blocking buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "for 4h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292426:4H [Temporal Concept]

Phrase: "at 37C,"

Phrase: "and"

Phrase: "visualized with a peroxidase reaction"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C1151518:peroxidase reaction [Molecular Function]
   760   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0234621:Visualized [Functional Concept]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
   760   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "3',"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "5'-tetramethylbenzidine as substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0046880:Tetramethylbenzidine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "detected at 450nm."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.61: The linear range (r20.99) of the used ELISA system was between 2.5and 100ng of A/ml. 

Phrase: "The linear range"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1514721:Range [Quantitative Concept]
   861   C2348147:Range [Quantitative Concept]
   861   C3542016:Range [Intellectual Product]

Phrase: "(r20.99"

Phrase: ")"

Phrase: "of the used ELISA system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "was between 2.5and 100ng of A/ml."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0043194:WAS [Disease or Syndrome]
   744   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0439526:/mL [Quantitative Concept]
   744   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.62: Serial dilutions of samples were used for measurements in the linear range. 

Phrase: "Serial dilutions of samples"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0031082:serial [Intellectual Product,Manufactured Object]
   770   C0079240:dilutions [Laboratory Procedure]
   737 E C1948037:Dilution [Functional Concept]

Phrase: "were"

Phrase: "used for measurements"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0242485:measurements [Functional Concept]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "in the linear range."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1514721:Range [Quantitative Concept]
   861   C2348147:Range [Quantitative Concept]
   861   C3542016:Range [Intellectual Product]
Processing 00000000.tx.63: In parallel, the concentrations of A42 in each sample were determined using a commercially available kit (Innogenetics) according to provider's instructions. 

Phrase: "In parallel,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C2348042:Parallel [Qualitative Concept]
   861   C2826345:PARALLEL [Research Activity]

Phrase: "the concentrations of A42"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "in each sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a commercially available kit (Innogenetics"

Phrase: ")"

Phrase: "according to provider's instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.64: Titer Assays-- Blood was taken from the tail veins at the times of injections and before sacrificing the mice. 

Phrase: "Titer Assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "--"

Phrase: "Blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "was"

Phrase: "taken from the tail veins"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C2985205:Tail Vein [Body Part, Organ, or Organ Component]
   760   C0039259:Tail [Body Part, Organ, or Organ Component]
   760   C0042449:Veins [Body Part, Organ, or Organ Component]
   760   C1883727:Taken [Conceptual Entity]
   726 E C1278960:Vein [Body Part, Organ, or Organ Component]
   726 E C1515187:Take [Health Care Activity]

Phrase: "at the times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:times [Temporal Concept]
  1000   C1632851:Times [Quantitative Concept]
   966 E C3541383:Time [Temporal Concept]
   928 E C0442043:Temporal [Spatial Concept]
   928 E C2362314:Temporal [Temporal Concept]

Phrase: "of injections"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0021485:injections [Therapeutic or Preventive Procedure]
  1000   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
  1000   C1828121:Injections [Functional Concept]
   966 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "and"

Phrase: "before"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332152:Before [Temporal Concept]
  1000   C1705850:Before [Intellectual Product]

Phrase: "sacrificing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0681205:Sacrifice [Idea or Concept]

Phrase: "the mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.65: Anti-A antibody titers were measured by incubating of serial dilutions of blood sera on A42-coated microplates that were blocked with 100mM Tris-HCl, pH 7.6,5% milk powder, and 0.1% Tween-20 and washed three times with PBS containing 0.02% Tween 20.

Phrase: "Anti-A antibody titers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0474643:antibody titers [Laboratory Procedure]
   861   C1287242:antibody titers [Laboratory or Test Result]
   779   C0475208:Titer [Quantitative Concept]
   708   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "were"

Phrase: "measured by incubating of serial dilutions of blood sera"
Meta Candidates (Total=16; Excluded=5; Pruned=0; Remaining=11)
   742   C0005767:Blood [Tissue]
   742   C0005768:blood [Body Substance]
   742   C0031082:serial [Intellectual Product,Manufactured Object]
   742   C0079240:dilutions [Laboratory Procedure]
   742   C0229664:Blood [Body Substance]
   742   C0229671:Sera [Body Substance]
           Blood Serum
   742   C0444706:Measured [Qualitative Concept]
   742   C1151254:SerA [Molecular Function]
   742   C1439852:incubating [Laboratory Procedure]
   742   C3541902:MEASURED [Diagnostic Procedure]
   708 E C0079809:Measure [Quantitative Concept]
   708 E C0242485:Measure [Functional Concept]
   708 E C1546774:Serum [Intellectual Product]
   708 E C1550100:Serum [Body Substance]
   708 E C1948037:Dilution [Functional Concept]

Phrase: "on A42-coated microplates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1709027:Microplate [Research Device]

Phrase: "that"

Phrase: "were"

Phrase: "blocked with 100mM Tris-HCl,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0028778:Blocked [Pathologic Function]
   760   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   760   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   760   C0332206:Blocked [Functional Concept]
   760   C0814229:TRI [Intellectual Product]
   760   C2983591:BLOCKED [Research Activity]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]

Phrase: "pH 7.6,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "5% milk powder,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   901   C1440965:Milk powder [Immunologic Factor]
   827   C0026131:Milk [Body Substance]
   827   C0032861:Powder [Biomedical or Dental Material]
   827   C0349374:Milk [Food]
   827   C0444318:Milk [Substance]
   827   C1382110:Powder [Substance]
   827   C2825079:Milk [Food]
   771 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   771 E C1281353:Lacteal [Body Part, Organ, or Organ Component]
   755 E C0443260:Milky [Finding]

Phrase: "and"

Phrase: "0.1% Tween-20"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   833 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   812   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   756 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "washed three times with PBS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0040223:times [Temporal Concept]
   748   C1632851:Times [Quantitative Concept]
   714 E C3541383:Time [Temporal Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.02% Tween 20."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   833 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   812   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   756 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.66: Serum samples were diluted in blocking buffer and incubated overnight at 4C while shaking. 

Phrase: "Serum samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0444266:Serum sample [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "diluted in blocking buffer"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0233660:Blocking [Mental or Behavioral Dysfunction]
   770   C0332206:Blocking [Functional Concept]
   737 E C0028778:Block [Pathologic Function]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737   C1720119:Dilute [Functional Concept]
   737   C1948037:Dilute [Functional Concept]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "and"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "overnight at 4C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439583:Overnight [Temporal Concept]
   790   C0450376:4c [Intellectual Product]

Phrase: "while"

Phrase: "shaking."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040822:Shaking [Sign or Symptom]
   966 E C1883023:Shake [Activity]
Processing 00000000.tx.67: Serial dilutions of monoclonal anti-A antibody 6E10 were used as positive control. 

Phrase: "Serial dilutions of monoclonal anti-A antibody 6E10"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0031082:serial [Intellectual Product,Manufactured Object]
   744   C0079240:dilutions [Laboratory Procedure]
   711 E C1948037:Dilution [Functional Concept]

Phrase: "were"

Phrase: "used as positive control."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   833   C1883676:Positive Control [Conceptual Entity]
   770   C0243148:control [Qualitative Concept]
   770   C0439178:% Positive [Quantitative Concept]
   770   C1273517:used [Finding]
   770   C1446409:Positive [Qualitative Concept]
   770   C1514241:Positive [Finding]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C2825490:Positive [Qualitative Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.68: Plates were washed four times and incubated with goat anti-mouse biotinylated IgG (heavy and light) antibody (Vector Laboratories) in PBS with 1% BSA for 2h at 37C. 

Phrase: "Plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1139930:plates [Medical Device]
   966 E C0005971:Plate [Medical Device]
   966 E C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "four times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "and"

Phrase: "incubated with goat"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0018019:goat [Mammal]
   790   C1265549:goat [Mammal]
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1510458:Goat [Mammal]

Phrase: "anti-mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]

Phrase: "biotinylated"

Phrase: "IgG ("

Phrase: "heavy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439539:Heavy [Qualitative Concept]

Phrase: "and"

Phrase: "light"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023693:Light [Natural Phenomenon or Process]
  1000   C1306462:Light [Functional Concept]
  1000   C1881376:Light [Qualitative Concept]

Phrase: ")"

Phrase: "antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Vector Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: ")"

Phrase: "in PBS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "with 1% BSA"

Phrase: "for 2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: "at 37C."
Processing 00000000.tx.69: Plates were then washed four times and incubated with peroxidase-conjugated streptavidin (Jackson Laboratories) for 30min at room temperature. 

Phrase: "Plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1139930:plates [Medical Device]
   966 E C0005971:Plate [Medical Device]
   966 E C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "then washed four times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0040223:times [Temporal Concept]
   812   C1632851:Times [Quantitative Concept]
   779 E C3541383:Time [Temporal Concept]
   741 E C0442043:Temporal [Spatial Concept]
   741 E C2362314:Temporal [Temporal Concept]

Phrase: "and"

Phrase: "incubated with peroxidase-conjugated streptavidin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0075278:Streptavidin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]
   760   C0522529:Conjugated [Spatial Concept]
   760   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "(Jackson Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: ")"

Phrase: "for 30min"

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.70: After five washes, plates were incubated with 3,3',5,5'-tetramethylbenzidine for 5min at room temperature, and the reactions were stopped with 1M sulfuric acid. 

Phrase: "After five washes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0441648:Wash [Activity]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1139930:plates [Medical Device]
   966 E C0005971:Plate [Medical Device]
   966 E C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "incubated with 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "3',"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "5'-tetramethylbenzidine for 5min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0046880:Tetramethylbenzidine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "at room temperature,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "and"

Phrase: "the reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "stopped with 1M sulfuric acid."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   806   C0038784:Sulfuric acid [Inorganic Chemical,Pharmacologic Substance]
   806   C1161333:sulphuric acid [Pharmacologic Substance]
   770 E C0038775:sulfur acid [Chemical Viewed Structurally]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0470296:1M [Quantitative Concept]
   760   C1272691:stopped [Qualitative Concept]
   756 E C0038787:Sulfurous acid [Inorganic Chemical]
   726 E C1947925:Stop [Activity]
   726 E C2746065:Stop [Temporal Concept]
Processing 00000000.tx.71: Optical densities were read at 450nm in a microplate reader (Victor2 Multilabel, EG&G Wallac, Turku, Finland). 

Phrase: "Optical densities"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   966   C0439164:Optical density [Quantitative Concept]
   966   C1268822:Optical density [Clinical Attribute]
   861   C0178587:densities [Quantitative Concept]
   805   C0042789:Vision [Organism Function]
   805   C2707266:Vision [Clinical Attribute]
   777 E C0439794:Dense [Qualitative Concept]

Phrase: "were"

Phrase: "read at 450nm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034754:Read [Daily or Recreational Activity]
   790   C1705179:read [Finding]

Phrase: "in a microplate reader"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0182258:Microplate Reader [Medical Device]
   861   C1514743:Reader [Professional or Occupational Group]
   861   C1706461:Reader [Manufactured Object]

Phrase: "(Victor2 Multilabel,"

Phrase: "EG&G Wallac,"

Phrase: "Turku,"

Phrase: "Finland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016132:Finland [Geographic Area]

Phrase: ")."
Processing 00000000.tx.72: NEP Peptidase Activity Assay-- Brain protein extracts were dialyzed against 4000volumes of PBS for 24h at 4C by using Slide-A-Lyzer dialysis cassettes (Pierce) with a 10-kDa cut off. 

Phrase: "NEP Peptidase Activity Assay"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   875   C1150197:neprilysin activity [Molecular Function]
   861   C1150095:peptidase activity [Molecular Function]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0205177:Activity [Functional Concept]
   812   C0243073:assay [Qualitative Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1510438:Assay [Laboratory Procedure]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "--"

Phrase: "Brain protein extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "dialyzed against 4000volumes of PBS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   748   C0031701:phosphate [Organophosphorus Compound]
   748   C0036082:Saline [Substance]
   748   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "for 24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Slide-A-Lyzer dialysis cassettes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0450240:cassettes [Medical Device]
   771 E C1706210:Cassette [Manufactured Object]

Phrase: "(Pierce"

Phrase: ")"

Phrase: "with a 10-kDa cut off."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C1442160:Cutoff [Functional Concept]
   804   C0000925:Cut [Injury or Poisoning]
   804   C1883724:CUT [Phenomenon or Process]
Processing 00000000.tx.73: Three independent samples of 10g of protein from each brain were incubated for 1h at 37C with 50M Z-Ala-Ala-Leu-p-nitroanilide (ZAAL-pNA, Bachem) in 50mM HEPES buffer, pH 7.2.

Phrase: "Three independent samples of 10g of protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C0370003:Sample [Substance]
   714   C2347026:Sample [Conceptual Entity]

Phrase: "from each brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "incubated for 1h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1442450:1H [Temporal Concept]

Phrase: "at 37C"

Phrase: "with 50M Z-Ala-Ala-Leu-p-nitroanilide"

Phrase: "(ZAAL-pNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600500:PNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "Bachem"

Phrase: ")"

Phrase: "in 50mM HEPES buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "pH 7.2."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.74: Thereafter, 0.4milliunits of leucine aminopeptidase (Sigma) were added to the reaction mixtures, incubated for additional 20min at 37C (21), and optical densities were measured at 405nm. 

Phrase: "Thereafter,"

Phrase: "0.4milliunits of leucine aminopeptidase"

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "added to the reaction mixtures,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0439962:mixtures [Substance]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
   760   C1524062:Added [Functional Concept]
   726 E C1883712:Add [Functional Concept]

Phrase: "incubated for additional 20min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1524062:Additional [Functional Concept]

Phrase: "at 37C"

Phrase: "(21"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "optical densities"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   966   C0439164:Optical density [Quantitative Concept]
   966   C1268822:Optical density [Clinical Attribute]
   861   C0178587:densities [Quantitative Concept]
   805   C0042789:Vision [Organism Function]
   805   C2707266:Vision [Clinical Attribute]
   777 E C0439794:Dense [Qualitative Concept]

Phrase: "were"

Phrase: "measured at 405nm."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.75: To inhibit NEP and related enzyme activities, 10M thiorphan (Sigma) was added for 5min at room temperature before the addition of ZAAL-pNA (21). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "NEP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "and"

Phrase: "related enzyme activities,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   867   C0243102:enzyme activity [Molecular Function]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "10M thiorphan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039945:Thiorphan [Organic Chemical,Pharmacologic Substance]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "was"

Phrase: "added for 5min"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1524062:Added [Functional Concept]
   756 E C1883712:Add [Functional Concept]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "before the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of ZAAL-pNA (21"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0600500:PNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")."
Processing 00000000.tx.76: Statistical Analysis-- Data were collected by investigators blinded to the genotype and treatment of the mice and were analyzed by non-parametric Mann-Whitney U tests.  

Phrase: "Statistical Analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "--"

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "collected by investigators"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0035173:Investigators [Professional or Occupational Group]
   790   C1516695:Collected [Idea or Concept]
   790   C1516698:Collected [Functional Concept]

Phrase: "blinded to the genotype"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0017431:Genotype [Organism Attribute]
   770   C0150108:Blinded [Research Activity]
   737 E C0456909:Blind [Disease or Syndrome]
   737 E C0525065:blind [Patient or Disabled Group]

Phrase: "and"

Phrase: "treatment of the mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "and"

Phrase: "were"

Phrase: "analyzed by non-parametric Mann-Whitney U tests."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   825   C0242927:Mann-Whitney U Test [Quantitative Concept]
   782   C1708930:Mann-Whitney Test [Intellectual Product]
   782   C1709255:Non-Parametric Test [Intellectual Product]
   750   C1711157:Parametric Test [Intellectual Product]
   744   C0022885:Tests [Laboratory Procedure]
   744   C0392366:Tests [Intellectual Product]
   744   C0936012:Analyzed [Research Activity]
   744   C1518422:Non [Functional Concept]
   711 E C0039593:Test [Functional Concept]
Processing 00000000.tx.77: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES A42 Increased Brain Concentrations of NEP-- To determine whether A42 is involved in the regulation of NEP levels in vivo, we injected 1l of PBS or a suspension of aggregated synthetic A42 into the brains of SwAPP mice and non-tg littermates and analyzed NEP by immunohistochemistry. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "A42"

Phrase: "Increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "Brain Concentrations of NEP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "A42"

Phrase: "is"

Phrase: "involved in the regulation of NEP levels"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   748   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0441889:Levels [Qualitative Concept]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1314939:Involved [Functional Concept]
   748   C1327622:Regulation [Biologic Function]
   748   C1366499:NEPRILYSIN [Gene or Genome]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "we"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "1l of PBS"

Phrase: "or"

Phrase: "a suspension of aggregated synthetic A42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0038960:Suspension [Biomedical or Dental Material]
   753   C1382107:Suspension [Substance]
   753   C1705537:Suspension [Functional Concept]

Phrase: "into the brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of SwAPP mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "non-tg littermates"

Phrase: "and"

Phrase: "analyzed NEP by immunohistochemistry."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1366499:NEPRILYSIN [Gene or Genome]
Processing 00000000.tx.78: Strongly stained NEP-immunopositive neurons were present at 20weeks following one single injection of A42 (Fig. 1). 

Phrase: "Strongly stained NEP-immunopositive neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0027882:Neurons [Cell]
   721 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "present at 20weeks"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "one single injection of A42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021485:injection [Therapeutic or Preventive Procedure]
   760   C1272883:Injection [Biomedical or Dental Material]
   760   C1533685:Injection [Therapeutic or Preventive Procedure]
   760   C1828121:Injection [Functional Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.79: In these mice, NEP immunoreactivity was high in cellular compartments of many pyramidal cells of the cerebral cortex in all cortical layers (Fig. 1, b, d, i, and k) and in the cell bodies of pyramidal hippocampal neurons (Fig. 1, f, h, j, and l). 

Phrase: "In these mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "NEP immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "high in cellular compartments of many pyramidal cells of the cerebral cortex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C0205250:High [Qualitative Concept]
   736   C1299351:High [Qualitative Concept]
   736   C2700149:HIGH [Intellectual Product]

Phrase: "in all cortical layers"
Meta Candidates (Total=10; Excluded=6; Pruned=0; Remaining=4)
   861   C0001613:Cortical [Body Part, Organ, or Organ Component]
   861   C0007776:Cortical [Body Part, Organ, or Organ Component]
   861   C0022655:Cortical [Body Part, Organ, or Organ Component]
   861   C0934502:layers [Body Part, Organ, or Organ Component]
   827 E C1522408:Layer [Qualitative Concept]
   827 E C1561599:Layer [Intellectual Product]
   805 E C0234875:bark [Organism Attribute]
   805 E C2700441:Bark [Plant]
   777 E C0205704:Cascara [Organic Chemical,Pharmacologic Substance]
   777 E C3486388:Cascara [Organic Chemical,Pharmacologic Substance]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "b,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "d,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "i,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "k)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and in the cell bodies of pyramidal hippocampal neurons"
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   787   C0599444:Cell body of neuron [Cell Component]
           bodies cell
           neuron cell body
   762   C0206441:Pyramidal cell [Cell]
   762   C2334588:Pyramidal cell [Cell]
   742   C0007634:Cell [Cell]
   742   C0019564:Hippocampal [Body Part, Organ, or Organ Component]
   742   C0027882:Neurons [Cell]
   742   C0242821:bodies [Human]
   742   C1269647:Cell [Cell]
   742   C1515981:And [Idea or Concept]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]
   742   C1995017:Bodies [Cell Component]
   731 E C2752549:cell body [Cell Component]
   728   C0682679:neuron body [Cell Component]
   708 E C0460148:Body [Anatomical Structure]
   708 E C1268086:Body [Anatomical Structure]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "f,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "j,"

Phrase: "and"

Phrase: "l)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.80: In contrast, neuronal NEP staining was weak and diffused in cerebral cortex (Fig. 1, a and c) and hippocampus (Fig. 1, e and g) of non-tg littermates (Fig. 1, a and e) and SwAPP mice (Fig. 1, c and g) injected with PBS. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "neuronal NEP staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "weak"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0004093:Weak [Sign or Symptom]
  1000   C1762617:Weak [Qualitative Concept]

Phrase: "and"

Phrase: "diffused in cerebral cortex"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   770   C0012222:Diffused [Natural Phenomenon or Process]
   770   C1176472:Cortex [Body Part, Organ, or Organ Component]
   770   C2700441:Cortex [Plant]
   737 E C0205219:Diffuse [Qualitative Concept]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "a"

Phrase: "and"

Phrase: "c)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "e"

Phrase: "and"

Phrase: "g) of non-tg littermates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439267:g% [Quantitative Concept]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "a"

Phrase: "and"

Phrase: "e)"

Phrase: "and"

Phrase: "SwAPP mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "c"

Phrase: "and"

Phrase: "g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "injected with PBS."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   726   C1720154:Inject [Functional Concept]
Processing 00000000.tx.81: Together these data show that A42 injections increased neuronal levels of NEP protein in most brain regions. 

Phrase: "Together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that A42 injections"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0021485:injections [Therapeutic or Preventive Procedure]
   861   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
   861   C1828121:Injections [Functional Concept]
   827 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "neuronal levels of NEP protein"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   781   C0428479:Protein level [Laboratory or Test Result]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in most brain regions."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C1273723:brain regions [Body Location or Region]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.82: For detailed analysis of tissue levels of NEP, we injected wild type mice bilaterally with A42 and analyzed them by Western blotting at 1,3,12,and 20weeks following the injections. 

Phrase: "For detailed analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "of tissue levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0040300:Tissue [Tissue]
   861   C0441889:Levels [Qualitative Concept]
   861   C1547928:Tissue [Intellectual Product]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "of NEP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "we"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "wild type mice bilaterally with A42"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   799   C1520150:Wild Type Mouse [Mammal]
   790   C1883559:Wild Type [Organism Attribute]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "them by Western blotting at 1,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   773 E C0949466:Western Blot [Laboratory Procedure]
   753   C1705493:Western [Spatial Concept]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "12,"

Phrase: "and"

Phrase: "20weeks"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the injections."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0021485:injections [Therapeutic or Preventive Procedure]
  1000   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
  1000   C1828121:Injections [Functional Concept]
   966 E C1272883:Injection [Biomedical or Dental Material]
Processing 00000000.tx.83: Control mice were injected with same amounts of A42R, BSA, or were injected with PBS only. 

Phrase: "Control mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "injected with same amounts of A42R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0445247:Same [Qualitative Concept]
   753   C1265611:amounts [Quantitative Concept]
   719   C1720154:Inject [Functional Concept]

Phrase: "BSA,"

Phrase: "or"

Phrase: "were"

Phrase: "injected with PBS only."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   783   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C0036082:Saline [Substance]
   753   C0205171:Only [Quantitative Concept]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   753   C1720467:Only [Intellectual Product]
   719   C1720154:Inject [Functional Concept]
Processing 00000000.tx.84: The levels of NEP protein were high in all injected groups 1week after the injections (Fig. 2a). 

Phrase: "The levels of NEP protein"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   781   C0428479:Protein level [Laboratory or Test Result]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "high in all injected"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205250:High [Qualitative Concept]
   770   C1299351:High [Qualitative Concept]
   770   C2700149:HIGH [Intellectual Product]

Phrase: "groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "1week after the injections"

Phrase: "(Fig. 2a"

Phrase: ")."
Processing 00000000.tx.85: However, three weeks after the injections, 3of 4A42-injected mice showed a higher NEP protein level than other injected mice (Fig. 2a). 

Phrase: "However,"

Phrase: "three weeks after the injections,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0439230:weeks [Temporal Concept]
   726 E C0332174:/week [Temporal Concept]

Phrase: "3of 4A42-injected mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a higher NEP protein level than other injected mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C0428479:Protein level [Laboratory or Test Result]
   762   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   745   C1334805:Mouse Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0441889:Level [Qualitative Concept]
   742   C0456079:Level [Classification]
   742   C1547707:Level [Geographic Area]
   742   C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 2a"

Phrase: ")."
Processing 00000000.tx.86: At 12weeks post-injection, all A42-injected mice showed higher NEP concentrations in brain tissue (4of 4) when compared with their control counterparts, whereas at 20weeks post-injection, 2of 4mice that had been injected with A42 exhibited a remarkably higher NEP protein level in the brain (Fig. 2a). 

Phrase: "At 12weeks"

Phrase: "post-injection,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C0687676:Post [Temporal Concept]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1704687:Post [Manufactured Object]
   861   C1828121:Injection [Functional Concept]
   789 E C1514253:Postal [Functional Concept]

Phrase: "all A42-injected mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "higher NEP concentrations in brain tissue"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "(4of 4"

Phrase: ")"

Phrase: "when"

Phrase: "compared with their control counterparts,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "whereas at 20weeks post-injection, 2of 4mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0021485:injection [Therapeutic or Preventive Procedure]
   748   C0687676:Post [Temporal Concept]
   748   C1272883:Injection [Biomedical or Dental Material]
   748   C1533685:Injection [Therapeutic or Preventive Procedure]
   748   C1704687:Post [Manufactured Object]
   748   C1828121:Injection [Functional Concept]

Phrase: "that"

Phrase: "had"

Phrase: "been"

Phrase: "injected with A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1720154:Inject [Functional Concept]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a remarkably higher NEP protein level in the brain"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C0428479:Protein level [Laboratory or Test Result]
   762   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0441889:Level [Qualitative Concept]
   742   C0456079:Level [Classification]
   742   C1547707:Level [Geographic Area]
   742   C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 2a"

Phrase: ")."
Processing 00000000.tx.87: NEP protein levels in the brains of PBS- or BSA-injected groups were similar to A42R group for each time point (data not shown). 

Phrase: "NEP protein levels in the brains of PBS-"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   757   C0428304:levels phosphate [Laboratory or Test Result]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0441889:Levels [Qualitative Concept]
   726   C0428479:Protein level [Laboratory or Test Result]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "or"

Phrase: "BSA-injected groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1552839:groups [Idea or Concept]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "similar to A42R group"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "for each time point"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C2348792:Time Point [Temporal Concept]
   861   C0040223:Time [Temporal Concept]
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.88: The persistent elevation of NEP levels was specific to A42-injected mice, because none of the control injected mice showed elevated NEP protein at 3weeks post-injection or later (Fig. 2, a and b). 

Phrase: "The persistent elevation of NEP levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439775:Elevation [Therapeutic or Preventive Procedure]
   753   C0702240:Elevation [Spatial Concept]

Phrase: "was"

Phrase: "specific to A42-injected mice,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205369:Specific [Qualitative Concept]
   760   C1552740:specific [Intellectual Product]

Phrase: "because"

Phrase: "none of the control injected mice"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0243148:control [Qualitative Concept]
   753   C0456148:None [Quantitative Concept]
   753   C0549184:None [Quantitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "elevated NEP protein at 3weeks"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0748024:elevated protein [Finding]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "post-injection"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C0687676:Post [Temporal Concept]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1704687:Post [Manufactured Object]
   861   C1828121:Injection [Functional Concept]
   789 E C1514253:Postal [Functional Concept]

Phrase: "or"

Phrase: "later"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205087:Late [Temporal Concept]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "a"

Phrase: "and"

Phrase: "b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.89: -Actin (Fig. 2, a and b) and glyceraldehyde-3-phosphate dehydrogenase (data not shown) Western blotting was performed for all groups as loading controls giving identical results. 

Phrase: "-Actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "a"

Phrase: "and"

Phrase: "b)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "glyceraldehyde-3-phosphate dehydrogenase"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
  1000   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]
           glyceraldehyde phosphate
   923   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   812   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "was"

Phrase: "performed for all"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "groups as loading controls"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   802   C0009932:Control Group [Group]
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552839:groups [Idea or Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]
   770   C1708715:Loading [Activity]
   737   C0243148:control [Qualitative Concept]
   737 E C1550025:Load [Idea or Concept]
   737   C1550141:Control [Substance]
   737 E C1704782:Load [Manufactured Object]
   737   C1882979:Control [Conceptual Entity]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]

Phrase: "giving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "identical results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.90: We next tested the NEP enzymatic activity in brain homogenates of mice 20weeks after the injections using the ZAAL-pNA peptide as the substrate (21). 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the NEP enzymatic activity in brain homogenates of mice 20weeks"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C2267219:Enzymatic Activity [Molecular Function]
   757   C0443158:Brain activity [Physiologic Function]
   757   C1150197:neprilysin activity [Molecular Function]
   739   C0205177:Activity [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1561536:*Activity [Idea or Concept]

Phrase: "after the injections"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0021485:injections [Therapeutic or Preventive Procedure]
  1000   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
  1000   C1828121:Injections [Functional Concept]
   966 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the ZAAL-pNA peptide as the substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.91: This assay revealed significantly higher NEP activities in brains that had been injected previously with A42 and that had higher brain levels of NEP on Western blots. 

Phrase: "This assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "significantly higher NEP activities in brains"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   773   C1150197:neprilysin activity [Molecular Function]
   753   C0441655:Activities [Activity]
   750   C0443158:Brain activity [Physiologic Function]
   719 E C0205177:Activity [Functional Concept]
   719 E C0439167:% activity [Quantitative Concept]
   719 E C1561536:*Activity [Idea or Concept]

Phrase: "that"

Phrase: "had"

Phrase: "been"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "previously with A42"

Phrase: "and"

Phrase: "that"

Phrase: "had"

Phrase: "higher brain levels of NEP"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0441889:Levels [Qualitative Concept]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "on Western blots."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0949466:Western Blots [Laboratory Procedure]
   966 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1705493:Western [Spatial Concept]
Processing 00000000.tx.92: The NEP enzyme inhibitor thiorphan blocked these increases (Fig. 2c). 

Phrase: "The NEP enzyme inhibitor thiorphan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0039945:Thiorphan [Organic Chemical,Pharmacologic Substance]

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "these increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:increases [Functional Concept]

Phrase: "(Fig. 2c"

Phrase: ")."
Processing 00000000.tx.93: View larger version (97K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(97K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.94: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.95: A42 injections increased neuronal NEP immunoreactivity in non-tg (a, b, e, f, i, and j) and SwAPP mice (c, d, g, h, k, and l). 

Phrase: "A42 injections"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0021485:injections [Therapeutic or Preventive Procedure]
   861   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
   861   C1828121:Injections [Functional Concept]
   827 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "neuronal NEP immunoreactivity in non-tg"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0597879:immunoreactivity [Molecular Function]

Phrase: "("

Phrase: "a,"

Phrase: "b,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "e,"

Phrase: "f,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "i,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "j)"

Phrase: "and"

Phrase: "SwAPP mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "(c,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "d,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "g,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "k,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "l)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.96: Twenty weeks after the injections, A42-induced increases in NEP immunoreactivity were detected in cell bodies and neurites of many pyramidal cells of the cerebral cortex (b, d, i, and k) and in the cell bodies of pyramidal neurons in hippocampus (f, h, j, and l) of the A42-injected non-tg (b, f, i, and j) and SwAPP (d, h, k, and l) mice. 

Phrase: "Twenty weeks after the injections,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0439230:weeks [Temporal Concept]
   726 E C0332174:/week [Temporal Concept]

Phrase: "A42-induced increases in NEP immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:increases [Functional Concept]

Phrase: "were"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "in cell bodies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   867   C0599444:Cell body [Cell Component]
   867   C2752549:cell body [Cell Component]
   827   C0242821:bodies [Human]
   827   C1995017:Bodies [Cell Component]
   793 E C0460148:Body [Anatomical Structure]
   793 E C1268086:Body [Anatomical Structure]

Phrase: "and"

Phrase: "neurites of many pyramidal cells of the cerebral cortex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0085103:Neurites [Cell Component]

Phrase: "(b,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "d,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "i,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "k)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and in the cell bodies of pyramidal neurons"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   800   C0599444:Cell body of neuron [Cell Component]
           bodies cell
           neuron cell body
   767   C0206441:Pyramidal cell [Cell]
   767   C2334588:Pyramidal cell [Cell]
   744   C0007634:Cell [Cell]
   744   C0027882:Neurons [Cell]
   744   C0242821:bodies [Human]
   744   C1269647:Cell [Cell]
   744   C1515981:And [Idea or Concept]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   744   C1995017:Bodies [Cell Component]
   737 E C2752549:cell body [Cell Component]
   734   C0682679:neuron body [Cell Component]
   711 E C0460148:Body [Anatomical Structure]
   711 E C1268086:Body [Anatomical Structure]

Phrase: "in hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "(f,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "j,"

Phrase: "and"

Phrase: "l) of the A42-injected non-tg"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0439394:l's [Quantitative Concept]
   748   C1706495:L- [Intellectual Product]
   748   C3642217:/L [Quantitative Concept]

Phrase: "(b,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "f,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "i,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "j)"

Phrase: "and"

Phrase: "SwAPP"

Phrase: "(d,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "k,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "l) mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.97: In contrast, PBS-injected non-tg (a and e) and SwAPP mice (c and g) showed only weak and diffuse NEP staining in these structures (a, b, c, d, i, and k: cerebral cortex; 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "PBS-injected non-tg"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0003069:Transgenic [Animal]
   799   C1518422:Non [Functional Concept]

Phrase: "("

Phrase: "a"

Phrase: "and"

Phrase: "e)"

Phrase: "and"

Phrase: "SwAPP mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "(c"

Phrase: "and"

Phrase: "g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "only weak"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0004093:Weak [Sign or Symptom]
   861   C1762617:Weak [Qualitative Concept]

Phrase: "and"

Phrase: "diffuse NEP staining in these structures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]

Phrase: "("

Phrase: "a,"

Phrase: "b,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "c,"

Phrase: "d,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "i,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "k"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: ":"

Phrase: "cerebral cortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: ";"
Processing 00000000.tx.98: e, f, g, h, j, and l: hippocampus). 

Phrase: "e,"

Phrase: "f,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "g,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "j,"

Phrase: "and"

Phrase: "l"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: ":"

Phrase: "hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.99: Scale: 300and 100m for i, j, k, and l. 

Phrase: "Scale"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0175659:Scale [Medical Device]
  1000   C0349674:Scale [Intellectual Product]
  1000   C1947916:Scale [Activity]
  1000   C3536777:Scale [Manufactured Object]
   928 E C1710017:Scalar [Qualitative Concept]
   916 E C0222045:Scales [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "300and 100m for i,"

Phrase: "j,"

Phrase: "k,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "l."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.100: View larger version (34K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(34K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.101: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.102: A42 caused a marked increase in NEP levels in injected brains. a, Western blots of all A42 and A42R control-injected wild-type mice are shown. 

Phrase: "A42"

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a marked increase in NEP levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "in injected brains."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "a,"

Phrase: "Western blots of all A42"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0949466:Western Blots [Laboratory Procedure]
   773 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C1705493:Western [Spatial Concept]

Phrase: "and"

Phrase: "A42R control-injected wild-type mice"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   858   C1707504:Control Type [Research Activity]
   858   C1879930:Control Type [Intellectual Product]
   827   C1520150:Wild Type Mouse [Mammal]
   827   C1883559:Wild Type [Organism Attribute]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
   799   C0332307:Type [Qualitative Concept]
   799   C0445392:Wild [Intellectual Product]
   799   C1547052:*Type [Quantitative Concept]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.103: Levels of NEP increased in all injected mice as early as 1week after the injections. 

Phrase: "Levels of NEP"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0441889:Levels [Qualitative Concept]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]

Phrase: "increased in all injected mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]

Phrase: "as early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279919:Early [Temporal Concept]

Phrase: "as 1week"

Phrase: "after the injections."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0021485:injections [Therapeutic or Preventive Procedure]
  1000   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
  1000   C1828121:Injections [Functional Concept]
   966 E C1272883:Injection [Biomedical or Dental Material]
Processing 00000000.tx.104: Three weeks after the injections, 3of 4mice injected with A42 showed a higher NEP protein level than the control-injected mice. 

Phrase: "Three weeks after the injections,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0439230:weeks [Temporal Concept]
   726 E C0332174:/week [Temporal Concept]

Phrase: "3of 4mice"

Phrase: "injected with A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1720154:Inject [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a higher NEP protein level than the control-injected mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0428479:Protein level [Laboratory or Test Result]
   757   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   741   C1334805:Mouse Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0441889:Level [Qualitative Concept]
   739   C0456079:Level [Classification]
   739   C1547707:Level [Geographic Area]
   739   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.105: At 12weeks post-injection, all A42-injected mice expressed a higher amount of NEP in the brain. 

Phrase: "At 12weeks"

Phrase: "post-injection,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C0687676:Post [Temporal Concept]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1704687:Post [Manufactured Object]
   861   C1828121:Injection [Functional Concept]
   789 E C1514253:Postal [Functional Concept]

Phrase: "all A42-injected mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "expressed"

Phrase: "a higher amount of NEP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "in the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.106: At 20weeks after A42 injections, 2of 4mice showed significantly higher NEP levels. 

Phrase: "At 20weeks"

Phrase: "after A42 injections,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0021485:injections [Therapeutic or Preventive Procedure]
   861   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
   861   C1828121:Injections [Functional Concept]
   827 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "2of 4mice"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "significantly higher NEP levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.107: Note that only A42-injected mice show long term elevated NEP protein levels. b, representative Western blot analysis of mice 12weeks following the injections. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that only A42-injected mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "long term"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0443252:Long-term [Temporal Concept]
   861   C0205166:Long [Qualitative Concept]
   861   C1515273:Term [Temporal Concept]
   861   C1705313:Term [Idea or Concept]
   861   C1706317:Long [Qualitative Concept]
   861   C2826302:TERM [Intellectual Product]

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "NEP protein levels. b,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   875   C0377800:protein B [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "representative Western blot analysis of mice 12weeks"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   778   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   748   C1705493:Western [Spatial Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the injections."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0021485:injections [Therapeutic or Preventive Procedure]
  1000   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
  1000   C1828121:Injections [Functional Concept]
   966 E C1272883:Injection [Biomedical or Dental Material]
Processing 00000000.tx.108: The levels of NEP protein of control mice injected with either A42R-peptide, PBS, or BSA did not differ from that of uninjected mice and was much lower than the A42-injected mice. 

Phrase: "The levels of NEP protein of control mice"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   750   C0428479:Protein level [Laboratory or Test Result]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "injected with either A42R-peptide,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   726   C1720154:Inject [Functional Concept]

Phrase: "PBS,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "BSA"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "differ from that of uninjected mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "was"

Phrase: "much lower than the A42-injected mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0441994:Lower [Spatial Concept]
   748   C1548802:Lower [Body Location or Region]
   748   C2003888:Lower [Activity]
Processing 00000000.tx.109: -Actin was used to control for equal protein loading. c, twenty weeks after the injections, A42-injected mice with high brain levels of NEP on Western blots exhibited also high NEP peptidase activity in brain protein extracts. 

Phrase: "-Actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "control for equal protein loading. c,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   783   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   783   C1168438:Protein C [Laboratory Procedure]
   783   C1418943:PROTEIN C [Gene or Genome]
   783   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205163:Equal [Qualitative Concept]
   753   C0243148:control [Qualitative Concept]
   753   C1549782:Equal [Idea or Concept]
   753   C1550141:Control [Substance]
   753   C1708715:Loading [Activity]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "twenty weeks after the injections,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0439230:weeks [Temporal Concept]
   726 E C0332174:/week [Temporal Concept]

Phrase: "A42-injected mice with high brain levels of NEP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   745   C1521713:Mouse Brain [Tissue]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]

Phrase: "on Western blots"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0949466:Western Blots [Laboratory Procedure]
   966 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1705493:Western [Spatial Concept]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "also high NEP peptidase activity in brain protein extracts."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C1150095:peptidase activity [Molecular Function]
   762   C0443158:Brain activity [Physiologic Function]
   762   C1150197:neprilysin activity [Molecular Function]
   762   C1537044:protein activity [Molecular Function]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.110: This activity was blocked by thiorphan. 

Phrase: "This activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "blocked by thiorphan."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0028778:Blocked [Pathologic Function]
   790   C0039945:Thiorphan [Organic Chemical,Pharmacologic Substance]
   790   C0332206:Blocked [Functional Concept]
   790   C2983591:BLOCKED [Research Activity]
   756 E C1533157:Block [Substance]
   756 E C1706084:Block [Geographic Area]
   756 E C2828370:Block [Quantitative Concept]
Processing 00000000.tx.111: NEP peptidase activity in brain protein homogenates was measured by using ZAAL-pNA as a substrate in absence or presence of 10M thiorphan. 

Phrase: "NEP peptidase activity in brain protein homogenates"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C1150095:peptidase activity [Molecular Function]
   774   C0443158:Brain activity [Physiologic Function]
   774   C1150197:neprilysin activity [Molecular Function]
   774   C1537044:protein activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "measured by"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0444706:Measured [Qualitative Concept]
   833   C3541902:MEASURED [Diagnostic Procedure]
   799 E C0079809:Measure [Quantitative Concept]
   799 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ZAAL-pNA as a substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0600500:PNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of 10M thiorphan."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.112: Enzymatic NEP activities in brains of A42-injected mice (solid bars) were higher than the activities in brains of two randomly chosen control mice that were injected with the A42R peptide (open bars). 

Phrase: "Enzymatic NEP activities in brains of A42-injected mice"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   748   C1150197:neprilysin activity [Molecular Function]
   745   C2267219:Enzymatic Activity [Molecular Function]
   742   C0441655:Activities [Activity]
   728   C0443158:Brain activity [Physiologic Function]
   708 E C0205177:Activity [Functional Concept]
   708 E C0439167:% activity [Quantitative Concept]
   708 E C1561536:*Activity [Idea or Concept]

Phrase: "(solid bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "higher than the activities"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "in brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of two randomly chosen control mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
   804   C0243148:control [Qualitative Concept]
   804   C1550141:Control [Substance]
   804   C1882979:Control [Conceptual Entity]
   804   C2587213:Control [Functional Concept]
   804   C3274648:Control [Qualitative Concept]

Phrase: "that"

Phrase: "were"

Phrase: "injected with the A42R peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   726   C1720154:Inject [Functional Concept]

Phrase: "(open bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.113: Bars represent meansS.D. of triplicate measurements. 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "meansS.D."

Phrase: "of triplicate measurements."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242485:measurements [Functional Concept]
Processing 00000000.tx.114: To determine whether the increases in brain levels of NEP were paralleled by increased levels of NEP message, we analyzed by real time reverse transcription-PCR the NEP mRNA prepared from same mouse brains. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the increases in brain levels of NEP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:increases [Functional Concept]

Phrase: "were"

Phrase: "paralleled by increased levels of NEP message,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   748   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0205217:Increased [Quantitative Concept]
   748   C0441889:Levels [Qualitative Concept]
   748   C0442805:Increased [Functional Concept]
   748   C0470166:Message [Intellectual Product]
   748   C1366499:NEPRILYSIN [Gene or Genome]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714   C2348042:Parallel [Qualitative Concept]
   714   C2826345:PARALLEL [Research Activity]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "we"

Phrase: "analyzed by real time reverse transcription-PCR"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   804   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   778   C0035380:Reverse Transcription [Genetic Function]
   778   C1550177:Real Time [Idea or Concept]
   748   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0040223:Time [Temporal Concept]
   748   C0040649:Transcription [Genetic Function]
   748   C0237400:Real [Qualitative Concept]
   748   C0677874:pCR [Finding]
   748   C0936012:Analyzed [Research Activity]
   748   C1555029:Reverse [Idea or Concept]
   748   C3272377:REAL [Intellectual Product]
   748   C3541383:Time [Temporal Concept]

Phrase: "the NEP mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "prepared from same mouse brains."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C1521713:Mouse Brain [Tissue]
   760   C0006104:Brains [Body Part, Organ, or Organ Component]
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C0445247:Same [Qualitative Concept]
   726 E C1269537:Brain [Body Part, Organ, or Organ Component]
   726   C1521827:Prepare [Functional Concept]
Processing 00000000.tx.115: One week after injections, the levels of NEP mRNA were 4-5-fold higher in all injected groups when compared with uninjected mice of the same age. 

Phrase: "One week after injections,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332174:/week [Temporal Concept]
   770   C0439230:week [Temporal Concept]

Phrase: "the levels of NEP mRNA"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "4-5-fold"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]
   734   C0450367:4 5 [Quantitative Concept]

Phrase: "higher in all injected groups"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "when"

Phrase: "compared with uninjected mice of the same age."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0001779:Age [Organism Attribute]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0445247:Same [Qualitative Concept]
   744   C1707455:Compared [Activity]
Processing 00000000.tx.116: This up-regulation was a consistent feature of the A42-injected mice. 

Phrase: "This up-regulation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0041904:Up-Regulation [Cell Function,Molecular Function]
  1000   C0162493:Up-Regulation [Genetic Function]
   861   C0547043:Up [Spatial Concept]
   861   C0851285:Regulation [Governmental or Regulatory Activity]
   861   C1282911:Up [Spatial Concept]
   861   C1327622:Regulation [Biologic Function]

Phrase: "was"

Phrase: "a consistent feature of the A42-injected mice."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C1521970:Feature [Qualitative Concept]
   744   C1706388:Feature [Conceptual Entity]
   744   C2346469:Feature [Qualitative Concept]
   744   C2348519:Feature [Qualitative Concept]
Processing 00000000.tx.117: At 20weeks post-injection, the mRNA level of NEP in all other groups had dropped to the level of uninjected mice, whereas A42-injected mice showed a 4.9-fold increase in NEP mRNA levels (Table I).  

Phrase: "At 20weeks"

Phrase: "post-injection,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C0687676:Post [Temporal Concept]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1704687:Post [Manufactured Object]
   861   C1828121:Injection [Functional Concept]
   789 E C1514253:Postal [Functional Concept]

Phrase: "the mRNA level of NEP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "in all"

Phrase: "other groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "had"

Phrase: "dropped to the level of uninjected mice,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C1705648:Dropped [Activity]
   748   C2946261:Level [Pharmacologic Substance]
   714 E C1321095:Drop [Quantitative Concept]
   714 E C2347093:Drop [Quantitative Concept]
   714 E C2348338:Drop [Quantitative Concept]

Phrase: "whereas"

Phrase: "A42-injected mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a 4.9-fold increase in NEP mRNA levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "(Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.118: View this table: [in this window] [in a new window]  Table I NEP mRNA levels increased after A42 injections A sustained overexpression of NEP mRNA was observed after A42 injections. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table I NEP mRNA levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   875   C0441925:i levels [Intellectual Product]
   804   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "increased after A42 injections"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0021485:injections [Therapeutic or Preventive Procedure]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
   770   C1828121:Injections [Functional Concept]
   737 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "A sustained overexpression of NEP mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514559:Overexpression [Genetic Function]

Phrase: "was"

Phrase: "observed after A42 injections."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0021485:injections [Therapeutic or Preventive Procedure]
   770   C1441672:Observed [Functional Concept]
   770   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
   770   C1828121:Injections [Functional Concept]
   737 E C1272883:Injection [Biomedical or Dental Material]
Processing 00000000.tx.119: When compared to those of uninjected group (set as 100%), the levels of NEP mRNA were significantly higher one week after the injections in all groups. 

Phrase: "When"

Phrase: "compared to those of uninjected group"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0441833:Group [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1552516:Group [Health Care Related Organization]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]
   753   C1707455:Compared [Activity]

Phrase: "(set as 100%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]

Phrase: ")"

Phrase: ","

Phrase: "the levels of NEP mRNA"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "significantly higher one week after the injections"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332174:/week [Temporal Concept]
   748   C0439230:week [Temporal Concept]

Phrase: "in all groups."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]
Processing 00000000.tx.120: 20weeks after the injections, however, mRNA levels of the control-injected mice did not differ from those of the uninjected mice, whereas this value was still high in A42-injected mice. 

Phrase: "20weeks after the injections,"

Phrase: "however,"

Phrase: "mRNA levels of the control-injected mice"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   748   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "differ from those of the uninjected mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]

Phrase: "whereas"

Phrase: "this value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522609:Value [Quantitative Concept]

Phrase: "was"

Phrase: "still high in A42-injected mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205250:High [Qualitative Concept]
   753   C1299351:High [Qualitative Concept]
   753   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.121: *, p0.05for comparison to uninjected group; 

Phrase: "*,"

Phrase: "p0.05for comparison to uninjected group"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707455:Comparison [Activity]

Phrase: ";"
Processing 00000000.tx.122: n.s., not significant. 

Phrase: "n.s.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "not significant."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1273937:Not significant [Finding]
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.123: A42-induced Increase in NEP Was Associated with Reduced Amyloid Plaque Formation-- To determine whether the A42-induced increase in neuronal NEP was associated with reduced amyloid plaque formation in transgenic SwAPP mice, we counted the number of brain amyloid plaques stained by immunohistochemistry at 20weeks after one single injection of A42. 

Phrase: "A42-induced Increase in NEP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "Was"

Phrase: "Associated with Reduced Amyloid Plaque Formation"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0333463:amyloid plaque [Acquired Abnormality]
           plaque
   790   C2936349:Plaque, Amyloid [Acquired Abnormality]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011389:Plaque [Disease or Syndrome]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0220781:formation [Biologic Function]
   753   C0332461:Plaque [Finding]
   753   C0392756:Reduced [Qualitative Concept]
   753   C0439634:formation [Spatial Concept]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1522492:Formation [Functional Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the A42-induced increase in neuronal NEP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "associated with reduced amyloid plaque formation"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0333463:amyloid plaque [Acquired Abnormality]
           plaque
   790   C2936349:Plaque, Amyloid [Acquired Abnormality]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011389:Plaque [Disease or Syndrome]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0220781:formation [Biologic Function]
   753   C0332461:Plaque [Finding]
   753   C0392756:Reduced [Qualitative Concept]
   753   C0439634:formation [Spatial Concept]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1522492:Formation [Functional Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in transgenic SwAPP mice,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0025936:Mice, Transgenic [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "we"

Phrase: "counted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]

Phrase: "the number of brain amyloid plaques"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   820   C0449793:Number of plaques [Quantitative Concept]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "stained by immunohistochemistry"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0021044:Immunohistochemistry [Laboratory Procedure]
   790   C2986582:Stained [Qualitative Concept]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "at 20weeks"

Phrase: "after one single injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0021485:injection [Therapeutic or Preventive Procedure]
   827   C1272883:Injection [Biomedical or Dental Material]
   827   C1533685:Injection [Therapeutic or Preventive Procedure]
   827   C1828121:Injection [Functional Concept]

Phrase: "of A42."
Processing 00000000.tx.124: Intracranially injected A42 suspension generated 4G8-immunoreactive deposits that were detectable up to 20weeks following the injections (Fig. 3, d and e, open arrow). 

Phrase: "Intracranially injected A42 suspension"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   839   C0991512:Injection suspension [Biomedical or Dental Material]
   812   C0038960:Suspension [Biomedical or Dental Material]
   812   C1382107:Suspension [Substance]
   812   C1705537:Suspension [Functional Concept]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "4G8-immunoreactive deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333562:Deposits [Functional Concept]

Phrase: "that"

Phrase: "were"

Phrase: "detectable up to 20weeks"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the injections"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0021485:injections [Therapeutic or Preventive Procedure]
  1000   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
  1000   C1828121:Injections [Functional Concept]
   966 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "d"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "e,"

Phrase: "open arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:Arrow [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.125: As expected, all of the control SwAPP mice (4of 4) tested at the end of the experiment exhibited numerous amyloid plaques that immunoreacted with the monoclonal antibody 4G8 directed against the amino acids 17-24 of human A (Fig. 3, a-c). 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "all of the control SwAPP mice"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0243148:control [Qualitative Concept]
   753   C0444868:All [Quantitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   753   C3539085:All [Idea or Concept]

Phrase: "(4of 4"

Phrase: ")"

Phrase: "tested at the end of the experiment"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   748   C0392366:tested [Intellectual Product]
   748   C0444930:End [Spatial Concept]
   748   C0681814:Experiment [Research Activity]
   748   C1706386:Experiment [Conceptual Entity]
   748   C2746065:End [Temporal Concept]
   714 E C0022885:Test [Laboratory Procedure]
   714 E C0039593:Test [Functional Concept]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "numerous amyloid plaques"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
   901   C2936349:Plaques, Amyloid [Acquired Abnormality]
   793 E C0011389:Plaque [Disease or Syndrome]
   793 E C0332461:Plaque [Finding]

Phrase: "that"

Phrase: "immunoreacted with the monoclonal antibody 4G8"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0746619:monoclonal [Finding]

Phrase: "directed against the amino acids 17-24"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   778   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0001128:Acids [Chemical]
   745 E C2917660:Amino Acid [Pharmacologic Substance]
   714 E C0202406:Acid [Laboratory Procedure]
   714   C0439851:Direct [Qualitative Concept]
   714   C1947931:Direct [Qualitative Concept]

Phrase: "of human A (Fig. 3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0086418:Human [Human]
   812   C0349966:Fig [Food]
   812   C1337208:FIG [Food]

Phrase: "a-c)."
Processing 00000000.tx.126: In particular, amyloid plaques were abundant throughout the cerebral cortex and, to a somewhat lesser extent, in the hippocampus. 

Phrase: "In particular, amyloid plaques"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
   901   C2936349:Plaques, Amyloid [Acquired Abnormality]
   793 E C0011389:Plaque [Disease or Syndrome]
   793 E C0332461:Plaque [Finding]

Phrase: "were"

Phrase: "abundant throughout the cerebral cortex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2346714:Abundant [Qualitative Concept]

Phrase: "and"

Phrase: ","

Phrase: "to a somewhat lesser extent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439792:Extent [Spatial Concept]

Phrase: "in the hippocampus."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
Processing 00000000.tx.127: Other A-specific antibodies including 6E10, 6H1, and 9G10 gave identical results. 

Phrase: "Other A-specific antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   896   C0368582:A Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   884   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "6E10,"

Phrase: "6H1,"

Phrase: "and"

Phrase: "9G10"

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "identical results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.128: In striking contrast, 4of 5A42-injected SwAPP mice were free of amyloid plaques at 31weeks of age or at 20weeks after the injection (Fig. 3, d-f). 

Phrase: "In striking contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1979874:Contrast [Qualitative Concept]

Phrase: "4of 5A42-injected SwAPP mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "free of amyloid plaques"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332296:free [Functional Concept]
   770   C1880497:Free [Qualitative Concept]
   770   C1996904:Free [Qualitative Concept]

Phrase: "at 31weeks"

Phrase: "of age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "or at 20weeks"

Phrase: "after the injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021485:injection [Therapeutic or Preventive Procedure]
  1000   C1272883:Injection [Biomedical or Dental Material]
  1000   C1533685:Injection [Therapeutic or Preventive Procedure]
  1000   C1828121:Injection [Functional Concept]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "d-"

Phrase: "f)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.129: These four mice were evaluated further in this study. 

Phrase: "These four mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "further in this study."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0557651:Study [Manufactured Object]
   770   C1517331:Further [Spatial Concept]
   770   C2603343:Study [Research Activity]
   737 E C0205108:far [Spatial Concept]
Processing 00000000.tx.130: In these mice, 4G8-immunoreactive material was observed only around the needle tract; 

Phrase: "In these mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "4G8-immunoreactive material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0520510:Material [Substance]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "only around the needle tract"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0027551:Needle [Medical Device]
   760   C0205171:Only [Quantitative Concept]
   760   C1185740:Tract [Body Part, Organ, or Organ Component]
   760   C1704318:Needle [Medical Device]
   760   C1720467:Only [Intellectual Product]
   760   C1882041:Needle [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.131: this material most probably represented the previous injected aggregated synthetic peptide (Fig. 3, d-e, open arrow). 

Phrase: "this material most probably"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0520510:Material [Substance]
   827   C0750492:Probably [Idea or Concept]

Phrase: "represented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "the previous injected aggregated synthetic peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   804   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   804   C1883254:synthetic [Activity]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "d-"

Phrase: "e,"

Phrase: "open arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:Arrow [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.132: View larger version (113K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(113K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.133: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.134: A42-mediated inhibition of amyloid plaque formation in transgenic SwAPP mice. 

Phrase: "A42-mediated inhibition of amyloid plaque formation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "in transgenic SwAPP mice."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0025936:Mice, Transgenic [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.135: Age-matched control SwAPP mice (a-c) exhibited numerous 4G8-positive plaques in cortex (b) and hippocampus (c). 

Phrase: "Age-matched control SwAPP mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "(a-c)"

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "numerous 4G8-positive plaques in cortex"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0333463:plaques [Acquired Abnormality]
   719 E C0011389:Plaque [Disease or Syndrome]
   719 E C0332461:Plaque [Finding]

Phrase: "(b)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "(c)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.136: Twenty weeks after injection of A42 aggregates into cortex of SwAPP mice (d-f), a significant reduction of 4G8-positive amyloid plaques was observed throughout the brain (d) and in cortex (e) and hippocampus (f). 

Phrase: "Twenty weeks after injection of A42"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0439230:weeks [Temporal Concept]
   719 E C0332174:/week [Temporal Concept]

Phrase: "aggregates into cortex of SwAPP mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0007776:Cortex [Body Part, Organ, or Organ Component]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0205418:Aggregate [Qualitative Concept]
   753   C1176472:Cortex [Body Part, Organ, or Organ Component]
   753   C2700441:Cortex [Plant]

Phrase: "("

Phrase: "d-"

Phrase: "f),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "a significant reduction of 4G8-positive amyloid plaques"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "observed throughout the brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1441672:Observed [Functional Concept]

Phrase: "("

Phrase: "d)"

Phrase: "and in cortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0007776:Cortex [Body Part, Organ, or Organ Component]
   790   C1176472:Cortex [Body Part, Organ, or Organ Component]
   790   C1515981:And [Idea or Concept]
   790   C2700441:Cortex [Plant]

Phrase: "(e)"

Phrase: "and"

Phrase: "hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "(f)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.137: Twenty weeks after the injections, the injected fibrillar A42 was still detectable by 4G8 immunostaining (open arrows). 

Phrase: "Twenty weeks after the injections,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0439230:weeks [Temporal Concept]
   726 E C0332174:/week [Temporal Concept]

Phrase: "the injected fibrillar A42"

Phrase: "was"

Phrase: "still detectable by 4G8 immunostaining"

Phrase: "(open arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:arrows [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.138: Scale: 1mm for a and d; 

Phrase: "Scale"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0175659:Scale [Medical Device]
  1000   C0349674:Scale [Intellectual Product]
  1000   C1947916:Scale [Activity]
  1000   C3536777:Scale [Manufactured Object]
   928 E C1710017:Scalar [Qualitative Concept]
   916 E C0222045:Scales [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "1mm for a"

Phrase: "and"

Phrase: "d"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ";"
Processing 00000000.tx.139: 200m for b, c, e, and f. 

Phrase: "200m for b,"

Phrase: "c,"

Phrase: "e,"

Phrase: "and"

Phrase: "f."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.140: To quantify the numbers of amyloid plaques, we stained every fiftieth coronal section (250m apart) of all mice beginning with a random section of the olfactory bulbs. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "quantify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantify [Quantitative Concept]

Phrase: "the numbers of amyloid plaques,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   844   C0449793:Number of plaques [Quantitative Concept]
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "we"

Phrase: "stained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2986582:Stained [Qualitative Concept]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "every fiftieth coronal section"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0205123:Coronal [Spatial Concept]
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "(250m apart"

Phrase: ")"

Phrase: "of all mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "beginning with a random section of the olfactory bulbs."
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   764   C0028936:Olfactory Bulbs [Body Part, Organ, or Organ Component]
   742   C0034656:RANDOM [Research Activity]
   742   C0037361:olfactory [Organism Function]
   742   C0205155:Section [Spatial Concept]
   742   C0439605:Random [Qualitative Concept]
   742   C0439659:Beginning [Temporal Concept]
   742   C0439826:Olfactory [Organism Function]
   742   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   742   C1449865:Bulbs [Plant]
   742   C1522472:Section [Substance]
   742   C1552923:Section [Quantitative Concept]
   742   C1705191:Section [Physical Object]
   731 E C1281094:Olfactory bulb [Body Part, Organ, or Organ Component]
   708 E C0025148:Bulb [Body Part, Organ, or Organ Component]
   708 E C1947952:Bulb [Anatomical Structure]
Processing 00000000.tx.141: We found only a few 4G8-immunoreactive plaques in SwAPP mice at 20weeks after A42 injections in addition to marked staining of the fimbria and occasional vascular amyloid deposits (data not shown). 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a few 4G8-immunoreactive plaques in SwAPP mice"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C0333463:plaques [Acquired Abnormality]
   711 E C0011389:Plaque [Disease or Syndrome]
   711 E C0332461:Plaque [Finding]

Phrase: "at 20weeks"

Phrase: "after A42 injections"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0021485:injections [Therapeutic or Preventive Procedure]
   861   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
   861   C1828121:Injections [Functional Concept]
   827 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "in addition to marked staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "of the fimbria"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031921:Fimbria [Cell Component]
  1000   C0152315:Fimbria [Body Part, Organ, or Organ Component]
  1000   C0227912:fimbria [Body Part, Organ, or Organ Component]
  1000   C1504307:Fimbria [Eukaryote]

Phrase: "and"

Phrase: "occasional vascular amyloid deposits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2936349:Amyloid Deposits [Acquired Abnormality]
   812   C0333562:Deposits [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.142: Plaque counts showed a significant decrease of average numbers of 4G8-stained amyloid plaques in A42-treated SwAPP mice as compared with control SwAPP littermates (Fig. 4a). 

Phrase: "Plaque counts"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439157:counts [Quantitative Concept]
   827 E C0750480:Count [Activity]
   827 E C1705566:Count [Quantitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a significant decrease of average numbers of 4G8-stained amyloid plaques"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0392756:Decrease [Qualitative Concept]
   738   C0547047:Decrease [Quantitative Concept]

Phrase: "in A42-treated SwAPP mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "as"

Phrase: "compared with control SwAPP littermates"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 4a"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.143: To determine whether the reduced amyloid pathology was associated with reduced concentrations of transgenic A, we measured the A concentrations in brain tissue by a sandwich ELISA that specifically recognized intact human A. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the reduced amyloid pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0030664:Pathology [Biomedical Occupation or Discipline]
   827   C0205469:pathology [Functional Concept]
   827   C0677042:pathology [Pathologic Function]
   755 E C1521733:Pathologic [Functional Concept]

Phrase: "was"

Phrase: "associated with reduced concentrations of transgenic A,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   762   C0424099:Reduced concentration [Finding]
   748   C0003069:Transgenic [Animal]
   748   C0086045:Concentrations [Mental Process]
   748   C0392756:Reduced [Qualitative Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1446561:Concentration [Quantitative Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "we"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the A concentrations in brain tissue"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "by a sandwich ELISA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014441:ELISA [Laboratory Procedure]

Phrase: "that specifically"

Phrase: "recognized"

Phrase: "intact human A."
Processing 00000000.tx.144: No human A was detected by ELISA in wild type mice. 

Phrase: "No human A"

Phrase: "was"

Phrase: "detected by ELISA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0014441:ELISA [Laboratory Procedure]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "in wild type mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.145: A levels measured in control SwAPP mice were significantly higher than in A42-treated SwAPP mice (Fig. 4b). 

Phrase: "A levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "measured in control SwAPP mice"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0243148:control [Qualitative Concept]
   760   C0444706:Measured [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "were"

Phrase: "significantly higher than"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0205250:High [Qualitative Concept]
   756   C1299351:High [Qualitative Concept]
   756   C2700149:HIGH [Intellectual Product]
   706 E C0489786:Height [Organism Attribute]

Phrase: "in A42-treated SwAPP mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "(Fig. 4b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.146: View larger version (9K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(9K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.147: 4.  

Phrase: "4."
Processing 00000000.tx.148: Numbers of amyloid plaques and brain levels of A were significantly lower 20weeks after intracranial injection of A42. 

Phrase: "Numbers of amyloid plaques"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   881   C0449793:Number of plaques [Quantitative Concept]
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "brain levels of A"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0441889:Levels [Qualitative Concept]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "significantly lower 20weeks after intracranial injection of A42."
Processing 00000000.tx.149: a, randomly chosen sections of A42-injected SwAPP (SwAPP/A42) mice and control age-matched SwAPP littermates (SwAPP) were examined for the presence of 4G8-positive amyloid plaques in randomly selected visual fields covering cortical areas equal to 5mm2 on 5-m thick paraffin sections. 

Phrase: "a,"

Phrase: "randomly chosen sections of A42-injected SwAPP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   714   C0205155:Section [Spatial Concept]
   714   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   714   C1522472:Section [Substance]
   714   C1552923:Section [Quantitative Concept]
   714   C1705191:Section [Physical Object]

Phrase: "(SwAPP/A42"

Phrase: ")"

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "control age-matched SwAPP littermates"

Phrase: "(SwAPP"

Phrase: ")"

Phrase: "were"

Phrase: "examined for the presence of 4G8-positive amyloid plaques"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   764   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
   764   C2936349:Plaques, Amyloid [Acquired Abnormality]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0332128:Examined [Finding]
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
   742   C0439178:% Positive [Quantitative Concept]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1446409:Positive [Qualitative Concept]
   742   C1514241:Positive [Finding]
   742   C2825490:Positive [Qualitative Concept]
   708 E C0011389:Plaque [Disease or Syndrome]
   708 E C0332461:Plaque [Finding]

Phrase: "in randomly"

Phrase: "selected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]

Phrase: "visual fields"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0042826:Visual Fields [Spatial Concept]
   861   C0234621:Visual [Functional Concept]
   827   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   827   C1521738:Field [Conceptual Entity]
   827   C2346620:Field [Conceptual Entity]
   827   C2349184:Field [Conceptual Entity]
   827   C3539073:FIELD [Spatial Concept]

Phrase: "covering"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0180153:covering [Medical Device]
  1000   C0439844:covering [Functional Concept]
   966 E C1707529:Cover [Medical Device]
   966 E C1999244:Cover [Functional Concept]

Phrase: "cortical areas"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   861   C0001613:Cortical [Body Part, Organ, or Organ Component]
   861   C0007776:Cortical [Body Part, Organ, or Organ Component]
   861   C0022655:Cortical [Body Part, Organ, or Organ Component]
   861   C0205146:areas [Spatial Concept]
   827 E C0017446:Area [Geographic Area]
   805 E C0234875:bark [Organism Attribute]
   805 E C2700441:Bark [Plant]
   777 E C0205704:Cascara [Organic Chemical,Pharmacologic Substance]
   777 E C3486388:Cascara [Organic Chemical,Pharmacologic Substance]

Phrase: "equal to 5mm2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0205163:Equal To [Qualitative Concept]
           Equal
   790   C1549782:Equal [Idea or Concept]

Phrase: "on 5-m thick paraffin sections."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0030415:Paraffin [Biomedical or Dental Material,Lipid]
   771   C0205155:Section [Spatial Concept]
   771   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   771   C1522472:Section [Substance]
   771   C1552923:Section [Quantitative Concept]
   771   C1705191:Section [Physical Object]
Processing 00000000.tx.150: Plaque counts were significantly reduced in SwAPP mice after A42 treatment. b, total A amounts were measured in formic acid extracted brain tissue. 

Phrase: "Plaque counts"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439157:counts [Quantitative Concept]
   827 E C0750480:Count [Activity]
   827 E C1705566:Count [Quantitative Concept]

Phrase: "were"

Phrase: "significantly"

Phrase: "reduced in SwAPP mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0392756:Reduced [Qualitative Concept]

Phrase: "after A42 treatment. b,"

Phrase: "total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "A amounts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "measured in formic acid"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   833   C0885348:formic acid [Organic Chemical]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: "brain tissue."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0440746:Brain tissue [Tissue]
  1000   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0040300:Tissue [Tissue]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   861   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.151: Twenty weeks following the injections, brain A levels in A42-injected SwAPP mice were also significantly reduced (*, p0.05,Mann-Whitney U test. Mean valuesS.D.). 

Phrase: "Twenty weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the injections,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0021485:injections [Therapeutic or Preventive Procedure]
  1000   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
  1000   C1828121:Injections [Functional Concept]
   966 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "A levels in A42-injected SwAPP mice"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "also significantly"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "("

Phrase: "*,"

Phrase: "p0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1417248:P0 [Gene or Genome]
   861   C1419691:P0 [Gene or Genome]

Phrase: "Mann-Whitney U test. Mean valuesS."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0242927:Mann-Whitney U Test [Quantitative Concept]
   700   C1708930:Mann-Whitney Test [Intellectual Product]

Phrase: "D."

Phrase: ")."
Processing 00000000.tx.152: In parallel, we measured serum levels of total A and A42 in SwAPP mice before and 20weeks after the injections. 

Phrase: "In parallel,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C2348042:Parallel [Qualitative Concept]
   861   C2826345:PARALLEL [Research Activity]

Phrase: "we"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "serum levels of total A"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   797   C1441420:Serum.total [Laboratory or Test Result]
   760   C0229671:Serum [Body Substance]
   760   C0441889:Levels [Qualitative Concept]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "A42 in SwAPP mice"

Phrase: "before"

Phrase: "and"

Phrase: "20weeks after the injections."
Processing 00000000.tx.153: We found that neither total A nor A42 levels differed among these two time points in any group (data not shown). 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "neither total A"

Phrase: "nor"

Phrase: "A42 levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "differed among these two time"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   765   C1948050:Two Times [Quantitative Concept]
   760   C0040223:Time [Temporal Concept]
   760   C0205448:Two [Quantitative Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "points in any group"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552961:Point [Quantitative Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]
   770   C2347617:point [Quantitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.154: Prevention of Amyloid Plaque Formation Was Accompanied by Reduced Reactive Astrocytosis-- Because brain amyloidosis in SwAPP mice is accompanied by reactive astrocytosis, we analyzed GFAP-reactive astrocytes in response to A42 injections (Fig. 5, a-c). 

Phrase: "Prevention of Amyloid Plaque Formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0199176:Prevention [Therapeutic or Preventive Procedure]
   760   C1706420:PREVENTION [Research Activity]
   760   C2700409:prevention [Qualitative Concept]

Phrase: "Was"

Phrase: "Accompanied by Reduced Reactive Astrocytosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205332:Reactive [Qualitative Concept]
   760   C0392756:Reduced [Qualitative Concept]
   760   C0751171:Astrocytosis [Pathologic Function]

Phrase: "-"

Phrase: "-"

Phrase: "Because"

Phrase: "brain amyloidosis in SwAPP mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0002726:Amyloidosis [Disease or Syndrome]

Phrase: "is"

Phrase: "accompanied by reactive astrocytosis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205332:Reactive [Qualitative Concept]
   770   C0751171:Astrocytosis [Pathologic Function]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "GFAP-reactive astrocytes in response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0333735:Reactive Astrocyte [Cell]
   760   C0004112:Astrocytes [Cell]

Phrase: "to A42 injections"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0021485:injections [Therapeutic or Preventive Procedure]
   861   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
   861   C1828121:Injections [Functional Concept]
   827 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "(Fig. 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "a-c)."
Processing 00000000.tx.155: Twenty weeks after injections, GFAP staining of reactive astrocytes was significantly lower in brains of A42-injected SwAPP mice (Fig. 5c) as compared with control SwAPP littermates (Fig. 5b) but significantly higher than in wild type littermates (Fig. 5a). 

Phrase: "Twenty weeks after injections,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0439230:weeks [Temporal Concept]
   737 E C0332174:/week [Temporal Concept]

Phrase: "GFAP staining of reactive astrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "significantly lower in brains of A42-injected SwAPP mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0441994:Lower [Spatial Concept]
   742   C1548802:Lower [Body Location or Region]
   742   C2003888:Lower [Activity]

Phrase: "(Fig. 5c"

Phrase: ")"

Phrase: "as"

Phrase: "compared with control SwAPP littermates"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 5b"

Phrase: ")"

Phrase: "but"

Phrase: "significantly higher than"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0205250:High [Qualitative Concept]
   756   C1299351:High [Qualitative Concept]
   756   C2700149:HIGH [Intellectual Product]
   706 E C0489786:Height [Organism Attribute]

Phrase: "in wild type littermates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "(Fig. 5a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.156: Moreover, the clusters of GFAP-positive cells commonly found in SwAPP mice were completely absent in response to A42 injections, paralleling the absence of amyloid plaques in A42-treated mice (Fig. 3, d-f). 

Phrase: "Moreover,"

Phrase: "the clusters of GFAP-positive cells commonly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C1179412:cell clusters [Body Part, Organ, or Organ Component]
   714   C1555715:Cluster [Idea or Concept]
   714   C1704332:Cluster [Quantitative Concept]

Phrase: "found in SwAPP mice"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0150312:Found [Quantitative Concept]
   737 E C0243095:Find [Finding]

Phrase: "were"

Phrase: "completely absent in response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:Absent [Quantitative Concept]
   770   C2699517:ABSENT [Finding]

Phrase: "to A42 injections,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0021485:injections [Therapeutic or Preventive Procedure]
   861   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
   861   C1828121:Injections [Functional Concept]
   827 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "paralleling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C2348042:Parallel [Qualitative Concept]
   966   C2826345:PARALLEL [Research Activity]

Phrase: "the absence of amyloid plaques"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]

Phrase: "in A42-treated mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "d-"

Phrase: "f)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.157: View larger version (39K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(39K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.158: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.159: A42 injections reduced astrogliosis associated with amyloid formation in SwAPP mice. 

Phrase: "A42 injections"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0021485:injections [Therapeutic or Preventive Procedure]
   861   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
   861   C1828121:Injections [Functional Concept]
   827 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "astrogliosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017639:Astrogliosis [Pathologic Function]

Phrase: "associated with amyloid formation"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1522492:Formation [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in SwAPP mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.160: Representative sections through the cortex and hippocampus are shown. a-c, 20weeks after A42 injections, the overall astrogliosis was lower in SwAPP mice treated with A42 (c) as compared with control SwAPP littermates (b) but higher than non-tg littermates (a). 

Phrase: "Representative sections through the cortex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   726   C0205155:Section [Spatial Concept]
   726   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   726   C1522472:Section [Substance]
   726   C1552923:Section [Quantitative Concept]
   726   C1705191:Section [Physical Object]

Phrase: "and"

Phrase: "hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "are"

Phrase: "shown. a-c, 20weeks after A42 injections,"

Phrase: "the overall astrogliosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017639:Astrogliosis [Pathologic Function]

Phrase: "was"

Phrase: "lower in SwAPP mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]

Phrase: "treated with A42"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "(c)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "as"

Phrase: "compared with control SwAPP littermates"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "(b)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "but"

Phrase: "higher than non-tg littermates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "("

Phrase: "a"

Phrase: ")."
Processing 00000000.tx.161: Note the nearly complete absence of astrogliosis in the cortex of treated SwAPP mice (c), whereas many reactive astrocytes could be found in hippocampus. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "the nearly"

Phrase: "complete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Complete [Qualitative Concept]

Phrase: "absence of astrogliosis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "in the cortex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "of treated SwAPP mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "(c),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "whereas"

Phrase: "many reactive astrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0333735:Reactive Astrocyte [Cell]
   861   C0004112:Astrocytes [Cell]

Phrase: "could"

Phrase: "be"

Phrase: "found in hippocampus."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   790   C0150312:Found [Quantitative Concept]
   790   C0949582:Hippocampus [Fish]
   790   C1029104:Hippocampus [Fish]
   790   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
   756 E C0243095:Find [Finding]
Processing 00000000.tx.162: Scale: 1mm. 

Phrase: "Scale"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0175659:Scale [Medical Device]
  1000   C0349674:Scale [Intellectual Product]
  1000   C1947916:Scale [Activity]
  1000   C3536777:Scale [Manufactured Object]
   928 E C1710017:Scalar [Qualitative Concept]
   916 E C0222045:Scales [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "1mm."
Processing 00000000.tx.163: Prevention of Amyloid Formation Was Independent of IgG-- An IgG-mediated immune response was implicated in the prevention of amyloid formation after active immunization of PDAPP mice against A (10). 

Phrase: "Prevention of Amyloid Formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0199176:Prevention [Therapeutic or Preventive Procedure]
   770   C1706420:PREVENTION [Research Activity]
   770   C2700409:prevention [Qualitative Concept]

Phrase: "Was Independent of IgG--"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0332291:Independent of [Functional Concept]
   770   C0043194:WAS [Disease or Syndrome]
   770   C0085862:Independent [Idea or Concept]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1299583:Independent [Finding]
   770   C1421478:WAS [Gene or Genome]

Phrase: "An IgG-mediated immune response"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   875   C0870868:mediated response [Mental Process]
   861   C0301872:Immune response [Organ or Tissue Function]
   812   C0439662:Immune [Functional Concept]
   812   C0871261:Response [Organism Attribute]
   812   C1704632:Response [Finding]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]

Phrase: "was"

Phrase: "implicated in the prevention of amyloid formation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0199176:Prevention [Therapeutic or Preventive Procedure]
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1522492:Formation [Functional Concept]
   748   C1706420:PREVENTION [Research Activity]
   748   C2700409:prevention [Qualitative Concept]

Phrase: "after active immunization"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0042196:active immunization [Therapeutic or Preventive Procedure]
           immunisation
  1000   C0205991:Active immunisation [Therapeutic or Preventive Procedure]
   861   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   861   C0205177:Active [Functional Concept]
   861   C3244291:immunization [Functional Concept]

Phrase: "of PDAPP mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "against A (10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052080:A-10 [Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.164: Therefore, we next tested our mice for the presence of endogenous immunoglobin antibodies at the amyloid injection sites and on the few plaques that had developed after A42 injections by immunochemistry with mouse-specific anti-immunoglobulin antibodies. 

Phrase: "Therefore,"

Phrase: "we next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "our mice for the presence of endogenous immunoglobin antibodies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]

Phrase: "at the amyloid injection sites"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   901   C0179694:injection sites [Medical Device]
   901   C0600077:Injection sites [Functional Concept]
   884 E C0221208:Injection site [Injury or Poisoning]
   884 E C2700396:Injection site [Spatial Concept]
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "and on the few plaques"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0333463:plaques [Acquired Abnormality]
   760   C1515981:And [Idea or Concept]
   726 E C0011389:Plaque [Disease or Syndrome]
   726 E C0332461:Plaque [Finding]

Phrase: "that"

Phrase: "had"

Phrase: "developed after A42 injections"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0021485:injections [Therapeutic or Preventive Procedure]
   770   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
   770   C1828121:Injections [Functional Concept]
   737 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "by immunochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020986:Immunochemistry [Biomedical Occupation or Discipline]

Phrase: "with mouse-specific anti-immunoglobulin antibodies."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   873   C0443641:Anti-immunoglobulin antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   853   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   836 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
       E   Antibody
   804   C1621846:immunoglobulin [Molecular Function]
Processing 00000000.tx.165: Neither the injected A42 remaining around the needle tract nor the few 4G8-immunoreactive plaques reacted with the anti-mouse antibodies. 

Phrase: "Neither"

Phrase: "the injected A42 remaining around the needle tract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1527428:Remaining [Qualitative Concept]

Phrase: "nor"

Phrase: "the few 4G8-immunoreactive plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0333463:plaques [Acquired Abnormality]
   779 E C0011389:Plaque [Disease or Syndrome]
   779 E C0332461:Plaque [Finding]

Phrase: "reacted with the anti-mouse antibodies."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   783   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.166: This was in sharp contrast to peripherally immunized mice that had abundant IgG-positive plaques (this study and Ref. 10). 

Phrase: "This"

Phrase: "was in sharp contrast to peripherally immunized mice"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0043194:WAS [Disease or Syndrome]
   744   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1421478:WAS [Gene or Genome]
   744   C1444775:Sharp [Finding]
   744   C1539835:SHARP [Gene or Genome]
   744   C1979874:Contrast [Qualitative Concept]

Phrase: "that"

Phrase: "had"

Phrase: "abundant IgG-positive plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0333463:plaques [Acquired Abnormality]
   779 E C0011389:Plaque [Disease or Syndrome]
   779 E C0332461:Plaque [Finding]

Phrase: "("

Phrase: "this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "Ref. 10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.167: We also determined serum levels of anti-A antibodies in SwAPP mice and non-tg littermates collected before and 20weeks after the injections. 

Phrase: "We also determined serum levels of anti-A antibodies"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   742   C0229671:Serum [Body Substance]
   742   C0441889:Levels [Qualitative Concept]
   742   C1546774:Serum [Intellectual Product]
   742   C1550100:Serum [Body Substance]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "in SwAPP mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "non-tg littermates"

Phrase: "collected before"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1516695:Collected [Idea or Concept]
   833   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "20weeks after the injections."
Processing 00000000.tx.168: We found no significant changes of anti-A antibody levels because of the A42 injections in any group (Fig. 6). 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no significant changes of anti-A antibody levels"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   750   C0442739:No change [Finding]
   750   C1548568:No change [Intellectual Product]
   744   C0392747:changes [Functional Concept]
   744   C0443172:changes [Quantitative Concept]
   711 E C1705241:Change [Quantitative Concept]

Phrase: "because of the A42 injections"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0021485:injections [Therapeutic or Preventive Procedure]
   861   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
   861   C1828121:Injections [Functional Concept]
   827 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "in any group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.169: View larger version (10K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(10K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.170: 6.  

Phrase: "6."
Processing 00000000.tx.171: Serum levels of anti-A antibodies did not differ significantly 20weeks before and after the injections of A42 or PBS in brains of SwAPP mice, and they were similar to the corresponding levels in non-tg littermates. 

Phrase: "Serum levels of anti-A antibodies"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0229671:Serum [Body Substance]
   753   C0441889:Levels [Qualitative Concept]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "differ"

Phrase: "significantly 20weeks before"

Phrase: "and after the injections of A42"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0021485:injections [Therapeutic or Preventive Procedure]
   753   C1515981:And [Idea or Concept]
   753   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
   753   C1828121:Injections [Functional Concept]
   719 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "or"

Phrase: "PBS in brains of SwAPP mice,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   744   C0031701:phosphate [Organophosphorus Compound]
   744   C0036082:Saline [Substance]
   744   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "they"

Phrase: "were"

Phrase: "similar to the corresponding levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "in non-tg littermates."
Processing 00000000.tx.172: Although these data do not exclude a role of the immune system in the prevention of amyloid formation in our experiments, they strongly suggest that the mechanisms involved in prevention of amyloid formation differ between the intracerebral injections of A42 fibrils and the peripheral immunization protocols with added adjuvants and repeated boosts. 

Phrase: "Although"

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "a role of the immune system"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in the prevention"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0199176:Prevention [Therapeutic or Preventive Procedure]
  1000   C1706420:PREVENTION [Research Activity]
  1000   C2700409:prevention [Qualitative Concept]

Phrase: "of amyloid formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "in our experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "they strongly"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "involved in prevention of amyloid formation"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0199176:Prevention [Therapeutic or Preventive Procedure]
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1314939:Involved [Functional Concept]
   753   C1522492:Formation [Functional Concept]
   753   C1706420:PREVENTION [Research Activity]
   753   C2700409:prevention [Qualitative Concept]

Phrase: "differ between the intracerebral injections of A42 fibrils"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   754   C0678828:intracerebral injection [Functional Concept]
   744   C0021485:injections [Therapeutic or Preventive Procedure]
   744   C0225328:fibrils [Cell Component]
   744   C0442111:Intracerebral [Spatial Concept]
   744   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
   744   C1828121:Injections [Functional Concept]
   711 E C1272883:Injection [Biomedical or Dental Material]
   711 E C1948066:Fibril [Physical Object]

Phrase: "and"

Phrase: "the peripheral immunization protocols with added adjuvants"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   748   C0442711:Protocols [Intellectual Product]
   741   C1510810:Adjuvant Protocol [Research Activity]
   714 E C1507394:Protocol [Intellectual Product]
   714 E C1522729:Protocol [Intellectual Product]
   714 E C2348563:Protocol [Intellectual Product]

Phrase: "and"

Phrase: "repeated boosts."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511253:Boost [Functional Concept]
   827   C1874596:BOOST [Food]
Processing 00000000.tx.173: Role of Other A-degrading Enzymes-- To determine whether other A-degrading proteases were involved in preventing amyloid formation in our mice, we also analyzed brain tissue levels of IDE, a 100-kDa Zn-metalloproteinase that is a major A-degrading enzyme in tissue culture (11, 22). 

Phrase: "Role of Other A-degrading Enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "other A-degrading proteases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C1947941:Proteases [Enzyme]

Phrase: "were"

Phrase: "involved in preventing amyloid formation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1314939:Involved [Functional Concept]
   760   C1522492:Formation [Functional Concept]
   726   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "in our mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "we also analyzed brain tissue levels of"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "IDE,"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0332257:include [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1552866:include [Idea or Concept]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C2700399:Include [Activity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "a 100-kDa Zn-metalloproteinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that"

Phrase: "is"

Phrase: "a major A-degrading enzyme in tissue culture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0014442:Enzyme [Enzyme,Organic Chemical]

Phrase: "(11,"

Phrase: "22"

Phrase: ")."
Processing 00000000.tx.174: 20weeks after the injections, the IDE-1 antibody (11) revealed very little if any differences in tissue levels of IDE in response to A42 injections (data not shown). 

Phrase: "20weeks after the injections,"

Phrase: "the"

Phrase: "IDE-1 antibody"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   876   C0021644:Insulin antibody [Immunologic Factor]
   861   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0014442:Enzyme [Enzyme,Organic Chemical]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0332257:include [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1552866:include [Idea or Concept]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C2700399:Include [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C0014445:enzymes [Functional Concept]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(11"

Phrase: ")"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "very little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
   861   C0700321:Little [Quantitative Concept]
   861   C2700395:Little [Quantitative Concept]

Phrase: "if"

Phrase: "any differences in tissue levels of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "IDE"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0332257:include [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1552866:include [Idea or Concept]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C2700399:Include [Activity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to A42 injections"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0021485:injections [Therapeutic or Preventive Procedure]
   861   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
   861   C1828121:Injections [Functional Concept]
   827 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.175: Moreover, metalloprotease 24.15,another A-degrading enzyme (12), was also unchanged in response to A injections. 

Phrase: "Moreover,"

Phrase: "metalloprotease 24.15,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0025543:METALLOPROTEASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "another A-degrading enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "(12"

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "also unchanged in response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442739:Unchanged [Finding]
   770   C2346711:Unchanged [Qualitative Concept]

Phrase: "to A injections."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0021485:injections [Therapeutic or Preventive Procedure]
  1000   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
  1000   C1828121:Injections [Functional Concept]
   966 E C1272883:Injection [Biomedical or Dental Material]
Processing 00000000.tx.176: Together, these data do not exclude the possible roles of IDE and 24.15in degrading A in vivo, but they clearly suggest an important role of NEP in preventing amyloid formation in our experimental model. 

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "the possible roles of"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0035820:Roles [Social Behavior]
   737 E C1705810:Role [Conceptual Entity]

Phrase: "IDE"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0332257:include [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1552866:include [Idea or Concept]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C2700399:Include [Activity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "24.15in"

Phrase: "degrading"

Phrase: "A in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "but"

Phrase: "they clearly"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "an important role of NEP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in preventing amyloid formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "in our experimental model."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086272:Experimental Model [Intellectual Product]
   861   C3161035:Model [Intellectual Product]
Processing 00000000.tx.177: As an additional control experiment, we tested brain tissue levels of ACE, an unrelated neuronal Zn-metalloendopeptidase (23-25) with no known affinity to A (26). 

Phrase: "As an additional control experiment,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   827   C0243148:control [Qualitative Concept]
   827   C0681814:Experiment [Research Activity]
   827   C1550141:Control [Substance]
   827   C1706386:Experiment [Conceptual Entity]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   755 E C1517586:Experimental [Qualitative Concept]

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "brain tissue levels of ACE,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   774   C0014440:enzyme levels [Laboratory Procedure]
   774   C1287349:enzyme levels [Laboratory or Test Result]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "an unrelated neuronal Zn-metalloendopeptidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1442934:Metalloendopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(23-25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: "with no known affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "to A (26"

Phrase: ")."
Processing 00000000.tx.178: The ACE levels also did not differ between treated and untreated following an A42 injection.  

Phrase: "The ACE levels also"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   884   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   840   C0014440:enzyme levels [Laboratory Procedure]
   840   C1287349:enzyme levels [Laboratory or Test Result]
   804   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "differ between treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332293:treated [Therapeutic or Preventive Procedure]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "untreated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332155:untreated [Finding]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "an A42 injection."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1828121:Injection [Functional Concept]
Processing 00000000.tx.179: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Our data show that injection of synthetic fibrillar A42 into mouse brains caused sustained increases of NEP over a period of 20weeks was associated with a dramatic reduction in brain tissue levels of A and with inhibition of amyloid plaque formation in our mice. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that injection of synthetic fibrillar A42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0021485:injection [Therapeutic or Preventive Procedure]
   753   C1272883:Injection [Biomedical or Dental Material]
   753   C1533685:Injection [Therapeutic or Preventive Procedure]
   753   C1828121:Injection [Functional Concept]

Phrase: "into mouse brains"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1521713:Mouse Brain [Tissue]
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "sustained increases of NEP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:increases [Functional Concept]

Phrase: "over a period"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0439531:/period [Temporal Concept]
  1000   C1948053:Period [Temporal Concept]
   928 E C0332182:Periodic [Temporal Concept]
   928 E C1706381:PERIODIC [Intellectual Product]
   900 E C0031084:Periodicities [Temporal Concept]

Phrase: "of 20weeks"

Phrase: "was"

Phrase: "associated with a dramatic reduction"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in brain tissue levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   734   C0440746:Brain tissue [Tissue]
   734   C0459385:Brain tissue [Body Part, Organ, or Organ Component]

Phrase: "of A"

Phrase: "and with inhibition of amyloid plaque formation"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   778   C0333463:amyloid plaque [Acquired Abnormality]
           plaque
   778   C2936349:Plaque, Amyloid [Acquired Abnormality]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011389:Plaque [Disease or Syndrome]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C0220781:formation [Biologic Function]
   748   C0332461:Plaque [Finding]
   748   C0439634:formation [Spatial Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1515981:And [Idea or Concept]
   748   C1522492:Formation [Functional Concept]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "in our mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.180: As claimed by the amyloid cascade hypothesis (3, 27), the overproduction of A or the failure to remove it can lead to the formation of amyloid plaques and subsequently to neuronal damage and is crucial to the development of AD. 

Phrase: "As"

Phrase: "claimed by the amyloid cascade hypothesis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1512571:Hypothesis [Idea or Concept]
   753   C1707310:Cascade [Manufactured Object]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "27"

Phrase: ")"

Phrase: ","

Phrase: "the overproduction of A"

Phrase: "or"

Phrase: "the failure to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0231174:Failure [Functional Concept]
   861   C0680095:failure [Individual Behavior]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "it"

Phrase: "can"

Phrase: "lead to the formation of amyloid plaques"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   778   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
   778   C2936349:Plaques, Amyloid [Acquired Abnormality]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   748   C1522492:Formation [Functional Concept]
   748   C1522538:Lead [Functional Concept]
   748   C2348269:Lead [Element, Ion, or Isotope]
   748   C3275067:LEAD [Therapeutic or Preventive Procedure]
   714 E C0011389:Plaque [Disease or Syndrome]
   714 E C0332461:Plaque [Finding]

Phrase: "and"

Phrase: "subsequently to neuronal damage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010957:Damage [Injury or Poisoning]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C1883709:Damage [Functional Concept]

Phrase: "and"

Phrase: "is"

Phrase: "crucial to the development of AD."
Processing 00000000.tx.181: A42 fibrils are probably formed by initial "seeding" followed by increased precipitation of additional A molecules into amyloid plaques (28). 

Phrase: "A42 fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0225328:fibrils [Cell Component]
   827 E C1948066:Fibril [Physical Object]

Phrase: "are"

Phrase: "probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "formed by initial ""seeding"""
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0205265:Initial [Temporal Concept]
   770   C0205431:Formed [Functional Concept]
   770   C1279901:Initial [Qualitative Concept]
   770   C1555582:Initial [Idea or Concept]
   770   C1705192:Seeding [Laboratory Procedure]
   770   C1705685:INITIAL [Functional Concept]
   737 E C0348078:Form [Qualitative Concept]
   737 E C0376315:Form [Manufactured Object]
   737 E C1522492:Form [Functional Concept]

Phrase: "followed by increased precipitation of additional"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0032931:Precipitation [Natural Phenomenon or Process]
   753   C0032932:Precipitation [Molecular Function]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C1524062:Additional [Functional Concept]
   753   C1642401:% precipitation [Quantitative Concept]
   753   C2584299:Precipitation [Natural Phenomenon or Process]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "A molecules into amyloid plaques"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0567416:molecules [Substance]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.182: However, our data show clearly that the injection of pure synthetic fibrillar A42 did not accelerate amyloid formation in SwAPP mice. 

Phrase: "However,"

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "clearly"

Phrase: "that"

Phrase: "the injection of pure synthetic fibrillar A42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021485:injection [Therapeutic or Preventive Procedure]
   748   C1272883:Injection [Biomedical or Dental Material]
   748   C1533685:Injection [Therapeutic or Preventive Procedure]
   748   C1828121:Injection [Functional Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "accelerate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "amyloid formation in SwAPP mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]
Processing 00000000.tx.183: These data are possibly at variance with reports that found evidence for accelerated amyloid plaque formation after intracerebral infusion of AD brain extracts into SwAPP mice (29). 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "possibly at variance with"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1711260:Variance [Qualitative Concept]
   770   C2348152:Variance [Quantitative Concept]
   770   C2362652:Possibly [Qualitative Concept]

Phrase: "reports"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that found evidence for accelerated amyloid plaque formation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0332120:Evidence [Functional Concept]

Phrase: "after intracerebral infusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0574032:Infusion [Therapeutic or Preventive Procedure]
   861   C1827465:Infusion [Functional Concept]

Phrase: "of AD brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "extracts into SwAPP mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C2828366:Extract [Substance]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.184: This apparent discrepancy may be related to the fact that in those experiments a complex mixture of plaque-bearing human brain extracts was injected into SwAPP mice, whereas our injected material consisted of chemically pure synthetic A42 fibrils. 

Phrase: "This apparent discrepancy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1290905:Discrepancy [Finding]

Phrase: "may"

Phrase: "be"

Phrase: "related to the fact"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0439849:Related [Qualitative Concept]
   770   C0445223:Related [Finding]
   737 E C0163712:Relate [Organic Chemical]

Phrase: "that in those experiments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0681814:Experiments [Research Activity]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "a complex mixture of plaque-bearing human brain extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0439962:Mixture [Substance]

Phrase: "was"

Phrase: "injected into SwAPP mice,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   737   C1720154:Inject [Functional Concept]

Phrase: "whereas"

Phrase: "our injected material"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0940886:Injected material [Substance]
   861   C0520510:Material [Substance]

Phrase: "consisted of chemically pure synthetic A42 fibrils."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0220806:Chemically [Chemical]
   748   C0225328:fibrils [Cell Component]
   748   C1883254:synthetic [Activity]
   748   C2247561:PurE [Molecular Function]
   714   C0332529:CONSIST [Qualitative Concept]
   714 E C1948066:Fibril [Physical Object]
Processing 00000000.tx.185: The possibility of existence of additional amyloidogenic factors in human brain extracts is further supported by the finding that similar seeding effect, caused by human brain extracts also occurred after immunodepletion of >80% A from the extracts.2 Thus, the effects of injections of brain extracts on amyloid formation may be independent of A and principally different from these described here. 

Phrase: "The possibility of existence of additional amyloidogenic factors"

Phrase: "in human brain extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2828366:Extract [Substance]

Phrase: "is"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "supported by the finding"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0037088:Finding [Sign or Symptom]
   770   C0243095:Finding [Finding]
   770   C1521721:Supported [Conceptual Entity]
   770   C2825141:Finding [Finding]
   737 E C0183683:Support [Medical Device]

Phrase: "that similar seeding effect,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1280500:Effect [Qualitative Concept]
   827   C2348382:Effect [Qualitative Concept]

Phrase: "caused by human brain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0086418:Human [Human]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   737   C0015127:cause [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]

Phrase: "extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828366:Extract [Substance]

Phrase: "also"

Phrase: "occurred after immunodepletion of >80% A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1709305:Occurred [Activity]
   719 E C2745955:OCCUR [Temporal Concept]

Phrase: "from the extracts.2 Thus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2828366:Extract [Substance]

Phrase: "the effects of injections of brain"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "extracts on amyloid formation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1522492:Formation [Functional Concept]
   770   C2828366:Extract [Substance]

Phrase: "may"

Phrase: "be independent of A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0332291:Independent of [Functional Concept]
   770   C0085862:Independent [Idea or Concept]
   770   C1299583:Independent [Finding]
   770   C2987476:Be [Conceptual Entity]

Phrase: "and"

Phrase: "principally different from these described here."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]
Processing 00000000.tx.186: Amyloidogenic factors in human brain extract may include the heptapeptide spinorphin, the endogenous brain-specific NEP inhibitor, that was shown to slow A-degradation in vivo (1, 30), thus accelerate amyloid plaque formation. 

Phrase: "Amyloidogenic factors in human brain extract"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1552291:Human Factors [Intellectual Product]
   783   C1552302:Human Factors [Intellectual Product]
   719   C1521761:Factor [Functional Concept]
   719   C2827422:Factor [Conceptual Entity]

Phrase: "may"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the heptapeptide spinorphin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0218564:spinorphin [Amino Acid, Peptide, or Protein]

Phrase: "the endogenous brain-specific NEP inhibitor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1999216:Inhibitor [Qualitative Concept]

Phrase: "that"

Phrase: "was"

Phrase: "shown to slow A-degradation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0243125:degradation [Functional Concept]
   760   C0439834:Slow [Qualitative Concept]
   760   C0699900:Degradation [Organism Function]
   726   C1547282:Show [Intellectual Product]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "30"

Phrase: ")"

Phrase: ","

Phrase: "thus"

Phrase: "accelerate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "amyloid plaque formation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   734   C0333463:amyloid plaque [Acquired Abnormality]
   734   C2936349:Plaque, Amyloid [Acquired Abnormality]
Processing 00000000.tx.187: Intracranially injected A can be cleared from the brain within minutes (31), possibly via receptor-mediated transport through ventricle and choroid plexus cells (32, 33). 

Phrase: "Intracranially"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "A"

Phrase: "can"

Phrase: "be"

Phrase: "cleared from the brain"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0521097:cleared [Functional Concept]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   737 E C2963144:Clear [Qualitative Concept]

Phrase: "within minutes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439232:minute [Temporal Concept]
  1000   C0700321:minute [Quantitative Concept]
  1000   C0702093:/minute [Temporal Concept]
  1000   C1282918:Minute [Quantitative Concept]
  1000   C2347166:Minute [Quantitative Concept]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "possibly via receptor-mediated transport"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0005528:Transport, NOS [Cell Function]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C1317949:Transport [Manufactured Object]
   760   C2362652:Possibly [Qualitative Concept]
   760   C3495449:transport [Medical Device]

Phrase: "through ventricle"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0018827:Ventricle [Body Part, Organ, or Organ Component]
  1000   C2355627:Ventricle [Body Part, Organ, or Organ Component]
   928 E C1522565:Ventricular [Spatial Concept]
   900 E C0038351:Ventriculus [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "choroid plexus cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C0008524:Choroid Plexus [Body Part, Organ, or Organ Component]
   734   C1280704:Choroid plexus [Body Part, Organ, or Organ Component]
   734   C2326827:Chorioid plexus [Anatomical Structure]

Phrase: "(32,"

Phrase: "33"

Phrase: ")."
Processing 00000000.tx.188: These data are consistent with two observations we made during this study, a sustained astrogliosis in hippocampus along with high 4G8 immunoreactivity in the fimbria of A42-treated SwAPP mice. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "consistent with two observations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "we"

Phrase: "made during this study,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
   737   C1881534:Make [Functional Concept]

Phrase: "a sustained astrogliosis in hippocampus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0017639:Astrogliosis [Pathologic Function]

Phrase: "along with high 4G8 immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597879:immunoreactivity [Molecular Function]

Phrase: "in the fimbria"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031921:Fimbria [Cell Component]
  1000   C0152315:Fimbria [Body Part, Organ, or Organ Component]
  1000   C0227912:fimbria [Body Part, Organ, or Organ Component]
  1000   C1504307:Fimbria [Eukaryote]

Phrase: "of A42-treated SwAPP mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
Processing 00000000.tx.189: Taken together, these data suggest an active role of the hippocampus and the ventricular system in clearing A from the brain. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "an active role of the hippocampus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "the ventricular system in clearing"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0007799:ventricular system [Body Space or Junction]
   760   C0449913:System [Functional Concept]
   760   C1553451:System [Manufactured Object]
   760   C1704459:System [Medical Device]

Phrase: "A from the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.190: We found no evidence for an involvement of IgG in mediating A clearance, because in contrast to active immunization by peripheral injections of A, we found no IgG in any injected brain. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no evidence for an involvement of IgG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in"

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "A clearance,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449297:Clearance [Qualitative Concept]
  1000   C1382187:Clearance [Clinical Attribute]
  1000   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "because in contrast to active immunization"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0042196:active immunization [Therapeutic or Preventive Procedure]
           immunisation
   790   C0205991:Active immunisation [Therapeutic or Preventive Procedure]
   753   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   753   C0205177:Active [Functional Concept]
   753   C1979874:Contrast [Qualitative Concept]
   753   C3244291:immunization [Functional Concept]

Phrase: "by peripheral injections"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0021485:injections [Therapeutic or Preventive Procedure]
   861   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
   861   C1828121:Injections [Functional Concept]
   827 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "of A,"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no IgG in any injected brain."
Processing 00000000.tx.191: In addition, serum levels of anti-A antibodies were unchanged before and 20weeks after the injections. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "serum levels of anti-A antibodies"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0229671:Serum [Body Substance]
   753   C0441889:Levels [Qualitative Concept]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "unchanged before"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0442739:Unchanged [Finding]
   833   C2346711:Unchanged [Qualitative Concept]

Phrase: "and"

Phrase: "20weeks after the injections."
Processing 00000000.tx.192: Moreover, serum levels of total A and A42 were identical before and after the injections. 

Phrase: "Moreover,"

Phrase: "serum levels of total A"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   797   C1441420:Serum.total [Laboratory or Test Result]
   760   C0229671:Serum [Body Substance]
   760   C0441889:Levels [Qualitative Concept]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "A42"

Phrase: "were"

Phrase: "identical before"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0205280:Identical [Qualitative Concept]

Phrase: "and after the injections."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0021485:injections [Therapeutic or Preventive Procedure]
   770   C1515981:And [Idea or Concept]
   770   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
   770   C1828121:Injections [Functional Concept]
   737 E C1272883:Injection [Biomedical or Dental Material]
Processing 00000000.tx.193: Therefore, a decrease in brain A levels in our experiments were not the result of immune responses similar to those found after intramuscular or intraperitoneal immunizations against A42 (10, 34, 44). 

Phrase: "Therefore,"

Phrase: "a decrease in brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]

Phrase: "A levels in our experiments"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the result of immune responses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "similar to those found"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "after"

Phrase: "intramuscular"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021492:INTRAMUSCULAR [Functional Concept]
  1000   C0442117:Intramuscular [Spatial Concept]

Phrase: "or"

Phrase: "intraperitoneal immunizations against A42"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0020971:Immunizations [Therapeutic or Preventive Procedure]
   737 E C0042196:immunization [Therapeutic or Preventive Procedure]
   737 E C3244291:immunization [Functional Concept]

Phrase: "(10,"

Phrase: "34,"

Phrase: "44"

Phrase: ")."
Processing 00000000.tx.194: These results are in agreement with the interpretation that increased brain levels and proteolytic activities of NEP resulted in the cleavage and removal of A and consequently in prevention of amyloid plaque formation in these mice. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are in agreement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0680240:Agreement [Social Behavior]
   790   C1551058:Are [Quantitative Concept]

Phrase: "with the interpretation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0459471:Interpretation [Intellectual Product]
  1000   C3173575:Interpretation [Clinical Attribute]

Phrase: "that increased brain levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0441889:Levels [Qualitative Concept]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "proteolytic activities of NEP"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C1150197:neprilysin activity [Molecular Function]
   770   C0441655:Activities [Activity]
   770   C0597304:Proteolytic [Molecular Function]
   770   C1947941:proteolytic [Enzyme]
   737 E C0205177:Activity [Functional Concept]
   737 E C0439167:% activity [Quantitative Concept]
   737 E C1561536:*Activity [Idea or Concept]

Phrase: "resulted in the cleavage"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0010813:cleavage [Cell Function]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "and"

Phrase: "removal of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0015252:Removal [Therapeutic or Preventive Procedure]
   790   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "consequently in prevention of amyloid plaque formation"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   778   C0333463:amyloid plaque [Acquired Abnormality]
           plaque
   778   C2936349:Plaque, Amyloid [Acquired Abnormality]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011389:Plaque [Disease or Syndrome]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0199176:Prevention [Therapeutic or Preventive Procedure]
   748   C0220781:formation [Biologic Function]
   748   C0332461:Plaque [Finding]
   748   C0439634:formation [Spatial Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1522492:Formation [Functional Concept]
   748   C1706420:PREVENTION [Research Activity]
   748   C2700409:prevention [Qualitative Concept]

Phrase: "in these mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.195: Our results are consistent with previous data showing that deleting the NEP gene in mice caused deficient cleavage of either endogenous or exogenous A (35) and that elevating the expression of NEP in neurons reduced both secreted and cell-associated A (36). 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "consistent with previous data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that deleting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880274:Delete [Activity]

Phrase: "the NEP gene in mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1417166:MICE gene [Gene or Genome]
   760   C0017337:Gene [Gene or Genome]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "deficient cleavage of either endogenous"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0010813:cleavage [Cell Function]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]

Phrase: "or"

Phrase: "exogenous A (35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205101:Exogenous [Spatial Concept]
   827   C0205228:Exogenous [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "that elevating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205250:elevate [Qualitative Concept]

Phrase: "the expression of NEP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "both secreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreted [Cell Function]

Phrase: "and"

Phrase: "cell-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "associated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "A (36"

Phrase: ")."
Processing 00000000.tx.196: The mechanism that links A42 to increased NEP levels is unknown. 

Phrase: "The mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "links"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "A42 to increased NEP levels"

Phrase: "is"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.197: Our data favor the possibility of a transcriptional activation of NEP gene expression in response to injections and a sustained stimulation of this mechanism by highly insoluble A42 aggregates, ensuring a long term elevation of NEP protein levels in the brain. 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "favor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "the possibility of a transcriptional activation of NEP gene expression"

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to injections"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0021485:injections [Therapeutic or Preventive Procedure]
  1000   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
  1000   C1828121:Injections [Functional Concept]
   966 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "and"

Phrase: "a sustained stimulation of this mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   753   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "by highly insoluble A42 aggregates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205418:aggregates [Qualitative Concept]

Phrase: "ensuring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0218063:Ensure [Food]

Phrase: "a long term elevation of NEP protein levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0439775:Elevation [Therapeutic or Preventive Procedure]
   744   C0702240:Elevation [Spatial Concept]

Phrase: "in the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.198: This scenario is supported by the fact that the synthetic A aggregates injected into mouse brains were remarkably stable over 20weeks following the injection and seem to be resistant to the clearing mechanism triggered here, constantly causing the induction of the unknown signal for the NEP up-regulation. 

Phrase: "This scenario"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683579:scenario [Functional Concept]

Phrase: "is"

Phrase: "supported by the fact"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1521721:Supported [Conceptual Entity]
   737 E C0183683:Support [Medical Device]

Phrase: "that"

Phrase: "the synthetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:synthetic [Activity]

Phrase: "A aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:aggregates [Qualitative Concept]

Phrase: "injected into mouse brains"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   816   C1521713:Mouse Brain [Tissue]
   770   C0006104:Brains [Body Part, Organ, or Organ Component]
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]
   737 E C1269537:Brain [Body Part, Organ, or Organ Component]
   737   C1720154:Inject [Functional Concept]

Phrase: "were"

Phrase: "remarkably stable over 20weeks"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205360:Stable [Qualitative Concept]
   770   C1547311:Stable [Intellectual Product]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021485:injection [Therapeutic or Preventive Procedure]
  1000   C1272883:Injection [Biomedical or Dental Material]
  1000   C1533685:Injection [Therapeutic or Preventive Procedure]
  1000   C1828121:Injection [Functional Concept]

Phrase: "and"

Phrase: "seem"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "resistant to the clearing mechanism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332325:Resistant to [Functional Concept]
           Resistant
   760   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "triggered"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0032930:Trigger [Clinical Attribute]
   966   C1444748:Trigger [Qualitative Concept]

Phrase: "here,"

Phrase: "constantly"

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "the induction of the unknown signal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1519308:Signal Induction [Molecular Function]
   753   C0205263:Induction [Functional Concept]
   753   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "for the NEP up-regulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0851285:Regulation [Governmental or Regulatory Activity]
   827   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.199: This may explain the long term increases in NEP levels in response to A injections. 

Phrase: "This"

Phrase: "may"

Phrase: "explain"

Phrase: "the long term"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0443252:Long-term [Temporal Concept]
   861   C0205166:Long [Qualitative Concept]
   861   C1515273:Term [Temporal Concept]
   861   C1705313:Term [Idea or Concept]
   861   C1706317:Long [Qualitative Concept]
   861   C2826302:TERM [Intellectual Product]

Phrase: "increases in NEP levels"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0441889:Levels [Qualitative Concept]
   770   C0442805:Increase [Functional Concept]
   770   C1366499:NEPRILYSIN [Gene or Genome]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]
   715 E C1517378:Gain [Quantitative Concept]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to A injections."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0021485:injections [Therapeutic or Preventive Procedure]
  1000   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
  1000   C1828121:Injections [Functional Concept]
   966 E C1272883:Injection [Biomedical or Dental Material]
Processing 00000000.tx.200: Altered gene expression as a response to unilateral neuronal injury is often not restricted to the ipsilateral site and is also found contralaterally (37-39). 

Phrase: "Altered gene expression as a response"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0017262:Gene Expression [Genetic Function]
   753   C0017337:Gene [Gene or Genome]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "to unilateral neuronal injury"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C3263722:Injury [Injury or Poisoning]
   827   C3263723:Injury [Injury or Poisoning]

Phrase: "is"

Phrase: "often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Often [Temporal Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "restricted to the ipsilateral site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205145:Site [Spatial Concept]
   760   C0441989:Ipsilateral [Spatial Concept]
   760   C0443288:Restricted [Functional Concept]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "is"

Phrase: "also"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "contralaterally"

Phrase: "(37-39"

Phrase: ")."
Processing 00000000.tx.201: Most interestingly, an increase in the expression of NEP-related genes such as tachykinins and bradykinin receptors in response to unilateral neuronal injury is also found contralaterally to the lesion site (40, 41). 

Phrase: "Most interestingly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205393:Most [Quantitative Concept]

Phrase: "an increase in the expression of NEP-related genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "such as tachykinins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039241:Tachykinins [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "bradykinin receptors in response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0107053:Receptors, Bradykinin [Amino Acid, Peptide, or Protein,Receptor]
   770   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "to unilateral neuronal injury"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C3263722:Injury [Injury or Poisoning]
   827   C3263723:Injury [Injury or Poisoning]

Phrase: "is"

Phrase: "also"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "contralaterally to the lesion site"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0449685:lesion site [Spatial Concept]
   760   C0205145:Site [Spatial Concept]
   760   C0221198:Lesion [Finding]
   760   C1515974:Site [Body Location or Region]
   760   C1546698:Lesion [Intellectual Product]
   760   C2825164:Site [Spatial Concept]

Phrase: "(40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "41"

Phrase: ")."
Processing 00000000.tx.202: Therefore, increased NEP expression throughout the brain in our study may very well be initiated by the damage done to the tissue by our injections during the deposition of the fibrillar A42 and sustained because of the stability of the injected A42 fibrils in brain tissue. 

Phrase: "Therefore,"

Phrase: "increased NEP expression throughout the brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "may"

Phrase: "very well"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205170:Well [Qualitative Concept]
   861   C0442824:Very [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "be"

Phrase: "initiated by the damage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0010957:Damage [Injury or Poisoning]
   770   C1883709:Damage [Functional Concept]
   737   C1548602:Initiate [Idea or Concept]
   737   C1704686:Initiate [Functional Concept]

Phrase: "done to the tissue"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0040300:Tissue [Tissue]
   770   C1272695:Done [Qualitative Concept]
   770   C1547928:Tissue [Intellectual Product]
   770   C2746065:Done [Temporal Concept]

Phrase: "by our injections"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0021485:injections [Therapeutic or Preventive Procedure]
  1000   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
  1000   C1828121:Injections [Functional Concept]
   966 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "during the deposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:Deposition [Functional Concept]

Phrase: "of the fibrillar A42"

Phrase: "and"

Phrase: "sustained because of the stability of the injected A42 fibrils"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   739   C0205360:Stability [Qualitative Concept]
   739   C0225328:fibrils [Cell Component]
   739   C0443318:Sustained [Functional Concept]
   739   C2347098:Stability [Qualitative Concept]
   706 E C1948066:Fibril [Physical Object]
   706 E C2732140:Sustain [Organic Chemical,Pharmacologic Substance]

Phrase: "in brain tissue."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0440746:Brain tissue [Tissue]
  1000   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0040300:Tissue [Tissue]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   861   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.203: NEP expression is reduced on mRNA and protein levels in AD brains, indicating a crucial role of NEP down-regulation in the pathophysiology of AD (27, 42, 43). 

Phrase: "NEP expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "reduced on mRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0392756:Reduced [Qualitative Concept]

Phrase: "and"

Phrase: "protein levels in AD brains,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   773   C0428479:Protein level [Laboratory or Test Result]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "indicating"

Phrase: "a crucial role of NEP down-regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in the pathophysiology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031847:pathophysiology [Functional Concept]
  1000   C0277785:Pathophysiology [Qualitative Concept]

Phrase: "of AD (27,"

Phrase: "42,"

Phrase: "43"

Phrase: ")."
Processing 00000000.tx.204: Moreover, neprilysin deficiency led to reduced degradation of exogenously administered A and in the metabolic suppression of the endogenous A levels in a gene dose-dependent manner in mice (35). 

Phrase: "Moreover,"

Phrase: "neprilysin deficiency"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0011155:Deficiency [Functional Concept]
   861   C0162429:Deficiency [Disease or Syndrome]
   861   C1623416:deficiency [Qualitative Concept]
   789 E C1636779:% deficient [Quantitative Concept]

Phrase: "led to reduced degradation of exogenously"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   753   C0243125:degradation [Functional Concept]
   753   C0392756:Reduced [Qualitative Concept]
   753   C0699900:Degradation [Organism Function]
   753   C1708698:LED [Manufactured Object]
   719 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   719 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   719 E C1522538:Lead [Functional Concept]
   719 E C2348269:Lead [Element, Ion, or Isotope]
   719 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "administered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521801:Administered [Functional Concept]
   966 E C1621583:Administer [Functional Concept]

Phrase: "A"

Phrase: "and in the metabolic suppression of the endogenous"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0301625:Metabolic Suppression [Organism Function]
           Suppression
   744   C0205227:Endogenous [Functional Concept]
   744   C0221103:Suppression [Pathologic Function]
   744   C0311400:Metabolic [Functional Concept]
   744   C0439181:% suppression [Quantitative Concept]
   744   C0728721:suppression [Mental Process]
   744   C1515981:And [Idea or Concept]
   744   C1524026:Metabolic [Cell Function]
   744   C2707259:Metabolic [Clinical Attribute]

Phrase: "A levels in a gene dose-dependent manner"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   750   C0178602:Dose Level [Quantitative Concept]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.205: Our data suggest the possibility that the increase in NEP is related to the inhibition of amyloid plaque formation by decreasing the brain levels of A. 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "the possibility"

Phrase: "that"

Phrase: "the increase in NEP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:Increase [Functional Concept]

Phrase: "is"

Phrase: "related to the inhibition of amyloid plaque formation"
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   770   C0333463:amyloid plaque [Acquired Abnormality]
           plaque
   770   C2936349:Plaque, Amyloid [Acquired Abnormality]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011389:Plaque [Disease or Syndrome]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C0220781:formation [Biologic Function]
   744   C0332461:Plaque [Finding]
   744   C0439634:formation [Spatial Concept]
   744   C0439849:Related [Qualitative Concept]
   744   C0445223:Related [Finding]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1522492:Formation [Functional Concept]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]
   711 E C0163712:Relate [Organic Chemical]

Phrase: "by decreasing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0442797:Decreasing [Qualitative Concept]
   966 E C0392756:Decrease [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the brain levels of A."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0441889:Levels [Qualitative Concept]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.206: As a consequence, amyloid plaque-related astrogliosis was also reduced. 

Phrase: "As a consequence,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0686907:Consequence [Functional Concept]

Phrase: "amyloid plaque-related astrogliosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017639:Astrogliosis [Pathologic Function]

Phrase: "was"

Phrase: "also"

Phrase: "reduced."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]
Processing 00000000.tx.207: Further research is necessary to characterize the mechanisms of NEP function in brain amyloid formation, and the role of physiological and pharmacological regulators including spinorphin needs to be characterized. 

Phrase: "Further research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]

Phrase: "is"

Phrase: "necessary to"

Phrase: "characterize"

Phrase: "the mechanisms of NEP function"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0441712:Mechanisms [Functional Concept]
   726 E C1706376:Mechanism [Manufactured Object]

Phrase: "in brain amyloid formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "the role of physiological"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "pharmacological regulators"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0182953:regulators [Medical Device]
   827 E C1704734:Regulator [Medical Device]
   827 E C1704735:Regulator [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "spinorphin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218564:spinorphin [Amino Acid, Peptide, or Protein]

Phrase: "needs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "characterized."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]
Processing 00000000.tx.208: In particular, possible strategies of increasing NEP levels or activating its functions may contribute to the development of treatments designed to reduce or prevent amyloid formation in subjects at risk for AD.  

Phrase: "In particular, possible strategies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0679199:strategies [Mental Process]

Phrase: "of increasing NEP levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "or"

Phrase: "activating"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:activating [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "its functions"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0542341:Functions [Functional Concept]
   966 E C0031843:function [Physiologic Function]
   966 E C0700205:FUNCTION [Classification]
   966 E C1705273:Function [Intellectual Product]
   916 E C0205245:Functional [Functional Concept]
   916 E C2700217:Functional [Conceptual Entity]

Phrase: "may"

Phrase: "contribute to the development of treatments"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   753   C0087111:Treatments [Therapeutic or Preventive Procedure]
   753   C0243107:development [Physiologic Function]
   753   C0678723:Development [Organism Function]
   753   C1527148:Development [Functional Concept]
   753   C1880177:Contribute [Activity]
   719 E C0039798:treatment [Functional Concept]
   719 E C1522326:Treatment [Functional Concept]
   719 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   719 E C1705169:Treatment [Conceptual Entity]
   719 E C3538994:TREATMENT [Research Activity]

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reduce"

Phrase: "or"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "amyloid formation in subjects"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "at risk for AD."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1444641:At risk [Qualitative Concept]
   770   C0035647:Risk [Qualitative Concept]
   770   C1516077:At [Spatial Concept]
Processing 00000000.tx.209: ACKNOWLEDGEMENTS We thank Dr. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.210: K.Hsiao for providing the SwAPP mice, Drs. 

Phrase: "K.Hsiao for providing"

Phrase: "the SwAPP mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "Drs."
Processing 00000000.tx.211: K.

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.212: Vekrellis and D.J.Selkoe for providing the IDE-1 antibody, Dr. 

Phrase: "Vekrellis"

Phrase: "and"

Phrase: "D.J.Selkoe for providing"

Phrase: "the"

Phrase: "IDE-1 antibody,"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   876   C0021644:Insulin antibody [Immunologic Factor]
   861   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0014442:Enzyme [Enzyme,Organic Chemical]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0332257:include [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1552866:include [Idea or Concept]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C2700399:Include [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C0014445:enzymes [Functional Concept]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.213: J.

Phrase: "J."
Processing 00000000.tx.214: Pohlner for providing the 6H1 antibody, and Dr. 

Phrase: "Pohlner for providing"

Phrase: "the 6H1 antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.215: C.

Phrase: "C."
Processing 00000000.tx.216: Abraham for providing the antibodies against 24.15proteins. 

Phrase: "Abraham for providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0442982:Abraham [Intellectual Product]

Phrase: "the antibodies against 24.15proteins."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.217: We also thank H.Li, J.Opuku, and E.Moritz for excellent technical assistance and J.Tracy for useful comments on this paper.  

Phrase: "We also"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "H.Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "J.Opuku,"

Phrase: "and"

Phrase: "E.Moritz for excellent technical assistance"

Phrase: "and"

Phrase: "J.Tracy for useful comments"

Phrase: "on this paper."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030351:Paper [Manufactured Object]
  1000   C1547566:Paper [Idea or Concept]
Processing 00000000.tx.218: FOOTNOTES * This work was supported in part by University of Zurich, the Swiss National Science Foundation, the European Union DIADEM Program, and the National Competence Center of Research on Neuronal Plasticity and Repair.

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by University of Zurich,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "the Swiss National Science Foundation,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0016617:Foundation [Organization]
   729 E C0002055:base [Inorganic Chemical]
   729 E C0178499:Base [Chemical Viewed Functionally]
   729 E C1626935:Bases [Quantitative Concept]
   729 E C1880279:Base [Biomedical or Dental Material]
   706 E C0205112:Basal [Spatial Concept]

Phrase: "the European Union DIADEM Program,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1709697:Program [Conceptual Entity]
   812   C2728259:Program [Pharmacologic Substance]
   812   C3484370:Program [Functional Concept]

Phrase: "and"

Phrase: "the National Competence Center of Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0683939:center research [Manufactured Object,Organization]
   753   C0205099:Center [Spatial Concept]

Phrase: "on Neuronal Plasticity"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0027880:Neuronal Plasticity [Organ or Tissue Function]
   861   C0521390:Neuronal [Immunologic Factor]
   861   C0678558:Plasticity [Natural Phenomenon or Process]
   789 E C0027882:Neuron [Cell]
   789 E C0032167:Plastic [Substance]

Phrase: "and"

Phrase: "Repair."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043240:Repair, NOS [Organism Function]
  1000   C0374711:Repair [Therapeutic or Preventive Procedure]
Processing 00000000.tx.219: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.220: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.221: Section 1734solely to indicate this fact. 

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.222: To whom correspondence should be addressed. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.223: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.224: 41-1-634-8872; 

Phrase: "41-1-634-8872"

Phrase: ";"
Processing 00000000.tx.225: Fax: 41-1-634-8874; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "41-1-634-8874"

Phrase: ";"
Processing 00000000.tx.226: E-mail: mohajeri@bli.unizh.ch. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "mohajeri@bli.unizh.ch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0558269:Ch. [Professional or Occupational Group]
   812   C1552984:[Ch] [Quantitative Concept]
Processing 00000000.tx.227: Published, JBC Papers in Press, July 8,2002,DOI 10.1074/jbc.M202899200 2 L. 

Phrase: "Published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: ","

Phrase: "JBC Papers in Press,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0030351:Papers [Manufactured Object]
   737 E C1547566:Paper [Idea or Concept]

Phrase: "July 8,"

Phrase: "2002,"

Phrase: "DOI 10.1074/jbc.M202899200 2 L."
Processing 00000000.tx.228: Walker, personal communication.  

Phrase: "Walker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043016:Walker [Medical Device]

Phrase: "personal communication."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086792:Personal Communication [Social Behavior]
   861   C0009452:Communication [Social Behavior]
Processing 00000000.tx.229: ABBREVIATIONS The abbreviations used are: AD, Alzheimer's Disease; 

Phrase: "ABBREVIATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "AD,"

Phrase: "Alzheimer's Disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.230: A, -amyloid peptide; 

Phrase: "A, -"

Phrase: "amyloid peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.231: A42R, reversed A42-peptide; 

Phrase: "A42R,"

Phrase: "reversed A42-peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: ";"
Processing 00000000.tx.232: IDE, insulin-degrading enzyme; 

Phrase: "IDE,"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0332257:include [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1552866:include [Idea or Concept]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C2700399:Include [Activity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.233: ACE, angiotensin-converting enzyme; 

Phrase: "ACE,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "angiotensin-converting enzyme"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: ";"
Processing 00000000.tx.234: NEP, neprilysin; 

Phrase: "NEP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "neprilysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.235: SwAPP, Swedish double mutation of APP; 

Phrase: "SwAPP,"

Phrase: "Swedish double mutation of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0026882:Mutation [Genetic Function]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: ";"
Processing 00000000.tx.236: non-tg, non-transgenic; 

Phrase: "non-tg, non-transgenic"

Phrase: ";"
Processing 00000000.tx.237: PBS, phosphate-buffered saline; 

Phrase: "PBS,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "phosphate-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.238: GFAP, glial fibrillary acidic protein; 

Phrase: "GFAP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017626:GFAP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415042:GFAP [Gene or Genome]

Phrase: "glial fibrillary acidic protein"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0017626:Glial Fibrillary Acidic Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1325793:glial fibrillary acidic protein [Cell Component]
  1000   C1415042:GLIAL FIBRILLARY ACIDIC PROTEIN [Gene or Genome]
   812   C0001128:Acidic [Chemical]
   812   C0027836:Glial [Cell]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   741 E C0202406:Acid [Laboratory Procedure]
   741 E C1087003:Glia [Plant]

Phrase: ";"
Processing 00000000.tx.239: BSA, bovine serum albumin; 

Phrase: "BSA,"

Phrase: "bovine serum albumin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   901   C0728877:serum albumin [Laboratory or Test Result]
   827   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0007452:Bovine [Mammal]
   827   C0229671:Serum [Body Substance]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: ";"
Processing 00000000.tx.240: ELISA, enzyme-linked immunosorbent assay; 

Phrase: "ELISA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014441:ELISA [Laboratory Procedure]

Phrase: "enzyme-linked immunosorbent assay"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   902   C2717977:Enzyme Assay [Laboratory Procedure]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
   779   C1517892:Link [Intellectual Product]
   779   C1704666:Link [Intellectual Product]
   729 E C0014445:enzymes [Functional Concept]

Phrase: ";"
Processing 00000000.tx.241: Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine; 

Phrase: "Tricine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0077068:tricine [Organic Chemical]

Phrase: "N-[2-hydroxy-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441922:N+ [Intellectual Product]
   812   C0700307:Hydroxy [Inorganic Chemical]
   812   C1553036:[n] [Quantitative Concept]

Phrase: "1-bis("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0556985:BIS [Temporal Concept]
   861   C2247301:BIS [Molecular Function]
   861   C3540495:BIS [Intellectual Product]

Phrase: "hydroxymethyl"

Phrase: ")"

Phrase: "ethyl"

Phrase: "]glycine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0522461:Glycine [Plant]

Phrase: ";"
Processing 00000000.tx.242: pNA, p-nitroanilide.  

Phrase: "pNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600500:PNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "p-nitroanilide."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.243: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.244: Iwata, N., Tsubuki, S., Takaki, Y., Watanabe, K., Sekiguchi, M., Hosoki, E., Kawashima-Morishima, M., Lee, H. 

Phrase: "Iwata,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Tsubuki,"

Phrase: "S."

Phrase: ","

Phrase: "Takaki,"

Phrase: "Y.,"

Phrase: "Watanabe,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sekiguchi,"

Phrase: "M."

Phrase: ","

Phrase: "Hosoki,"

Phrase: "E.,"

Phrase: "Kawashima-Morishima,"

Phrase: "M."

Phrase: ","

Phrase: "Lee,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.245: J., Hama, E., Sekine-Aizawa, Y., and Saido, T. 

Phrase: "J.,"

Phrase: "Hama,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1291910:HAMA [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1295018:HAMA [Laboratory Procedure]
  1000   C3541258:HAMA [Intellectual Product]

Phrase: "E.,"

Phrase: "Sekine-Aizawa,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Saido,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.246: C. 

Phrase: "C."
Processing 00000000.tx.247: (2000) Nat. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.248: Med. 

Phrase: "Med."
Processing 00000000.tx.249: 6, 143-150[CrossRef][Medline] [OrderarticleviaInfotrieve] 2. 

Phrase: "6,"

Phrase: "143-150"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.250: Younkin, S. 

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.251: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.252: (1995) Ann. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.253: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.254: 37, 287-288[Medline] [OrderarticleviaInfotrieve] 3. 

Phrase: "37,"

Phrase: "287-288"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.255: Selkoe, D. 

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.256: J. 

Phrase: "J."
Processing 00000000.tx.257: (1999) Nature 399 Suppl. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nature 399 Suppl."
Processing 00000000.tx.258: 6738, A23-A31[CrossRef][Medline] [OrderarticleviaInfotrieve] 4. 

Phrase: "6738,"

Phrase: "A23-A31"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 4."
Processing 00000000.tx.259: Borchelt, D. 

Phrase: "Borchelt,"

Phrase: "D."
Processing 00000000.tx.260: R., Thinakaran, G., Eckman, C. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Eckman,"

Phrase: "C."
Processing 00000000.tx.261: B., Lee, M. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Lee,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.262: K., Davenport, F., Ratovitsky, T., Prada, C. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Davenport,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Ratovitsky,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Prada,"

Phrase: "C."
Processing 00000000.tx.263: M., Kim, G., Seekins, S., Yager, D., Slunt, H. 

Phrase: "M."

Phrase: ","

Phrase: "Kim,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Seekins,"

Phrase: "S."

Phrase: ","

Phrase: "Yager,"

Phrase: "D."

Phrase: ","

Phrase: "Slunt,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.264: H., Wang, R., Seeger, M., Levey, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Wang,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Seeger,"

Phrase: "M."

Phrase: ","

Phrase: "Levey,"

Phrase: "A."
Processing 00000000.tx.265: I., Gandy, S. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Gandy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.266: E., Copeland, N. 

Phrase: "E.,"

Phrase: "Copeland,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.267: G., Jenkins, N. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Jenkins,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.268: A., Price, D. 

Phrase: "A.,"

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.269: L., Younkin, S. 

Phrase: "L., Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.270: G., and Sisodia, S. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.271: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.272: (1996) Neuron 17, 1005-1013[Medline] [OrderarticleviaInfotrieve] 5. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Neuron 17,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "1005-1013"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.273: Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C. 

Phrase: "Duff,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Zehr,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "X.,"

Phrase: "Prada,"

Phrase: "C."
Processing 00000000.tx.274: M., Perez-tur, J., Hutton, M., Buee, L., Harigaya, Y., Yager, D., Morgan, D., Gordon, M. 

Phrase: "M."

Phrase: ","

Phrase: "Perez-tur,"

Phrase: "J.,"

Phrase: "Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "Buee,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Harigaya,"

Phrase: "Y.,"

Phrase: "Yager,"

Phrase: "D."

Phrase: ","

Phrase: "Morgan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582521:morgan [Quantitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Gordon,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.275: N., Holcomb, L., Refolo, L., Zenk, B., Hardy, J., and Younkin, S. 

Phrase: "N., Holcomb,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Refolo,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Zenk,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.276: (1996) Nature 383, 710-713[CrossRef][Medline] [OrderarticleviaInfotrieve] 6. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Nature 383,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "710-713"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 6."
Processing 00000000.tx.277: Citron, M., Eckman, C. 

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Eckman,"

Phrase: "C."
Processing 00000000.tx.278: B., Diehl, T. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Diehl,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.279: S., Corcoran, C., Ostaszewski, B. 

Phrase: "S."

Phrase: ","

Phrase: "Corcoran,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Ostaszewski,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.280: L., Xia, W., Levesque, G., St., George Hyslop, P., Younkin, S. 

Phrase: "L., Xia,"

Phrase: "W.,"

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "St.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]

Phrase: "George Hyslop,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.281: G., and Selkoe, D. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.282: J. 

Phrase: "J."
Processing 00000000.tx.283: (1998) Neurobiol. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.284: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.285: 5, 107-116[CrossRef][Medline] [OrderarticleviaInfotrieve] 7. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "107-116"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 7."
Processing 00000000.tx.286: Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. 

Phrase: "Scheuner,"

Phrase: "D."

Phrase: ","

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Jensen,"

Phrase: "M."

Phrase: ","

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "X.,"

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.287: D., Hardy, J., Hutton, M., Kukull, W., Larson, E., Levy-Lahad, E., Viitanen, M., Peskind, E., Poorkaj, P., Schellenberg, G., Tanzi, R., Wasco, W., Lannfelt, L., Selkoe, D., and Younkin, S. 

Phrase: "D."

Phrase: ","

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "Kukull,"

Phrase: "W.,"

Phrase: "Larson,"

Phrase: "E.,"

Phrase: "Levy-Lahad,"

Phrase: "E.,"

Phrase: "Viitanen,"

Phrase: "M."

Phrase: ","

Phrase: "Peskind,"

Phrase: "E.,"

Phrase: "Poorkaj,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Schellenberg,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Tanzi,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Wasco,"

Phrase: "W.,"

Phrase: "Lannfelt,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Selkoe,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.288: (1996) Nat. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.289: Med. 

Phrase: "Med."
Processing 00000000.tx.290: 2, 864-870[Medline] [OrderarticleviaInfotrieve] 8. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "864-870"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 8."
Processing 00000000.tx.291: Glabe, C. 

Phrase: "Glabe,"

Phrase: "C."
Processing 00000000.tx.292: (2000) Nat. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.293: Med. 

Phrase: "Med."
Processing 00000000.tx.294: 6, 133-134[CrossRef][Medline] [OrderarticleviaInfotrieve] 9. 

Phrase: "6,"

Phrase: "133-134"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 9."
Processing 00000000.tx.295: Vassar, R., Bennett, B. 

Phrase: "Vassar,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Bennett,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.296: D., Babu-Khan, S., Kahn, S., Mendiaz, E. 

Phrase: "D."

Phrase: ","

Phrase: "Babu-Khan,"

Phrase: "S."

Phrase: ","

Phrase: "Kahn,"

Phrase: "S."

Phrase: ","

Phrase: "Mendiaz,"

Phrase: "E."
Processing 00000000.tx.297: A., Denis, P., Teplow, D. 

Phrase: "A.,"

Phrase: "Denis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332319:denis [Qualitative Concept]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.298: B., Ross, S., Amarante, P., Loeloff, R., Luo, Y., Fisher, S., Fuller, J., Edenson, S., Lile, J., Jarosinski, M. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "S."

Phrase: ","

Phrase: "Amarante,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Loeloff,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Luo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337841:Luo [Population Group]

Phrase: "Y.,"

Phrase: "Fisher,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325045:Fisher [Mammal]

Phrase: "S."

Phrase: ","

Phrase: "Fuller,"

Phrase: "J.,"

Phrase: "Edenson,"

Phrase: "S."

Phrase: ","

Phrase: "Lile,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1688274:Lile [Fish]

Phrase: "J.,"

Phrase: "Jarosinski,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.299: A., Biere, A. 

Phrase: "A.,"

Phrase: "Biere,"

Phrase: "A."
Processing 00000000.tx.300: L., Curran, E., Burgess, T., Louis, J. 

Phrase: "L., Curran,"

Phrase: "E.,"

Phrase: "Burgess,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Louis,"

Phrase: "J."
Processing 00000000.tx.301: C., Collins, F., Treanor, J., Rogers, G., and Citron, M. 

Phrase: "C., Collins,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Treanor,"

Phrase: "J.,"

Phrase: "Rogers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3463939:Roger [Eukaryote]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.302: (1999) Science 286, 735-741[Abstract/Free FullText] 10. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Science 286,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "735-741"

Phrase: "[Abstract/Free FullText"

Phrase: "] 10."
Processing 00000000.tx.303: Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., Kholodenko, D., Lee, M., Liao, Z., Lieberburg, I., Motter, R., Mutter, L., Soriano, F., Shopp, G., Vasquez, N., Vandevert, C., Walker, S., Wogulis, M., Yednock, T., Games, D., and Seubert, P. 

Phrase: "Schenk,"

Phrase: "D."

Phrase: ","

Phrase: "Barbour,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Dunn,"

Phrase: "W.,"

Phrase: "Gordon,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Grajeda,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Guido,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hu,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Huang,"

Phrase: "J.,"

Phrase: "Johnson-Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0043217:Wood [Substance]
   805 E C0144237:Sylvan [Organic Chemical]
   777 E C0442548:Woods [Geographic Area]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Khan,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kholodenko,"

Phrase: "D."

Phrase: ","

Phrase: "Lee,"

Phrase: "M."

Phrase: ","

Phrase: "Liao,"

Phrase: "Z.,"

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Motter,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Mutter,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Soriano,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Shopp,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Vasquez,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Vandevert,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Walker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043016:Walker [Medical Device]

Phrase: "S."

Phrase: ","

Phrase: "Wogulis,"

Phrase: "M."

Phrase: ","

Phrase: "Yednock,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Games,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0150593:games [Daily or Recreational Activity]

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Seubert,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.304: (1999) Nature 400, 173-177[CrossRef][Medline] [OrderarticleviaInfotrieve] 11. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nature 400,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "173-177"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 11."
Processing 00000000.tx.305: Vekrellis, K., Ye, Z., Qiu, W. 

Phrase: "Vekrellis,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ye,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043402:YE [Geographic Area]

Phrase: "Z.,"

Phrase: "Qiu,"

Phrase: "W."
Processing 00000000.tx.306: Q., Walsh, D., Hartley, D., Chesneau, V., Rosner, M. 

Phrase: "Q., Walsh,"

Phrase: "D."

Phrase: ","

Phrase: "Hartley,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0324525:Hartley [Mammal]

Phrase: "D."

Phrase: ","

Phrase: "Chesneau,"

Phrase: "V.,"

Phrase: "Rosner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.307: R., and Selkoe, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.308: J. 

Phrase: "J."
Processing 00000000.tx.309: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.310: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.311: 20, 1657-1665[Abstract/Free FullText] 12. 

Phrase: "20,"

Phrase: "1657-1665"

Phrase: "[Abstract/Free FullText"

Phrase: "] 12."
Processing 00000000.tx.312: Yamin, R., Malgeri, E. 

Phrase: "Yamin,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Malgeri,"

Phrase: "E."
Processing 00000000.tx.313: G., Sloane, J. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Sloane,"

Phrase: "J."
Processing 00000000.tx.314: A., McGraw, W. 

Phrase: "A.,"

Phrase: "McGraw,"

Phrase: "W."
Processing 00000000.tx.315: T., and Abraham, C. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Abraham,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442982:Abraham [Intellectual Product]

Phrase: "C."
Processing 00000000.tx.316: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.317: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.318: Biol. 

Phrase: "Biol."
Processing 00000000.tx.319: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.320: 274, 18777-18784[Abstract/Free FullText] 13. 

Phrase: "274,"

Phrase: "18777-18784"

Phrase: "[Abstract/Free FullText"

Phrase: "] 13."
Processing 00000000.tx.321: Roques, B. 

Phrase: "Roques,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.322: P., Noble, F., Dauge, V., Fournie-Zaluski, M. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Noble,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Dauge,"

Phrase: "V.,"

Phrase: "Fournie-Zaluski,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.323: C., and Beaumont, A. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Beaumont,"

Phrase: "A."
Processing 00000000.tx.324: (1993) Pharmacol. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Pharmacol."
Processing 00000000.tx.325: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.326: 45, 87-146[Medline] [OrderarticleviaInfotrieve] 14. 

Phrase: "45,"

Phrase: "87-146"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 14."
Processing 00000000.tx.327: Lu, B., Gerard, N. 

Phrase: "Lu,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024171:LU [Body System]
  1000   C0024176:LU [Geographic Area]
  1000   C2697939:LU [Quantitative Concept]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Gerard,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.328: P., Kolakowski, L. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Kolakowski,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.329: F., Jr., Bozza, M., Zurakowski, D., Finco, O., Carroll, M. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Bozza,"

Phrase: "M."

Phrase: ","

Phrase: "Zurakowski,"

Phrase: "D."

Phrase: ","

Phrase: "Finco,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Carroll,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.330: C., and Gerard, C. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Gerard,"

Phrase: "C."
Processing 00000000.tx.331: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.332: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.333: Med. 

Phrase: "Med."
Processing 00000000.tx.334: 181, 2271-2275[Abstract] 15. 

Phrase: "181,"

Phrase: "2271-2275"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 15."
Processing 00000000.tx.335: Lu, B., Gerard, N. 

Phrase: "Lu,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024171:LU [Body System]
  1000   C0024176:LU [Geographic Area]
  1000   C2697939:LU [Quantitative Concept]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Gerard,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.336: P., Kolakowski, L. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Kolakowski,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.337: F., Jr., Finco, O., Carroll, M. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Finco,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Carroll,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.338: C., and Gerard, C. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Gerard,"

Phrase: "C."
Processing 00000000.tx.339: (1996) Ann. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.340: N.Y.Acad. 

Phrase: "N.Y.Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0268596:ACAD [Disease or Syndrome]
   827   C2700624:ACAD [Cell Function]
Processing 00000000.tx.341: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.342: 780, 156-163[Abstract] 16. 

Phrase: "780,"

Phrase: "156-163"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 16."
Processing 00000000.tx.343: Li, C., Booze, R. 

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Booze,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.344: M., and Hersh, L. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Hersh,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.345: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.346: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.347: Biol. 

Phrase: "Biol."
Processing 00000000.tx.348: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.349: 270, 5723-5728[Abstract/Free FullText] 17. 

Phrase: "270,"

Phrase: "5723-5728"

Phrase: "[Abstract/Free FullText"

Phrase: "] 17."
Processing 00000000.tx.350: Li, C., and Hersh, L. 

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Hersh,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.351: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.352: (1998) Arch. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.353: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.354: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.355: 358, 189-195[CrossRef][Medline] [OrderarticleviaInfotrieve] 18. 

Phrase: "358,"

Phrase: "189-195"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 18."
Processing 00000000.tx.356: Hsiao, K. 

Phrase: "Hsiao,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.357: K., Borchelt, D. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Borchelt,"

Phrase: "D."
Processing 00000000.tx.358: R., Olson, K., Johannsdottir, R., Kitt, C., Yunis, W., Xu, S., Eckman, C., Younkin, S., Price, D., Iadecola, C., Clark, H. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Olson,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Johannsdottir,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kitt,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Yunis,"

Phrase: "W.,"

Phrase: "Xu,"

Phrase: "S."

Phrase: ","

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Younkin,"

Phrase: "S."

Phrase: ","

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Iadecola,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Clark,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.359: B., and Carlson, G. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Carlson,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.360: (1995) Neuron 15, 1203-1218[Medline] [OrderarticleviaInfotrieve] 19. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Neuron 15,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "1203-1218"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 19."
Processing 00000000.tx.361: Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., and Cole, G. 

Phrase: "Hsiao,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Chapman,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Nilsen,"

Phrase: "S."

Phrase: ","

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Harigaya,"

Phrase: "Y.,"

Phrase: "Younkin,"

Phrase: "S."

Phrase: ","

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Cole,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.362: (1996) Science 274, 99-102[Abstract/Free FullText] 20. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Science 274,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "99-102"

Phrase: "[Abstract/Free FullText"

Phrase: "] 20."
Processing 00000000.tx.363: Franklin, K. 

Phrase: "Franklin,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.364: B.J., and Paxinos, G. 

Phrase: "B.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Paxinos,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.365: (1996) The Mouse Brain in Stereotaxic Coordinates , Academic Press, San Diego, CA 21. 

Phrase: "(1996"

Phrase: ")"

Phrase: "The Mouse Brain in Stereotaxic Coordinates ,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1521713:Mouse Brain [Tissue]
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "Academic Press,"

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA 21."
Processing 00000000.tx.366: Shirotani, K., Tsubuki, S., Iwata, N., Takaki, Y., Harigaya, W., Maruyama, K., Kiryu-Seo, S., Kiyama, H., Iwata, H., Tomita, T., Iwatsubo, T., and Saido, T. 

Phrase: "Shirotani,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tsubuki,"

Phrase: "S."

Phrase: ","

Phrase: "Iwata,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Takaki,"

Phrase: "Y.,"

Phrase: "Harigaya,"

Phrase: "W.,"

Phrase: "Maruyama,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kiryu-Seo,"

Phrase: "S."

Phrase: ","

Phrase: "Kiyama,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Iwata,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Saido,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.367: C. 

Phrase: "C."
Processing 00000000.tx.368: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.369: Biol. 

Phrase: "Biol."
Processing 00000000.tx.370: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.371: 276, 21895-21901[Abstract/Free FullText] 22. 

Phrase: "276,"

Phrase: "21895-21901"

Phrase: "[Abstract/Free FullText"

Phrase: "] 22."
Processing 00000000.tx.372: Qiu, W. 

Phrase: "Qiu,"

Phrase: "W."
Processing 00000000.tx.373: Q., Walsh, D. 

Phrase: "Q., Walsh,"

Phrase: "D."
Processing 00000000.tx.374: M., Ye, Z., Vekrellis, K., Zhang, J., Podlisny, M. 

Phrase: "M."

Phrase: ","

Phrase: "Ye,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043402:YE [Geographic Area]

Phrase: "Z.,"

Phrase: "Vekrellis,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Zhang,"

Phrase: "J.,"

Phrase: "Podlisny,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.375: B., Rosner, M. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Rosner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.376: R., Safavi, A., Hersh, L. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Safavi,"

Phrase: "A.,"

Phrase: "Hersh,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.377: B., and Selkoe, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.378: J. 

Phrase: "J."
Processing 00000000.tx.379: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.380: Biol. 

Phrase: "Biol."
Processing 00000000.tx.381: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.382: 273, 32730-32738[Abstract/Free FullText] 23. 

Phrase: "273,"

Phrase: "32730-32738"

Phrase: "[Abstract/Free FullText"

Phrase: "] 23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.383: Alvarez, R., Alvarez, V., Lahoz, C. 

Phrase: "Alvarez,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Alvarez,"

Phrase: "V.,"

Phrase: "Lahoz,"

Phrase: "C."
Processing 00000000.tx.384: H., Martinez, C., Pena, J., Sanchez, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Martinez,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Pena,"

Phrase: "J.,"

Phrase: "Sanchez,"

Phrase: "J."
Processing 00000000.tx.385: M., Guisasola, L. 

Phrase: "M."

Phrase: ","

Phrase: "Guisasola,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.386: M., Salas-Puig, J., Moris, G., Vidal, J. 

Phrase: "M."

Phrase: ","

Phrase: "Salas-Puig,"

Phrase: "J.,"

Phrase: "Moris,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Vidal,"

Phrase: "J."
Processing 00000000.tx.387: A., Ribacoba, R., Menes, B. 

Phrase: "A.,"

Phrase: "Ribacoba,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Menes,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.388: B., Uria, D., and Coto, E. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Uria,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1081327:Uria [Bird]

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Coto,"

Phrase: "E."
Processing 00000000.tx.389: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.390: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.391: Neurosurg. 

Phrase: "Neurosurg."
Processing 00000000.tx.392: Psychiatry 67, 733-736[Abstract/Free FullText] 24. 

Phrase: "Psychiatry 67,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0033872:Psychiatry [Professional or Occupational Group]
   861   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   789 E C0205487:Psychiatric [Functional Concept]

Phrase: "733-736"

Phrase: "[Abstract/Free FullText"

Phrase: "] 24."
Processing 00000000.tx.393: Amouyel, P., Richard, F., Berr, C., David-Fromentin, I., and Helbecque, N. 

Phrase: "Amouyel,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Richard,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Berr,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "David-Fromentin,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Helbecque,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.394: (2000) Ann. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.395: N.Y.Acad. 

Phrase: "N.Y.Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0268596:ACAD [Disease or Syndrome]
   827   C2700624:ACAD [Cell Function]
Processing 00000000.tx.396: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.397: 903, 437-441[Abstract/Free FullText] 25. 

Phrase: "903,"

Phrase: "437-441"

Phrase: "[Abstract/Free FullText"

Phrase: "] 25."
Processing 00000000.tx.398: Barnes, N. 

Phrase: "Barnes,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.399: M., Cheng, C. 

Phrase: "M."

Phrase: ","

Phrase: "Cheng,"

Phrase: "C."
Processing 00000000.tx.400: H., Costall, B., Naylor, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Costall,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Naylor,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.401: J., Williams, T. 

Phrase: "J.,"

Phrase: "Williams,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.402: J., and Wischik, C. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Wischik,"

Phrase: "C."
Processing 00000000.tx.403: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.404: (1991) Eur. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.405: J.

Phrase: "J."
Processing 00000000.tx.406: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.407: 200, 289-292[Medline] [OrderarticleviaInfotrieve] 26. 

Phrase: "200,"

Phrase: "289-292"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 26."
Processing 00000000.tx.408: McDermott, J. 

Phrase: "McDermott,"

Phrase: "J."
Processing 00000000.tx.409: R., and Gibson, A. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Gibson,"

Phrase: "A."
Processing 00000000.tx.410: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.411: (1997) Neurochem. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Neurochem."
Processing 00000000.tx.412: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.413: 22, 49-56[Medline] [OrderarticleviaInfotrieve] 27. 

Phrase: "22,"

Phrase: "49-56"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 27."
Processing 00000000.tx.414: Selkoe, D. 

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.415: J. 

Phrase: "J."
Processing 00000000.tx.416: (2001) Neuron 32, 177-180[Medline] [OrderarticleviaInfotrieve] 28. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Neuron 32,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "177-180"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 28."
Processing 00000000.tx.417: Jarrett, J. 

Phrase: "Jarrett,"

Phrase: "J."
Processing 00000000.tx.418: T., and Lansbury, P. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Lansbury,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.419: T., Jr. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.420: (1993) Cell 73, 1055-1058[Medline] [OrderarticleviaInfotrieve] 29. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Cell 73,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "1055-1058"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 29."
Processing 00000000.tx.421: Kane, M. 

Phrase: "Kane,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.422: D., Lipinski, W. 

Phrase: "D."

Phrase: ","

Phrase: "Lipinski,"

Phrase: "W."
Processing 00000000.tx.423: J., Callahan, M. 

Phrase: "J.,"

Phrase: "Callahan,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.424: J., Bian, F., Durham, R. 

Phrase: "J.,"

Phrase: "Bian,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Durham,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454851:Durham [Geographic Area]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.425: A., Schwarz, R. 

Phrase: "A.,"

Phrase: "Schwarz,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.426: D., Roher, A. 

Phrase: "D."

Phrase: ","

Phrase: "Roher,"

Phrase: "A."
Processing 00000000.tx.427: E., and Walker, L. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Walker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043016:Walker [Medical Device]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.428: C. 

Phrase: "C."
Processing 00000000.tx.429: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.430: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.431: 20, 3606-3611[Abstract/Free FullText] 30. 

Phrase: "20,"

Phrase: "3606-3611"

Phrase: "[Abstract/Free FullText"

Phrase: "] 30."
Processing 00000000.tx.432: Yamamoto, Y., Hashimoto, J., Shimamura, M., Yamaguchi, T., and Hazato, T. 

Phrase: "Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "Y.,"

Phrase: "Hashimoto,"

Phrase: "J.,"

Phrase: "Shimamura,"

Phrase: "M."

Phrase: ","

Phrase: "Yamaguchi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Hazato,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.433: (2000) Peptides 21, 503-508[CrossRef][Medline] [OrderarticleviaInfotrieve] 31. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Peptides 21,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "503-508"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.434: Ghersi-Egea, J. 

Phrase: "Ghersi-Egea,"

Phrase: "J."
Processing 00000000.tx.435: F., Gorevic, P. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Gorevic,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.436: D., Ghiso, J., Frangione, B., Patlak, C. 

Phrase: "D."

Phrase: ","

Phrase: "Ghiso,"

Phrase: "J.,"

Phrase: "Frangione,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Patlak,"

Phrase: "C."
Processing 00000000.tx.437: S., and Fenstermacher, J. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Fenstermacher,"

Phrase: "J."
Processing 00000000.tx.438: D. 

Phrase: "D."
Processing 00000000.tx.439: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.440: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.441: 67, 880-883[Medline] [OrderarticleviaInfotrieve] 32. 

Phrase: "67,"

Phrase: "880-883"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 32."
Processing 00000000.tx.442: Zlokovic, B. 

Phrase: "Zlokovic,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.443: V., Martel, C. 

Phrase: "V., Martel,"

Phrase: "C."
Processing 00000000.tx.444: L., Matsubara, E., McComb, J. 

Phrase: "L., Matsubara,"

Phrase: "E.,"

Phrase: "McComb,"

Phrase: "J."
Processing 00000000.tx.445: G., Zheng, G., McCluskey, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Zheng,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986502:Zheng [Therapeutic or Preventive Procedure]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "McCluskey,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.446: T., Frangione, B., and Ghiso, J. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Frangione,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Ghiso,"

Phrase: "J."
Processing 00000000.tx.447: (1996) Proc. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.448: Natl. 

Phrase: "Natl."
Processing 00000000.tx.449: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.450: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.451: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.452: 93, 4229-4234[Abstract/Free FullText] 33. 

Phrase: "93,"

Phrase: "4229-4234"

Phrase: "[Abstract/Free FullText"

Phrase: "] 33."
Processing 00000000.tx.453: Mackic, J. 

Phrase: "Mackic,"

Phrase: "J."
Processing 00000000.tx.454: B., Stins, M., McComb, J. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Stins,"

Phrase: "M."

Phrase: ","

Phrase: "McComb,"

Phrase: "J."
Processing 00000000.tx.455: G., Calero, M., Ghiso, J., Kim, K. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Calero,"

Phrase: "M."

Phrase: ","

Phrase: "Ghiso,"

Phrase: "J.,"

Phrase: "Kim,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.456: S., Yan, S. 

Phrase: "S."

Phrase: ","

Phrase: "Yan,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.457: D., Stern, D., Schmidt, A. 

Phrase: "D."

Phrase: ","

Phrase: "Stern,"

Phrase: "D."

Phrase: ","

Phrase: "Schmidt,"

Phrase: "A."
Processing 00000000.tx.458: M., Frangione, B., and Zlokovic, B. 

Phrase: "M."

Phrase: ","

Phrase: "Frangione,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Zlokovic,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.459: V. 

Phrase: "V."
Processing 00000000.tx.460: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.461: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.462: Invest. 

Phrase: "Invest."
Processing 00000000.tx.463: 102, 734-743[Abstract/Free FullText] 34. 

Phrase: "102,"

Phrase: "734-743"

Phrase: "[Abstract/Free FullText"

Phrase: "] 34."
Processing 00000000.tx.464: DeMattos, R. 

Phrase: "DeMattos,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.465: B., Bales, K. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Bales,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2826220:BALE [Quantitative Concept]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.466: R., Cummins, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Cummins,"

Phrase: "D."
Processing 00000000.tx.467: J., Dodart, J. 

Phrase: "J.,"

Phrase: "Dodart,"

Phrase: "J."
Processing 00000000.tx.468: C., Paul, S. 

Phrase: "C., Paul,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.469: M., and Holtzman, D. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Holtzman,"

Phrase: "D."
Processing 00000000.tx.470: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.471: (2001) Proc. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.472: Natl. 

Phrase: "Natl."
Processing 00000000.tx.473: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.474: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.475: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.476: 98, 8850-8855[Abstract/Free FullText] 35. 

Phrase: "98,"

Phrase: "8850-8855"

Phrase: "[Abstract/Free FullText"

Phrase: "] 35."
Processing 00000000.tx.477: Iwata, N., Tsubuki, S., Takaki, Y., Shirotani, K., Lu, B., Gerard, N. 

Phrase: "Iwata,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Tsubuki,"

Phrase: "S."

Phrase: ","

Phrase: "Takaki,"

Phrase: "Y.,"

Phrase: "Shirotani,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lu,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024171:LU [Body System]
  1000   C0024176:LU [Geographic Area]
  1000   C2697939:LU [Quantitative Concept]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Gerard,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.478: P., Gerard, C., Hama, E., Lee, H. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Gerard,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Hama,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1291910:HAMA [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1295018:HAMA [Laboratory Procedure]
  1000   C3541258:HAMA [Intellectual Product]

Phrase: "E.,"

Phrase: "Lee,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.479: J., and Saido, T. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Saido,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.480: C. 

Phrase: "C."
Processing 00000000.tx.481: (2001) Science 292, 1550-1552[Abstract/Free FullText] 36. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Science 292,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1550-1552"

Phrase: "[Abstract/Free FullText"

Phrase: "] 36."
Processing 00000000.tx.482: Hama, E., Shirotani, K., Masumoto, H., Sekine-Aizawa, Y., Aizawa, H., and Saido, T. 

Phrase: "Hama,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1291910:HAMA [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1295018:HAMA [Laboratory Procedure]
  1000   C3541258:HAMA [Intellectual Product]

Phrase: "E.,"

Phrase: "Shirotani,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Masumoto,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sekine-Aizawa,"

Phrase: "Y.,"

Phrase: "Aizawa,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Saido,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.483: C. 

Phrase: "C."
Processing 00000000.tx.484: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.485: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.486: (Tokyo) 130, 721-726[Abstract] 37. 

Phrase: "(Tokyo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: ")"

Phrase: "130,"

Phrase: "721-726"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 37."
Processing 00000000.tx.487: Beer, R., Franz, G., Srinivasan, A., Hayes, R. 

Phrase: "Beer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004922:Beer [Food]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Franz,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Srinivasan,"

Phrase: "A.,"

Phrase: "Hayes,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.488: L., Pike, B. 

Phrase: "L., Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0014878:Pike [Fish]
   861   C0522667:Pike [Manufactured Object]
   861   C0730321:PIC [Disease or Syndrome]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.489: R., Newcomb, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Newcomb,"

Phrase: "J."
Processing 00000000.tx.490: K., Zhao, X., Schmutzhard, E., Poewe, W., and Kampfl, A. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Zhao,"

Phrase: "X.,"

Phrase: "Schmutzhard,"

Phrase: "E.,"

Phrase: "Poewe,"

Phrase: "W.,"

Phrase: "and"

Phrase: "Kampfl,"

Phrase: "A."
Processing 00000000.tx.491: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.492: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.493: 75, 1264-1273[CrossRef][Medline] [OrderarticleviaInfotrieve] 38. 

Phrase: "75,"

Phrase: "1264-1273"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 38."
Processing 00000000.tx.494: Beer, R., Franz, G., Krajewski, S., Pike, B. 

Phrase: "Beer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004922:Beer [Food]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Franz,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Krajewski,"

Phrase: "S."

Phrase: ","

Phrase: "Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.495: R., Hayes, R. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hayes,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.496: L., Reed, J. 

Phrase: "L., Reed,"

Phrase: "J."
Processing 00000000.tx.497: C., Wang, K. 

Phrase: "C., Wang,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.498: K., Klimmer, C., Schmutzhard, E., Poewe, W., and Kampfl, A. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Klimmer,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Schmutzhard,"

Phrase: "E.,"

Phrase: "Poewe,"

Phrase: "W.,"

Phrase: "and"

Phrase: "Kampfl,"

Phrase: "A."
Processing 00000000.tx.499: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.500: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.501: 78, 862-873[CrossRef][Medline] [OrderarticleviaInfotrieve] 39. 

Phrase: "78,"

Phrase: "862-873"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 39."
Processing 00000000.tx.502: Dong, G. 

Phrase: "Dong,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.503: X., Singh, D. 

Phrase: "X.,"

Phrase: "Singh,"

Phrase: "D."
Processing 00000000.tx.504: K., Dendle, P., and Prasad, R. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Dendle,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Prasad,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.505: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.506: (2001) Brain Res. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.507: 903, 45-52[CrossRef][Medline] [OrderarticleviaInfotrieve] 40. 

Phrase: "903,"

Phrase: "45-52"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.508: Henken, D. 

Phrase: "Henken,"

Phrase: "D."
Processing 00000000.tx.509: B., Battisti, W. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Battisti,"

Phrase: "W."
Processing 00000000.tx.510: P., Chesselet, M. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Chesselet,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.511: F., Murray, M., and Tessler, A. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Murray,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Tessler,"

Phrase: "A."
Processing 00000000.tx.512: (1990) Neuroscience 39, 733-742[Medline] [OrderarticleviaInfotrieve] 41. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Neuroscience 39,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027910:Neuroscience [Biomedical Occupation or Discipline]
   861   C1552241:Neuroscience [Professional or Occupational Group]
   861   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "733-742"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 41."
Processing 00000000.tx.513: Eckert, A., Segond von Banchet, G., Sopper, S., and Petersen, M. 

Phrase: "Eckert,"

Phrase: "A.,"

Phrase: "Segond von Banchet,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Sopper,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Petersen,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.514: (1999) Pain 83, 487-497[CrossRef][Medline] [OrderarticleviaInfotrieve] 42. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Pain 83,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030193:Pain [Sign or Symptom]
   861   C1962977:Pain NOS [Finding]

Phrase: "487-497"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 42."
Processing 00000000.tx.515: Akiyama, H., Kondo, H., Ikeda, K., Kato, M., and McGeer, P. 

Phrase: "Akiyama,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kondo,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kato,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0721226:Kato [Inorganic Chemical,Pharmacologic Substance]
  1000   C1551914:Kato [Language]

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "McGeer,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.516: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.517: (2001) Brain Res. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.518: 902, 277-281[CrossRef][Medline] [OrderarticleviaInfotrieve] 43. 

Phrase: "902,"

Phrase: "277-281"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 43."
Processing 00000000.tx.519: Yasojima, K., McGeer, E. 

Phrase: "Yasojima,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "McGeer,"

Phrase: "E."
Processing 00000000.tx.520: G., and McGeer, P. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "McGeer,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.521: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.522: (2001) Brain Res. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.523: 919, 115-121[CrossRef][Medline] [OrderarticleviaInfotrieve] 44. 

Phrase: "919,"

Phrase: "115-121"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 44."
Processing 00000000.tx.524: Bard, F., Cannon, C., Barbour, R., Burke, R. 

Phrase: "Bard,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Cannon,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Barbour,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Burke"

Phrase: ","

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.525: L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., Kholodenko, D., Lee, M., Lieberburg, I., Motter, R., Nguyen, M., Soriano, F., Vasquez, N., Weiss, K., Welch, B., Seubert, P., Schenk, D., and Yednock, T. 

Phrase: "L., Games,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0150593:games [Daily or Recreational Activity]

Phrase: "D."

Phrase: ","

Phrase: "Grajeda,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Guido,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hu,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Huang,"

Phrase: "J.,"

Phrase: "Johnson-Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0043217:Wood [Substance]
   805 E C0144237:Sylvan [Organic Chemical]
   777 E C0442548:Woods [Geographic Area]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Khan,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kholodenko,"

Phrase: "D."

Phrase: ","

Phrase: "Lee,"

Phrase: "M."

Phrase: ","

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Motter,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Nguyen,"

Phrase: "M."

Phrase: ","

Phrase: "Soriano,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Vasquez,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Weiss,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Welch"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043114:Welsh [Population Group]

Phrase: ","

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Schenk,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Yednock,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.526: (2000) Nat. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.527: Med. 

Phrase: "Med."
Processing 00000000.tx.528: 6, 916-919[CrossRef][Medline] [OrderarticleviaInfotrieve] Copyright  2002 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "6,"

Phrase: "916-919"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Copyright  2002 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

